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ABSTRACT
DEVELOPING AND OPTIMIZING CONDITIONS FOR 
SINGLE CELL GENETIC ANALYSIS
Susan Adele Gitlin 
May 2005 
Director: Dr. Diane M. Duffy
Preimplantation Genetic Diagnosis (PGD) allows for couples to obtain 
genetic information at the embryo stage, therefore preventing lethal genetic 
diseases in their offspring. A recent multi-center study determined a 17% 
amplification failure rate overall and a 3.4% misdiagnosis rate (ESHRE PGD 
consortium steering committee, 2002). Experiments presented here were 
conducted to decrease those rates by optimizing single cell sensitivity and 
specificity of PGD techniques. Primer extension preamplification (PEP) was used 
after initial amplification failure, followed by gene specific PCR. Reamplification 
experiments yielded 54% amplification rates using blastomeres that previously 
failed amplification. In the clinical trial, four of six blastomeres were diagnosed 
that had previous amplification failure. PEP and subsequent PCR testing is a 
useful means to diagnose samples that previously failed amplification. Different 
lysis buffers/techniques were used to determine the amplification efficiencies of 
heterozygous single cells (n=100/group). Amplification rates were 38% using 
Liquid Nitrogen, 97% using Potassium hydroxide/dithiothreitol (KOH), 41% by 
boiling, and 85% for water. Allele drop-out was minimal in the KOH group, but 
was high in the water group. KOH lysis is superior in both sensitivity and 
specificity to other lysis methods tested. Nuclear and cytoplasmic morphology of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
biopsied blastomeres was evaluated and correlated with subsequent PCR 
amplification efficiencies. Cells with a visible nucleus had 100% amplification 
versus 36% in cells that did not, regardless of the cytoplasmic integrity. Nuclear 
evaluation studies demonstrate the importance of determining nuclear integrity of 
biopsied cells. Multiple displacement amplification (MDA) was used to generate 
sufficient DNA for eventual use in array comparative genomic hybridization 
(CGH) to determine chromosome complement. Sporadic MDA results occurred 
at the single cell level; larger cell quantities consistently amplified. MDA can 
generate sufficient quantities of DNA for array CGH. Preliminary results show 
promise; further optimization will be required to ascertain the use of array CGH. 
These studies provide optimization of single cell sensitivity/specificity and lay the 
foundation for further studies in single cell diagnosis. It is anticipated that an 
entire array of gene defects and chromosomal conditions can be diagnosed by 
PGD in the future prevention of severe human disease.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Preimplantation genetic diagnosis (PGD) is an accepted option for couples 
at risk of passing inherited diseases on to their offspring. The ability to analyze 
specific genetic information from a single cell removed from the developing embryo 
now allows many at-risk parents to decide the clinical outcome of the embryos that 
they have produced through the in vitro fertilization process. In such cases, only 
those embryos shown not to have the genetic pre-disposition for the studied 
condition are transferred to the uterus in the hope of initiating a pregnancy.
Prior to the advent of PGD, couples had several options to minimize the risk 
of having an affected child: not initiating a pregnancy, using donor gametes, or 
adoption. However, none of these options result in a biological child, which is 
fundamentally important for some people. The alternative for many at-risk couples 
is to initiate a pregnancy naturally and elected to have prenatal testing. This 
implies that these couples might be faced with the decision of whether to continue 
or terminate the pregnancy if tests indicated that their child could be born with a 
devastating genetic disease. For other couples, pregnancy termination is not a 
morally acceptable option, even if the likelihood of a medical condition is involved.
Those couples that accepted termination as an option were confronted with 
other factors when trying to conceive again. It became difficult for many to bond 
with the subsequent pregnancy during those initial prenatal months before 
chorionic villus sampling or amniocentesis could determine the genetic or 
chromosomal status of the fetus. This left them with many psychological issues to 
deal with: not knowing if their child would be healthy so that the pregnancy 
continued to term, not sharing the joy of pregnancy with family and friends until 
after prenatal testing, wondering how many times would they gamble with the roll 
of the genetic dice, even when the odds were in their favor (Pergament, 1991). For 
these couples, PGD offers a safe option to have genetic information about their 
offspring earlier in the process, prior to establishing a pregnancy.
The journal, Human Reproduction, was used as a model for this dissertation.
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Hundreds of healthy children have now been born as a result of PGD 
(Verlinsky et al., 2004). Beginning in 2004, the American Medical Association’s 
CRT (current procedural terminology) codebook lists procedural coding for the 
PGD process. Having CRT codes listed generally sets the standard that a 
procedure is no longer considered experimental in nature. That being said, multiple 
aspects of the PGD process continue to be evaluated for safety and efficacy.
Counseling and the informed consent process for patients undergoing PGD 
focuses on the following aspects of the procedure:
1) The safety of the embryo biopsy procedure. This concern has been previously 
addressed by other studies both in our institution and elsewhere (Takeuchi et al., 
1992; Hardy and Handyside, 1992; ESHRE PGD Consortium Steering Committee,
2002). Those studies support the findings that the embryo survives the biopsy 
procedure over 98% of the time and that embryo biopsy does not harm the further 
cleavage of the embryo in the majority of cases.
2) The sensitivity of single cell analysis. This includes discussion on PCR 
amplification rates; there is a chance of an incorrect diagnosis or a chance of no 
amplification, and thus, no diagnosis.
3) The specificity of single cell analysis. This includes discussion relating to the risk 
of allele dropout and contamination of the results by extraneous DNA that could 
interfere with the ability to obtain the correct genetic answer.
The latter two aspects are the main focuses of the studies undertaken here. In 
addition, studies were initiated to examine the application of the emerging 
technologies of microarray analysis for PGD. In the future, these technologies 
could provide more couples the opportunity to have a healthy child.




The ability to perform PGD emerged as biotechnology advanced in the later 
part of the 1980's and into the 1990's. The two main components of PGD, embryo 
biopsy and genetic analysis, are explained further below.
2.1 Embryo Biopsy
Micromanipulation and embryo biopsy were first reported using laboratory 
animals (Nicholas and Hall, 1942; Tarkowski, 1959, Tarkowski and Wroblewska, 
1967). These investigators studied early embryo development after removal of 
one or more blastomeres. The technique involved the use of a dissecting 
microscope to visualize the manipulated cell that was being held in place by 
suction applied to a mouth pipette. Two glass slides were placed at right angles 
to provide resistance; a glass needle was attached to those pieces and used to 
pierce the zona pellucida. These methodologies seem primitive when compared 
to today's technologies, which are listed in the Methods section of this 
dissertation.
There are three stages at which biopsy for PGD can be performed (De 
Vos and Van Steirtegham, 2001):
1) Polar Body Biopsy. The first polar body (PBI) of the unfertilized oocyte or the 
first and second polar body (PBII) of the newly fertilized oocyte is one option for 
PGD biopsy.
2) Cleavage Stage Embryo Biopsy. A blastomere can be removed from the 
cleavage stage embryo (generally at 6-8 cells 3 days after oocyte retrieval) as 
another option for PGD.
3) Trophectoderm Biopsy. Cells from the trophectoderm (TE) layer of the 
blastocyst (five days after oocyte retrieval) are biopsied as another option for 
PGD.
1) Polar Body Biopsy
Initially, polar body (PB) biopsy of the unfertilized oocyte appeared to be 
favorable for couples that wanted to circumvent the ethical issues of biopsying an
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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embryo (Vertinsky and Kuliev, 1992). Some couples may feel that life begins at 
the moment of fertilization and could have difficulty discarding the fertilized 
embryo, even if affected; these same couples may not feel uncomfortable with 
discarding a potentially affected unfertilized egg. However, the moral issue of 
testing the unfertilized oocyte no longer held true when it was realized that the 
oocyte should be inseminated before the PGD result was available in order to 
avoid in vitro aging of the oocyte. In addition, many centers that perform FBI 
biopsy now sample the PBII as well. The rationale for testing the PBII was to 
improve the accuracy of the genetic diagnosis. The moral objection was then not 
circumvented since the oocyte was inseminated and fertilization would have 
occurred at the time of testing (Gitlin et al, 2003).
The polar bodies are extracellular material and appear to have no function 
in embryo development. Removal of the PBI does not appear to interfere with 
fertilization or subsequent cleavage (Vertinsky and Kuliev, 1992). Lastly, an 
advantage of PB biopsy is the ability to obtain the genetic information earlier in 
the IVF culture process (Wells et al., 2002). Newer technologies such as 
comparative genomic hybridization (CGH) or DNA microarrays require a whole 
genome amplification (WGA) step in order to have sufficient quantities of DNA 
template for testing. Most WGA methods take 8-10 hours to perform, in addition 
to the time required for the CGH or microarray process. The testing window from 
PB sampling to blastocyst is 4-6 days as compared to 2-3 days when biopsying a 
6-8 cell embryo, thus allowing more time for these other techniques. The timing is 
important for clinical applications when the embryo must be transferred to the 
uterus within the day 5-6 (after oocyte retrieval) window of implantation (Bergh 
and Navot, 1992).
The major limitation with PB biopsy is that the genetic material of the PBI 
and PBII only reflects the maternal contribution to the subsequent embryo; the 
paternal genetic contribution remains unknown (De Vos and Van Steirteghem, 
2001). PB biopsy was initially used for screening the maternal contribution to 
single gene defects. PB biopsy cannot be used for gender selection in the case 
of X-linked diseases, conditions that constitute a paternally-inherited dominant
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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disease, or for the diagnosis of conditions where only the paternal mutation is 
known. Embryos resulting from oocytes that were diagnosed with an affected 
female allele would not be transferred, thus reducing the number of embryos 
eligible for transfer. In most autosomal recessive diseases, oocytes reported to 
have the mutation still have a 50% chance of resulting in a phenotypically normal 
embryo, depending upon the subsequent paternal contribution (Gitlin et al.,
2003). For most patients undergoing a PGD cycle, the more embryos available 
for transfer results in a higher chance of conceiving (Vandervost et al., 1998).
Eighty-five percent of chromosomal abnormalities are attributed to 
maternal origin (Hassold and Chiu, 1985). Therefore, PB biopsy with subsequent 
PGD has the potential to detect the vast majority of chromosomal errors. 
However, it is interesting to note that in 75% of Turner syndrome patients (XO), 
the lone X is maternal in origin (Hassold et al., 1988). Thus, even though the 
overall majority of aneuploidy causes are attributed to maternal nondisjunction, 
the majority of XO cases are from sperm missing the sex chromosome by either 
paternal meiotic non-disjunction or anaphase lag. This demonstrates another 
disadvantage of polar body testing in its ability to detect the majority of sex 
chromosome aneuploidies (Gitlin et al., 2003).
One of the most comprehensive reports of PB testing for single gene 
defects was described by Rechitsky et al. (2001). Over 1000 oocytes were tested 
for single gene defects and linked polymorphic markers by using PCR. Two 
hundred thirty seven unaffected oocytes were identified for potential transfer in 
114 couples resulting in 34 pregnancies and the birth of 23 healthy children with 
no misdiagnoses. These studies demonstrate the successful application of PB 
testing for at-risk couples to have healthy children.
2) Cleavage Stage Biopsy (Figure 1)
The majority of embryos biopsied for PGD are at the cleavage stage, 
generally consisting of six to eight cells after three days of embryo culture 
(ESHRE PGD consortium steering committee, 2002). The biopsy of embryos 
consisting of less than six cells appears to decrease the developmental potential 
of the embryo in several animal model studies. Krzyminska et al. (1990)





Figure 1. Cleavage stage embryo biopsy. Panel 1A demonstrates the biopsy of 
a cleavage stage embryo with at least 7 cells visible. The aspiration pipette to 
the right has an inner diameter of 40 microns. The biopsied blastomere is shown 
after removal from the embryo (Panel 1B). Note the visible nucleus in the center 
of the cell.
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biopsied mouse embryos at the four-cell, eight-cell, and morula stage. Embryo 
biopsy at the eight-cell stage did not reduce the blastulation rate (95% versus 
99% for controls), nor the implantation rate (biopsy 82% versus 87% for 
controls). However, at the four-cell stage, the subsequent blastulation rate fell to 
76% and the implantation rate decreased to 44%. The authors concluded that 
embryo biopsy at the 8-cell or greater appeared to be more successful by not 
affecting the subsequent blastulation and implantation rates.
Since embryo biopsy involves the random selection and removal of one to 
two cells, totipotency and polarity of blastomeres are important considerations to 
study. At this early stage, the embryo is still totipotent, that is, each individual 
cell (blastomere) has the theoretical potential to develop into a healthy offspring 
(Ziomek et al., 1982). This hypothesis was tested experimentally when Rossant 
(1976) separated each blastomere from mouse four to eight cell embryos. Each 
individual cell was inserted into an empty zona and returned to the oviduct. 
Embryonic development arrested at 5.5 days; the authors suggested that this 
was due to a reduction in the total number of cells at the time of embryo 
cavitation. One study provided evidence of the totipotency at an earlier stage in 
4-cell cattle embryos (Johnson et al., 1995). Individual blastomeres were isolated 
and inserted into emptied zona pellucida, then cultured to the blastocyst stage. 
Two embryos each were transferred into recipient cows, resulting in the birth of 
two sets of identical twin calves, all genetically from the same 4-cell embryo. 
Although this study demonstrated the early totipotency of bovine embryos, no 
additional studies in the literature have been reported.
To determine the existence of polarity in blastomeres in early human 
cleavage stage embryos, Mottla et al. (1995) injected a fluorescent lineage tracer 
(Texas Red-lysine-dextran) into individual blastomeres of human two- to eight­
cell embryos. The embryos were then cultured to the blastocyst stage at which 
time they were fixed and examined using confocal microscopy to identify the 
location of the tracer. In successfully injected embryos that developed to 
expanded blastocysts, randomly injected blastomeres formed both TE and an 
inner cell mass (ICM); however, more labeled cells were found in TE than in ICM.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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These results suggested that early blastomeres are not yet committed to 
specifically become either TE or ICM.
An interesting study by Gueth-Hallonet and Maro (1992) involving eight­
cell mouse embryos demonstrated that blastomere organization changing from 
symmetrical to polarized led to the two different cell lineages -  one giving rise to 
the TE (generally the cells on the perimeter) and the other giving rise to the ICM 
(generally the cells on the inside of the embryo that do not border the inside of 
the zona pellucida). However, blastomeres may behave differently in an intact 
versus a disrupted embryo. The cell fate may be determined by positioning of the 
cell in the embryo; however, it is not irreversibly fixed. The researchers found that 
the inside cells which do not normally contribute to TE could become totipotent if 
the integrity of the embryo was disturbed. This provided the embryo with a 
degree of positional flexibility that may play an important role to compensate for 
damage or loss of blastomeres. In a different study (Ciemerych et al., 2000), 8- 
cell mouse embryos were injected with a fluorescent protein and similarly, cells 
were traced through blastocyst development. Their findings concurred with the 
results of Gueth-Hallonet and Maro (1992) that polarity exists, but is not 
irreversibly established.
Other investigators have studied polarity as well (Edwards and Beard, 
1997). However, the majority of the research was conducted using animal 
models such as the mouse and rabbit while little work exists with human 
embryos. Due to difference in the timing of embryonic genome activation (post 
first cleavage in the mouse compared with post third cleavage in the human, 
Braude et al., 1988, Heikinheimo et al., 1995), it is difficult to discern if evidence 
of polarity by the second cleavage stage can be extrapolated to the human. One 
such study provides evidence of early polarity by the measurement and tracing of 
two proteins, leptin and Stat3, throughout the oocyte and cleavage to the 
blastocyst stage in both mice and human (Antczak and Van Blerkom, 1997). 
Higher concentrations of both proteins were seen in the outer most cells of the 
embryo and in the TE as opposed to the ICM. Presence of these proteins in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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intact ovarian follicles suggest that these proteins may be maternally derived and 
have a role in embryo development and the establishment of polarity.
The viability of human cleavage stage embryos after biopsy was assessed 
in several different studies. Hardy et al. (1990) examined the effects of the 
removal of 1, 2, or 3 cells from an eight-cell human embryo. Additionally, nuclei 
from the ICM and TE were differentially labeled and counted to assess the 
allocation of cell number. Their studies concluded that removal of two of the eight 
cells did not affect subsequent blastocyst development. The ratio of ICM:TE cells 
also was not altered even though there was a reduction in the actual total 
numbers of cells. Uptake of pyruvate and glucose were also measured in 
droplets of spent culture medium to assess metabolism in the aforementioned 
studies (pyruvate is an end-product of metabolism in glycolysis). Even though 
uptake was reduced in 7/8 embryos and 6/8 biopsied embryos (i.e., 7 of 8 cells 
and 6 of 8 cells remaining when one and two cells were removed, respectively), 
this was interpreted to be due to the reduction of cellular mass resulting from the 
decreased cell number (Hardy and Handyside, 1992). Development to the 
blastocyst stage did not appear to be adversely affected by the cell removal.
Tarin et al. (1992) conducted a similar study, removing one quarter of the cells 
from human four to eight-cell embryos. Pyruvate uptake and cell number were 
measured at the blastocyst stage. The authors concluded that there was no 
significant difference in the number of embryos that reached the blastocyst stage 
as compared to non-biopsied controls. As expected, the total number of cells and 
the pyruvate uptake were markedly reduced.
From these studies, it is concluded that cleavage stage embryo biopsy 
can be performed without adversely affecting subsequent embryo development.
3) Trophectoderm biopsy
TE biopsy is another option for embryo biopsy (although rarely used in 
PGD). Initial work in animal models demonstrated that biopsied blastocysts could 
implant and lead to pregnancies (sheep, Rowson and Moore, 1966; rabbit, 
Gardner and Edwards, 1968; mice, Gardner and Johnson, 1972; Monk et al., 
1988; cattle Betteridge et al., 1981; marmosets Summers et al., 1988). The
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greatest advantages of biopsying at the blastocyst stage are that more cells are 
available, and that the TE is extraembryonic material (Dokras et a I., 1990). TE 
biopsy may also circumvent ethical issues that a couple may have as only 
extraembryonic cells are being removed, and the ICM cells that become the fetus 
remain intact.
There is limited knowledge on how the TE represents the genetic 
constituency of the remaining embryo cells. There is evidence to suggest that the 
TE may contain cells that are tetraploid or mosaic from the inner cell mass (it is 
known that there are multinucleated trophectoderm cells); the genetic make-up of 
these cells might not reflect the true genetic constituency of the eventual fetus 
(Everett and West, 1996).
One of the major disadvantages of blastocyst biopsy relates to the timing 
of the procedure. Blastocyst formation occurs approximately five days after 
fertilization. Although there appears to be no difference in pregnancy rates in 
studies of day 5 versus day 6 embryo transfers (de los Santos et al., 2003), there 
are logistical issues that must be overcome: will the PGD results be available by 
day 6? If the blastocysts hatch, are they more difficult to transfer? 
Cryopreservation of the embryos could be considered as an option although 
there are limited studies with cryopreserved biopsied blastocysts, and the 
subsequent success rates of survival and implantation are also not known. One 
anecdotal report described an 80% survival rate with 46 frozen 
morula/blastocysts; 35 embryos were transferred and 10 implanted for an 
implantation rate of 28.6% (L Veeck-Gosden, personal communication). Many 
centers have reported only limited survival at the time of thawing of 
cryopreserved cleavage stage biopsied embryos (9%, Magli et al., 1999; 15%, 
Joris et al., 1999). Jericho et al. (2003) modified their standard propanediol 
cryopreservation protocol by elevating sucrose (0.2M) and serum concentrations 
(20% volume:volume), resulting in a 75% survival rate in 185 frozen/thawed 
cryopreserved embryos. These results demonstrate promising use of 
cryopreservation of biopsied embryos in PGD cycles that may allow for greater
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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flexibility of timing of the embryo transfer during the 5-6 day window of 
implantation.
2.2 Genetic Analysis
Edwards and Gardner (1967) were among the first to report studies 
attempting to determine the genetics in a preimplantation embryo. These 
researchers determined the sex of rabbit embryos by identifying the sex chromatin 
(Barr body) of the TE from an intact blastocyst. The Barr body, found when more 
than one X chromosome is present, is the highly condensed chromatin of the 
inactive X chromosome. The following year, these researchers described embryo 
biopsy and the ability to excise small pieces of the trophectoderm from a rabbit 
blastocyst (Gardner and Edwards, 1968). Under the microscope, suction was 
applied to a micropipette holding the blastocyst in place. A second pipette was 
placed directly opposite the holding pipette, and suction was applied. This caused 
a small amount of trophectoderm to be isolated; a microscissors was then used to 
excise the extruding trophectoderm mass from the blastocyst. The biopsied 
material was subsequently analyzed by acridine orange staining (a DNA stain) 
under fluorescent microscopy to determine the presence of sex chromatin. The 
presence of sex chromatin in a high proportion of trophoblast nuclei is indicative of 
a female. In those initial studies, 77 embryos were transferred to recipient female 
does. Only 3 of 77 implanted; the only assessment at day 13 gestation that was 
given was that the fetuses appeared normal, and no sex results were listed. The 
low implantation rates were attributed to culture conditions. Embryos were 
obtained by flushing the blastocysts from the uterus, excising a portion of 
trophectoderm cells, and holding the embryos in serum for 1-2 hours while the 
tests were performed. After optimizing the culture conditions, 109 blastocysts were 
transferred to recipient does, of which 80 (73%) implanted. From those, 18 
offspring were bom. All 18 (100%) were correctly sexed at the blastocyst stage. 
Shortly after, changes were made in culture media and culture conditions 
(including allowing time for the blastocysts to re-expand) that demonstrated 
improved implantation rates (Edwards, 1969). Despite the low rates of live
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offspring, this initial animal work laid the foundation for further animal studies along 
with human trials almost twenty years later (Monk et al., 1987).
2.2.1 The Polymerase Chain Reaction
PCR revolutionized biotechnology. The discovery of the PCR technique 
(Mullis et al., 1986; Saiki et al., 1988) allowed for millions of copies of specific 
genetic information to be replicated from a DNA template. By denaturing the 
double-stranded DNA, adding specific synthetic oligonucleotide primers bracketing 
the gene locus of interest, and extending new strands of DNA using a 
thermostable polymerase, millions of copies of the desired sequence can be 
amplified.
The story is well documented of Kary Mullis's late night drive into the 
California mountains where the revelation of the PCR process came to him (Mullis, 
1990). During the three-hour drive, he analyzed and reanalyzed each step of the 
process where he proposed to synthesize millions of copies of DNA from a single 
template. At one point, he stopped on the roadside, drawing out DNA molecules, 
the strands denaturing, the primers hybridization, and the new strand extension 
with DNA polymerase, an enzyme that had been discovered twenty years 
previously (Kornberg et al., 1964). The next several months after that trip led him 
on the scientific journey, first searching the literature that revealed no one else had 
published his idea. Months of laboratory preparation, trial and error with buffer 
concentrations, different temperatures, all the optimization steps discussed below, 
followed. Finally, Mullis selected what he called his favorite kind of experiment', 
one that was run in a single tube and involved a yes/no answer. The answer was 
yes. Yes, segments of DNA could be amplified to produce millions of copies.
The story continues as Science magazine awarded its Molecule of the Year 
in 1989 to the technique of PCR (Guyer and Koshland, 1989). Mullis received the 
Nobel Prize in Chemistry in 1993 for developing the polymerase chain reaction. By 
Mullis's own admission (Mullis, 1990), one of the most crucial keys to success with 
PCR was the introduction of the thermostable polymerase known as Taq (Saiki et 
a I., 1988). The discovery of Thermus aquaticus (Taq), a thermostable bacteria 
from which the polymerase is derived was made by Thomas Brock and Hudson
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Freeze (Brock and Freeze, 1969), two names that are not as recognizable nor 
given as much credit as that of Mullis, but who certainly made a significant 
contribution, nonetheless.
Initially, Brock had the idea to study bacteria in hot springs since at the time, 
thermophilic bacteria were thought to have an upper temperature limit of 55°C with 
the upper limit for life at 63°C (Kempner, 1963). His pursuits involved a study of 
photosynthesis; the hot springs provided a 'steady state' ecosystem that led him to 
Yellowstone National Park. Due to its altitude, the boiling temperature of the 
springs is actually 92°C. Although he did find an upper limit of photosynthetic life at 
70-73°C, he also found bacteria living at higher temperatures. However, it was 
difficult to cultivate organisms from these higher temperatures. His focus turned to 
a spring with the temperature of 73°C. There, T. aquaticus, among other bacteria 
was isolated. Soon after, it was discovered that artificial hot-water systems also 
housed bacteria. Indeed, bacteria can survive boiling water temperatures (Brock, 
1995).
The original name for bacterium Taq had been Caldobacter trichogenes 
after an extensive literature search of thermophilic bacterium (Brock, 1995). Caldo 
is Italian for hot, tricho is the Greek for filaments, which the bacterium formed 
under certain conditions. The name was changed to Thermus Balnearius (heat + 
thermal bath), before Brock decided upon Thermus aquaticus referring to the water 
(aquaticus) where the bacterium grew. Brock mused that scientists might not have 
known the enzyme as Taq polymerase but rather Cat (caldobacter trichogenes) 
polymerase instead.
David Gelfand of Cetus Corporation presented the idea of using the 
thermophilic bacterium as the source for DNA polymerase (Saiki et a/.,1988; Innis,
1988). Similarly, researchers in Cincinnati described a thermostable polymerase 
from T. aquaticus (Chien et al., 1976). Initially, the experiments designed by Mullis 
used the Klenow fragment of Escherichia coli DNA polymerase I as the enzyme to 
catalyze the extension step of the process. However, fresh enzyme had to be 
added to each tube after each denaturation step of each cycle since the E. Coli 
polymerase was not heat stable at the high denaturation temperatures. Also,
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E.Coli polymerases did not appear to synthesize the entire gene segment desired 
(Wickner et al., 1972). At that time, the researchers suggested that the 
temperature range provided a possibility that Taq polymerase could be used for 
gene synthesis. The half-life for Taq polymerase at 92.5°C is 130 minutes, 40 
minutes at 95°C, and 5-6 minutes at 97.5°C (Saiki et al., 1988). The thermo-stable 
Taq could be added at the beginning and did not need to be replenished as the 
E.coli polymerase had.
The substitution of Taq not only simplified the process, it also demonstrated 
improved sensitivity, specificity and increased yields (Suzuki et al., 1972; Taylor et 
al., 1972; Verma et al., 1972). This was partially due to the fact that the Klenow 
fragment was incubated at 37°C while the Taq is incubated around 70°C; the 
increased temperatures increase the specificity. In the initial work by Saiki et al. 
(1988) comparing the two polymerases, samples with the Klenow fragment 
showed non-specific DNA products, assumed to be due to the decreased 
stringency at the lower temperature. At the higher temperature of Taq, the non­
specific priming templates would dissociate, leaving only the complementary 
primer stands annealed. The higher temperature threshold of the Taq made it ideal 
since it may have been possible to melt the secondary and tertiary structure of the 
template at those higher temperatures. The increased yield was observed due to 
the increased efficiency of the Taq polymerase.
A disadvantage of the use of Taq is the misincorporation rate (the rate at 
which the wrong nucleoside is inserted into the DNA strand extension). For Taq, 
the misincorporation rates were calculated to be once every 2 x104 bases while for 
the Klenow fragment the rate was one in every 8 x 105 bases. However, this 
difference was overcome by analyzing many different aliquots of the same sample 
and coming to a consensus of the resulting sequence.
There are three basic steps to PCR (Figure 2):
1) The denaturation of the template DNA
2) The annealing of the oligonucleotide primers
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3) The extension of the new strands aided by the polymerase and dNTPs. The 
strand extension involves the coupling of a dNTP to the free 3'OH group at the 
end of the template. (Tindall and Kunkel, 1988).
1) Denaturation
Prior to the cycling, samples can be heated to 100°C to remove impurities 
in the DNA sample and proteases (Rolfs et al., 1992). For thermocycling 
conditions, one cycle of initial denaturation for three minutes at 95°C is 
performed to separate the double-stranded template. Slightly higher 
temperatures may be need for G-C rich regions due to the stronger triple bonds 
of the G-C. If the denaturation temperature is too low, the partially denatured 
strand will snap back together when slightly cooled and thus the primers could 
not anneal. Subsequent cycles require less time for denaturation since the 
template never completely renatures under themocycling conditions.
2) Primer annealing
The second step of the PCR is the annealing of the complementary 
primers. In the initial cycles of the PCR, the primers act as 'scavengers', 
performing a genomic screening to find their complementary base sequences. 
The probability of the primers annealing is determined by several conditions of 
primer design: annealing temperature, time of reaction, and product 
concentration (Rolfs etal., 1992). Annealing time and temperatures are 
discussed here while the primer design and concentration is discussed in the 
section concerning the components of the PCR.
Annealing time
Annealing time is generally between 20-40 seconds. Longer annealing 
times are needed for low copy initial templates to allow time for the primers to 
find their target.
Annealing Temperature
Higher annealing temperatures increase the stringency of the reaction 
(likelihood of specific hybridization) by minimizing the priming events due to DNA 
secondary structures such as hairpin loops. However, annealing temperatures
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Figure 2. Polymerase Chain Reaction. Double Stranded DNA is denatured. 
The primers anneal to their complementary sequences. Taq polymerase 
binds and extends the new strand of DNA in the 5'-» 3' direction. The two new 
strands of DNA will denature and go through the cycle again.
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that are too high will reduce the chance of annealing occurring (Innis et al.,
1990). Decreasing the annealing temperature lowers the stringency of the 
reaction, but may also increase the likelihood of amplification occurring. The 
stringency is decreased because the primers may bind to partial complementarity 
not involving the 3' end. The highest annealing temperature possible should be 
used to provide the optimum results of sensitivity and specificity.
There are several methods used to calculate the annealing temperature 
as described below. The general rule is to start with an annealing temperature 
that is 5°C lower than the calculated melting temperature, Tm, of the 
oligonucleotide strand (McPherson et al., 1991). The Tm is defined as the 
temperature at which 50% of the oligonucleotide is annealed to its 
complementary DNA strand. There are several formulas to calculate the melting 
temperature.
The Tm calculation by the nearest-neighbor method is based on similarity of a 
random object (temperature) to the object studied (Equation 1; Rychlik et al., 
1990).
AH
Tm= 273.15 + 16.6 log [salt] (1)
(A + aS) + Rln (Ct/4)
Where:
o a H (cal mole-1) is the sum of the nearest-neighbor enthalpy 
changes for hybrid formation (<0).
o A (cal K-1 mole-1) is a constant for helix initiation which is equal to - 
10.8 cal K-1 mole-1 for nonself-complementary sequences and = -
12.4 for self-complementary sequences).
o aS (cal K-1 mole-1) is the sum of the nearest-neighbor entropy 
changes for hybrid formation (<0)
o R is the molar gas constant (1.987 cal K-1 mole-1)
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o Ct is the total molar concentration of strands when oligonucleotides 
are not self-complementary or it is equal to 4 times this 
concentration in the case of self-complementary sequences.
Another method for calculating the melting temperature is shown as Equation 2 
(Sambrook and Russell, 1989).
Tm = 81.5 + 16.6 (log10[J+] + 0.41 (%G+C) -  (600/I) -  0.63 (%FA) (2)
° Where J+ = concentration of monovalent ions 
° L = length of nucleotide 
° FA = formamide
Wu etal., (1991) proposed this calculation for annealing temperature (Equation 
3).
TP = 22 + 1.46 (Ln) (3)
° Where Tp = optimized annealing =/2-5C 
0 Ln= length of oligo
These elaborate formulas have been replaced by the standard method that most
researchers use known as the Wallace formula (Equation 4; Thien and Wallace,
1986). This has become a preferred calculation since the Tm is easily calculated 
and the results serve as a good basis for optimization experiments.
Tm = 2°C(A+T)+4°C(C+G) (4)
The actual annealing temperature used for the reaction can vary by as much as 
12°C due to differences in primer concentration that will favor hybrid formation 
and result in increased melting temperatures (McPherson etal., 1991). Also, the 
Tm will be higher with higher salt concentrations due to the high ionic strength as 
cations stabilize the DNA duplexes.
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3) Extension
Strand extension or elongation at 72°C is optimal for reactions using Taq 
polymerase. As little as 20 seconds may be needed for strands shorter than 500 
base pairs to elongate, while 40 seconds may be enough for strands up to 1.2 
kilobases (kb) (Rolfs et al., 1992). The presence of secondary structures 
increases elongation time. Many PCR protocols call for a final extension of 5-15 
minutes at 72°C after the last PCR cycle to complete extension of all products. 
Theoretically, it appeared to be more efficient to increase the extension time after 
each cycle, giving the new product time to extend before further denaturation (a 
choice employed by our laboratory).
2.2.1.1 The components of the PCR
There are seven essential components of PCR with a discussion of each 
component to follow (McPherson et al., 1991):
1) The template DNA
2) The use of a thermostable polymerase
3) The oligonucleotide primers
4) Deoxynucleotide triphosphates (dNTP’s)
5) Divalent Cations
6) Monovalent Cations
7) Buffer to maintain pH
1) The template DNA
The template DNA can consist of as little as a single copy of the segment of 
interest. The PCR technique was initially designed with large quantities of starting 
template in mind. However, variations of the standard PCR protocols can be used 
to achieve greater sensitivity and specificity even when using a limited number of 
cells down to the level of a single cell as in PGD (Handyside et al., 1989). One of 
the modifications that has enhanced the ability to perform PGD is called nested 
PCR (Oste 1988). Nested PCR uses two primer sets encompassing the target 
locus in two separate rounds of PCR. The second set is designed downstream 
(nested) to the first set. The reasons that nested PCR is advantageous when using 
low amounts of initial DNA template are two-fold:
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20
A) It increases the sensitivity by using two rounds of the amplification 
reaction. PCR is a finite reaction; beyond the threshold of amplification (which is 
achieved as reagents are expended), non-specific priming/DNA amplification is 
seen. By performing approximately 20 cycles of PCR, removing an aliquot of the 
product, then revitalizing the reaction with additional components of the DNA 
master mix, exponential amplification can continue from the new reaction starting 
point.
B) Nested PCR increases the specificity by using two targeted sites on the 
gene for amplification. Using an 18-25 base primer set in one PCR reaction not 
only amplifies the target loci, it also allows for the possibility that another 
homologous sequence in the three billion base pair genome could theoretically 
amplify. In order to minimize the chance of that occurrence, another primer pair 
within the same area of the specific locus is used in a second PCR reaction. This 
substantially decreases the possibility of erroneously amplifying a similar (yet 
unsought) area of the genome since the template for the second reaction 
consists of only the segments amplified in the first reaction.
The utility of nested PCR is demonstrated in Figure 3. The upper photo is 
a gel with samples that were subjected to 50 consecutive cycles of PCR. The 
lower photo is a gel with the same samples, but after the first twenty cycles of 
PCR, a 2pl aliquot was removed and subjected to an additional 30 cycles of 
nested PCR (with the same first primer set). Therefore, both sets of samples 
were subjected to 50 cycles of PCR. Two additional samples showed 
amplification in the nested reaction that would not have otherwise amplified with 
the standard one-step PCR. This gel demonstrates the increased sensitivity seen 
in nested PCR.
2) The use of a thermostable polymerase
As discussed above, the substitution of Taq polymerase from the original
E. coli polymerase was one of the most important keys to the development of 
PCR. One unit of enzyme is classified as the amount of enzyme that will 
catalyze the incorporation of 10nmol of total nucleotide in 30 minutes at 74°C 
(McPherson et al., 1991). Too much enzyme can lead to a decrease in
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Figure 3. The sensitivity and specificity of nested PCR. Upper and lower photos 
of 7% polyacrylamide gel lanes contain the same controls (C), single cell 
samples (S) or negatives (N) along with a DNA marker ladder (M) except that the 
reaction tubes in panel A were exposed to 50 continuous cycles of PCR while the 
reaction tubes in panel B contain an aliquot that was removed after 20 cycles of 
PCR from the corresponding reaction tube. Additional master mix was added and 
those tubes continued for an additional 30 cycles. Both groups had a total of 50 
cycles, but two additional samples amplified in the nested group that did not in 
the non-nested group.
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specificity. When using Taq polymerase, the new DNA strand extends at 35-100 
nucleosides/second at 70-80°C. As mentioned before, the half-life for Taq 
polymerase at 92.5°C is 130 minutes, 40 minutes at 95°C, and 5-6 minutes at 
97.5°C (Saiki et al., 1988).
Processivity of an enzyme is defined as the average numbers of 
nucleotides synthesized before the enzyme dissociates from the template 
(McPherson et al., 1991). Fidelity refers to the frequency of enzyme-induced 
errors. Each error would then be amplified in subsequent PCR reactions. Fidelity 
is determined by the ability of the enzyme to discriminate between the dNTPs 
and select the proper complementary dNTP based on the sequence of the DNA 
template. Fidelity is affected by the balance of the individual dNTP concentration. 
Proofreading selectively removes misincorporated nucleosides at the 3' end of 
the primer. High dNTP concentration reduces proofreading activity (Kunkel, 
1988). Proofreading is also affected by magnesium (Mg2+) concentration, pH, 
secondary structure, and the amount of template available. A->C and T-»C are 
the most common errors (Tindall and Kunkel, 1988). Taq polymerase has no 
proof reading (3'->5'exonuclease) activity. However, those errors will for the 
most part be lost because they do not yield full-length DNA products for further 
amplification (Tindall and Kunkel, 1988).
Pfu polymerase (pyrococcus furiosus) has a twelve-fold higher fidelity than 
Taq polymerase (McPherson et al., 1991). Pfu polymerase has 3' to 5' 
exonuclease activity, which Taq polymerase lacks. The temperature range for its 
use is 72°-78°C. After 1 hour at 95°C, the Pfu polymerase still has 95% of its 
activity. However, it will begin to degrade template DNA in the absence of dNTPs 
so it must be added last to the reaction mix, after the dNTPs have been added. 
Pfu polymerase requires increased Tris concentrations, and decreased 
potassium; the lower salt requires a decrease in annealing temperatures from 
what is used for Tag-driven reactions (the importance of these components are 
discussed further below).
The Stoffel fragment of Taq polymerase is a deletion of the 289 N-terminal 
amino acids of the native Taq (Lawyer et al., 1993). It has approximately 2-times
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the thermostability of Taq polymerase (97.5°C for 20 minutes), but lacks the 
5'-*3' exonuclease activity. It requires a broader range of magnesium ion 
concentrations. As with the other polymerases other than Taq, inconsistent 
amplification results and lack of optimized conditions precluded their use. The 
choice of polymerase is dependent upon the type of amplification reaction along 
with the sensitivity and reproducibility of the reaction.
3) Oligonucleotide Primers
The oligonucleotide primers are complementary base sequences that 
anneal to the specific strand of DNA in order to initiate strand replication (Ehrlich, 
1989, McPherson etal., 1991, Rolfs et al., 1992). They are generally 18-30 
bases in length and are complementary to the DNA sequence of interest. Primers 
are synthesized using an automated DNA synthesizer to direct each letter 
(A,T,C,G) in its appropriate place.
Primer optimization is critical for efficient PCR. The primer sequence 
determines the length of the final PCR product, the annealing temperature, and 
the ultimate yield of the product (McPherson et al., 1991). The primary goal of 
primer design is specificity. There are over 3 billion base pairs of DNA in the 
human genome; a perfect match has to be found in 18-30 bases. Although 
primer design is somewhat empiric, the guidelines discussed below are based on 
thermodynamic and structural principles of the DNA. Following the guidelines 
discussed below does not guarantee success, but disregarding them usually 
leads to failure.
Computer-assisted programs can aid in primer design. These programs 
can show complementarity, potential primer-dimer sites, calculate annealing 
temperatures, and show restriction enzyme sites. An example of primer design 
and the computer assistance is given in Appendix A. The ideal primers contain 
45-55% guanine (G) and cytosine (C) nucleotides due to the more stable triple 
hydrogen bonds of the GC that will enhance the annealing (Figure 4). This also 
sets the annealing temperature around 55-60°C. Run-on bases (a string of the 
same nucleotide) should be avoided; GC stretches can promote non-specific 
annealing while AT stretches make the primer template complex more vulnerable
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to dissociation since the AT double bonds are weaker. This could lower 
amplification efficiency.
Primers should have one of the following - G or C, CG or GC - at the 3' 
end (McPherson et al., 1991). This prevents "breathing" of the 3' ends 
(dissociation) and increases efficiency of priming. The 3' ends of the primer pair 
should not be complementary to each other, otherwise primer dimers will be 
extended preferentially to any other product and decrease the yield of the desired 
product. Primer dimers are so called because of the complex of the 
oligonucleotide with itself or the other primer in the pair, thus forming the dimer.
A primer by itself should also not be self-complementary. This is to avoid having 
the primer fold back on itself to form secondary structures such as hair-pin loops. 
In that instance, less primer would be available for the desired reaction.
Primer concentration is easily determined by ultraviolet (UV) 
spectrophotometry and measuring the optical density at 260nm. One OD is equal 
to approximately 33ug of primer (Rolfs et al., 1992). Optimally the primer 
concentration is related to the length of the amplified product and can be 
calculated as shown in Table I. Generally, it is simpler to dilute the primers to a 
working concentration of 0.1 to 1 pM than it is to calculate the concentration from 
the table. Primer concentrations should be adjusted to as low as possible for 
amplification; higher primer concentrations may promote the formation of primer 
dimers and other non-specific products.
4) Deoxynucleotide Triphosphates (dNTPs)
Concentrations of 200-250mM of each dNTP (dATP, dCTP, dGTP, dTTP) 
are added to the PCR. The lower the dNTP concentration, the lower the error 
rate of the base incorporation (Bebenek and Kunkel, 1990). Higher 
concentrations of the dNTPs can be inhibitory, perhaps by sequestering too 
much of the Mg2+. However, reaction times need to be increased at low dNTP 
concentration to increase synthesis and minimizes error as T-G mismatches 
(Bebenek and Kunkel, 1990). dNTPS should be pyrophosphate-free (which can 
inhibit PCR). The pH of the dNTP solution should be around pH 8.1; the alkalinity
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Figure 4. The components of double stranded DNA. The deoxyribose links 
the bases Adenine (A), Thymine (T), Guanine (G), and Cytosine (C) to the 
sugar-phosphate backbone of the DNA double helix (not shown). The two 
strands are linked together with either two or three hydrogen bonds (H) 
from the complementary bases (AT and GC, respectively).
Reprinted with permission from Essentials of Molecular Biology, third 
edition, Jones and Bartlett Publishers, Sudbury, MA.
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Table 1. Determination of optimal primer concentrations
Incorporated primers per
strand (molar concentration)
Yield of 200 bp 800 bp Incorporated dNTPs
produced fragment fragment absolute molecular
double-stranded concentration/ACT G
fragment irrespective of length
1 p.g/1 OOjul 8 pmol 2 pmol 3.2 nmol
(0.08pM) (0.02pM) (8pM)
3 (j.g/1 OOjLxl 24 pmol 6 pmol 9.6 nmol
(0.24pM) (O.Q6pM) (24pM)
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of the solution helps to protect damage during freeze-thaw process. The signal 
intensity may decrease if the dNTP solution is older than 2 months.
5) Divalent Cations
Mg2+ is used to stabilize the polymerase; the divalent cation influences the 
processivity and Tm of the reaction since oligonucleotides can bind to Mg2+ 
(Eckert and Kunkel, 1990). Mg2+ is the most efficient cation; manganese has 
limited efficiency while calcium is ineffective. Increased fidelity of the reaction can 
be achieved by decreasing Mg2+ concentrations to the total dNTP concentration 
(Eckert and Kunkel 1990). The concentration of free Mg2+ depends upon the 
dNTP concentration and the EDTA concentration which binds stoichiometrically 
to the Mg2+. However, too much EDTA or other chelating agents can sequester 
too much of the Mg2+ and inhibit the reaction. Generally, a good starting
concentration is 1,5mM MgCh although some reactions can require a
2+
concentration as high as 6mM Mg . The optimal concentration must be 
determined for each protocol.
6) Monovalent cations
Potassium chloride (KCI) is a component of the PCR buffer that adds a 
monovalent cation to the reaction (McPherson etal., 1991). KCI concentration 
should be less than 100 mM or it will decrease the polymerase activity. 
Polymerase I actually is insensitive to high salt (Chien etal., 1976).
7) Buffer to maintain pH
Control of the pH is accomplished by using Tris buffer. The pH of the 
reaction should be between 8.3-8.8 at room temperature (McPherson et al.,
1991). Since the extension step and new strand extension occurs at 72°C, the 
elevated temperature will effectively lower the pH to around 7.2 for the reaction. 
Optimal pH increases the polymerase activity and decreases the error rate. An 
increase in one point of the pH can increase the error by 60 fold (Eckert and 
Kunkel, 1990). Incubation of DNA at high temp and low pH can change 
amplification efficiency by inducing DNA damage due to the deamination of 
cytosine to produce uracil, the same as coding for thymine. Also, DNA damage at
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high temperature/low pH can cause spontaneous base release due to increased 
hydrolysis of the N-glycosylic bond. (Lindahl, 1979).
Generally the reagent components (the above components other than the 
template DNA) are mixed together and added as an aliquot together to each 
reaction tube for consistency. This is known as the master mix. The master mix 
and the samples are kept on ice, and the thermal cycler is preheated to the initial 
denaturation temperature for a more efficient amplification. Leaving the reaction 
mixture for 5 minutes at room temperature could have a 1000-fold effect on 
decreasing the amplification (Rolfs etal., 1992).
2.2.1.2 PCR Controls
PCR protocols should include both negative and positive controls.
Negative controls contain all reagents but no template DNA and are designed to 
detect extraneous DNA contamination (Rolfs etal., 1992). Since no starting 
template was added to the reaction, no amplification result should be seen; 
amplification should only be seen in reactions where template DNA was added. If 
amplification is seen in the negative control, the amplification observed in the 
samples may not be valid and may be due to contamination of extraneous DNA 
(contamination control is discussed further in Appendix B). Positive controls 
contain DNA of interest and verify the occurrence of amplification and should 
provide an amplification result. If positive controls do not amplify, possible 
explanations may be that inhibitory activity may be present in the reaction, a 
reagent was not properly added (omitted or at the wrong concentration), or PCR 
conditions may not be optimized. Both positive and negative controls must be 
exposed to the same conditions as the reaction samples, including the 
preparation and extraction steps, so that the sample results can be compared 
with controls for the validity of results.
2.2.1.3 Other types of PCR
A multitude of PCR techniques concurrently exist, still based on the three 
basic steps of denaturation, annealing, and extension. Some of the modifications 
include the following techniques:
1) Hot-start PCR is a method designed to avoid mispriming by keeping the
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master mix components separate from the template prior to denaturation (Chou 
et al., 1992). As the reaction temperature rises to the starting denaturation 
temperature, primers could inadvertently anneal as the temperature passes 
through the annealing temperature range. The Hot-start PCR tube contains a 
wax-barrier that melts when denaturation temperature is reached.
2) Touchdown PCR is the variation of the annealing temperature during 
the reaction itself (Don et al., 1991). The initial annealing temperature is set 
above the calculated annealing temperature. It is decreased by 1°C increments 
every two cycles to below the calculated temperature. This decrease is known as 
the 'touch-down'. These variations in temperature will increase the stringency of 
the reaction and decrease the non-specific priming over the range of 
temperatures. It is used in circumstances with several primers to encompass 
different annealing temperatures, or used to overcome instances when it is 
difficult to identify the optimal annealing temperature.
3) Fluorescent PCR uses fluorescently labeled primers that can be 
detected at a greater sensitivity than conventional PCR primers (Chehab et al., 
1992). The amplified product is detected with the assistance of computer 
software rather than conventional gel electrophoresis.
None of these techniques were used in these experiments, or were tested with 
little improvements in conditions.
2.2.2 Whole Genome Amplification (WGA)
One of the constraints in performing single cell genetic analysis is the 
limited quantity of DNA. A single cell contains approximately 10pg of DNA, which 
can limit the number of diagnostic procedures that can be performed to gather 
information from the cell. To overcome these limitations, whole genome 
amplification techniques such as primer extension preamplification (PEP), 
degenerate oligonucleotide primers (DOP), or multiple displacement amplification 
(MDA) can be applied to increase the amount of DNA (Zhang et al., 1992; Xu et 
al., 1993; Kristjansson et al., 1994). These techniques use primers consisting of 
random nucleotides that have the capability of producing multiple copies of
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segments of the genome. An explanation for several whole genome amplification 
techniques follows.
2.2.2.1 Primer Extension Preamplification (PEP)
PEP is a PCR-based molecular technique that initially was applied to 
spermatozoa to amplify and study several large fragments of DNA (Zhang et al., 
1992). A mixture of 15-base oligonucleotide primers is added, containing random 
combinations of the four nucleotide bases. The primer mixture is theoretically 
composed of 4 15 sequences (415 = approx 1.07 billion). The cell is lysed and the 
primer mixture is added with buffer, dNTPs, and Taq polymerase. The sample is 
then thermocycled for 50 cycles with a slow rise (ramping) of annealing 
temperatures in the second step to encompass several annealings during that 
step. In the initial experiments, Zhang and colleagues (1992) subjected single 
human sperm to PEP, then analyzed each of 18 sperm for 12 different loci in 30 
aliquots by PCR. From these experiments, the researchers concluded that 
approximately 78% of the genome had been copied at least 30 times. Similarly, 
several studies were undertaken to demonstrate the ability of blastomeres to 
amplify multiple loci post-PEP (Xu et al., 1993; Kristjansson et al., 1994).
2.2.22  Degenerate Oligonucleotide Primers (POP)
DOP is another WGA PCR-based technique, which differs from PEP in 
several ways. The primer mix consists of a random hexamer surrounded by a 
known oligonucleotide sequence on either side of the random nucleotides 
(5‘ -  CCGACTCGAGNNNNNNATGTGG- 3', where N is any nucleotide). This 
partial 'degeneracy' is thought to allow for the priming from multiple dispersed 
sites along the genome since the ATGTGG sequence should occur once every 
4630 base pairs (Telenius et al., 1992). Rather than ramping the annealing 
temperature as in PEP, there are two series of steps in the DOP process.
Initially, the annealing temperature is lowered to around 30°C for eight cycles; as 
discussed previously, lower annealing temperatures lower the stringency. This 
allows more random primer binding, including the chance that any of the six 
bases will anneal at the 3' end. The annealing temperature is subsequently 
raised to 60°C for more specific annealing.
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Wells et al. (1999) compared the techniques of DOP and PEP, Ninety one 
percent (228/250 cells) of the genome amplified post PEP while 89% (223/250) 
amplified post-DOP. Furthermore, DOP reactions produced larger quantities of 
DNA than PEP as evidenced by the presence of a DNA smear on a 1 % agarose 
gel. No smear appearance was seen on the gel with the PEP products. 
Unfortunately, the study did not specify the quantitation of DNA in their results 
although they were able to conduct 90 separate PCR amplifications from a single 
cell post DOP. PEP generates approximately 40ng of product while DOP can 
generate 1-6pg (Lasken and Egholm, 2003).
There are a few disadvantages of these WGA techniques. The process is 
relatively easy to set-up, but the amplification process requires approximately 10 
hours. Also the products tended to be less than 500 base pairs which can 
introduce bias. Internal regions of previously amplified product would amplify in 
subsequent cycles so that whole segments of the genome were either under 
represented or not present at all in the final product. This could lead to allele 
drop-out (ADO, the amplification of only one allele of the two alleles present) 
(Paunio etal., 1996; Wells etal., 1999).
2.2.2.3 Multiple Displacement Amplification (MPA)
A newly introduced WGA technique offers great promise as a 
comprehensive technique with minimal bias (Dean et al., 2002). The technique, 
MDA, also known as rolling circle amplification, was first proposed by Lizardi et 
al. (1998). This WGA technique differs from DOP or PEP in that it does not 
require PCR. The technique is isothermal, and amplifications take place entirely 
at 30°C. The method involves strand displacement in that the template is 
amplified over and over again; the polymerase amplifies a new copy as it 
displaces previously synthesized copies. This is in contrast to PCR where the 
polymerase dissociates from the previously made copy and new polymerase 
starts the next strand synthesis (Figure 5).
The key to the MDA technique, just as in the PCR, is the type of 
polymerase used. For MDA, 029 (Phi 29) polymerase is used. 029 DNA 
polymerase (from the bacteriophage of the same name) is highly processive and
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has the ability to incorporate 70,000 nucleotides in a single binding event (Blanco 
et al., 1989.) As the 029 polymerase encounters a synthesized strand of DNA, 
the polymerase displaces the strand, thus inducing single stranded DNA that can 
serve as a template for further primer annealing and strand replication. The 
products generated from an MDA reaction are generally up to 12 kb in length.
The isothermal technique, while eliminating the cycling, avoids sequence- 
dependent events such as differences in G-C content that favor amplification of 
certain regions over others (Lasken and Egholm (2003). The error rate for 029  
is only 1 in 106 to 107 bases (Esteban et al., 1993).
The three primary advantages of MDA are:
1) it is an easy method to perform (and thus can be automated)
2) large quantities of DNA are generated
3) DNA yields are uniform and independent of initial starting material since 
the reaction proceeds until reaching a similar quantity endpoint.
Isothermal amplification in human single lymphocytes (n=5) and 
blastomeres (n=11) has been reported (Handyside et al., 2004; Hellani et al., 
2004). Individual cells were subjected to MDA, and an aliquot of the sample 
post-MDA was then subjected to PCR amplification of 20 different loci. All five 
lymphocytes and 10 of 11 blastomeres demonstrated successful WGA as 
evidenced by either DNA yield and/or PCR amplification (100% and 91%, 
respectively). The lymphocyte aliquots amplified in 92/100 (92%) subsequent 
PCR attempts. However, ADO was detected in 22/70 reaction (31%). The 10 
blastomeres that were successfully amplified by the isothermal technique were 
subjected to subsequent PCR as well. Eight of the ten blastomeres demonstrated 
PCR amplification with an Allele drop-out (ADO) rate of 4/25 reactions (16%) 
(Handyside et al., 2004). Similarly, Hellani et al. (2004) subjected 45 single 
leukocyte cells to the isothermal WGA technique. Successful amplification was 
determined in all 45 cells as evidenced by the presence of a smear on a 1% 
agarose gel. Forty of the cells were subsequently subjected to PCR for a known 
p globin mutation. Thirty-nine of 40 cells amplified by PCR (97.5%). There was 
evidence of ADO in 4/39 cells (10.3%). In the Handyside studies (2004), the yield
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Figure 5. Multiple Displacement Amplification. A. Random hexamer primers 
anneal to the template DNA at multiple sites. B. Phi 29 DNA polymerase initiates 
replication at multiple sites on the denatured DNA simultaneously. C. As 
polymerization proceeds, strand displacement of downstream replicated DNA 
generates new single stranded DNA. D. Additional primers bind to the newly 
synthesized single-stranded DNA. E. Subsequent priming and strand 
displacement produce large quantities of high-molecular weight, double-stranded 
DNA
Reprinted with permission from the GenomiPhi manual, GE Healthcare.
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of DNA after MDA ranged from 42-53pg as assessed by Picogreen analysis. 
Hellani et al. (2004) reported 35± 5pg in their MDA products. From these studies, 
the researchers concluded that these data provide the initial steps to the 
applications of isothermal WGA techniques in single cell genetic analysis.
2.2.3 Microarrav Analysis
Standard microarray analysis involves the simultaneous use of two 
fluorescent dyes, one for the sample of DNA/RNA to be tested, and one for the 
normal control. The sample and control are labeled with the separate dyes, then 
the two are combined and allowed to hybridize to the microarray. The dye 
intensities are compared to determine gene expression or levels of DNA. The 
premise is that the measured spot intensity is proportional to the abundance of 
corresponding gene or message present (Edwards, 2003).
The first microarray paper studied quantitative gene expression in 
Arabidopsis thaliana, a small mustard plant (Schena et al.,1995). The 
technology developed rapidly the following year to included gene expression 
studies in the yeast, mouse and human (Shalon et al, 1996; Schena et al., 1996; 
Lockhart et al., 1996, respectively). To date, microarray technology has now 
been used in over 100 organisms (Stears etal., 2003). The technology can be 
used to determine and monitor the level of thousands of genes simultaneously 
since the DNA or RNA probes are miniaturized onto a small glass or silica slide. 
The principles of DNA and RNA detection are that a complementary probe binds 
or hybridizes to the sequence of interest; in microarray technology the scale has 
changed dramatically in that thousands of sequences can be detected from a 
single array. Generally a two-fold change (increase or decrease) is used as the 
threshold to determine significance. There are three components to microarray 
technology:
1) The array slides containing the target DNA
2) Labeled samples (probes) which that are hybridized to the array
3) A detection system to quantitate the hybridization signal.
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1) The array slides containing the target DNA (Figure 6)
Microarray slides are 'spotted' with DNA oligonucleotides (generally 15-30 
bases) or PCR amplified cDNA sequences (Stears et al., 2003). The short 
oligonucleotide arrays are generally used for SNPs (single nucleotide 
polymorphisms) that require single mismatch discrimination. They can also be 
used for gene expression analysis although the short oligos may lack the single 
gene specificity. cDNAs work well for gene expression analysis. These longer 
sequences (0.2-1.2kb) tend to produce strong signals that are highly specific 
(Heller et al., 1997). Either of these elements is deposited (spotted) onto the 
surface of a glass slide, generally as 0.5-1 OnL droplets with a concentration of 
approximately 500ng/pJ on spots that are 100-150pm in diameter (Wildsmith and 
Elcock, 2001). The spots are generally 200-250pm apart, depending on the type 
of instrument performing the spotting. The spots are cross-linked and dried 
(Sasik et al., 2004). The spots generally are duplicated elsewhere on the slide to 
serve as hybridization controls that can aid in determining reproducibility. 
Additionally, blank spots with no DNA are used as negative controls and can be 
used to detect background fluorescence since they should not exhibit signal.
2) Labeled samples (probes) that are hybridized to the array
In microarray technology, the labeled sample/control is known as the probe. 
The sample is labeled with fluorescent dyes as explained below.
2.2.3.1 Dyes
Fluorescence is defined as the molecular absorption of light energy (photon) and 
its re-emission at another wavelength. Molecules that can both absorb and emit 
light are known as fluorochromes or fluorophores. Fluorescent dyes are used to 
label the sample and control. The advantage that fluorescent dyes have is that 
more than one can be used and detected at a time. The fundamental principle of 
microarray analysis is that there is a presumed relationship between the signal 
intensity and the abundance of a gene transcript or target DNA (Cox et al., 2004). 
Therefore the ratio of the two dyes should be 1:1 in genes that are equally 
expressed (or in DNA present in the same amount). Furthermore, the signals


















Figure 6. Illustration of microarray slide. The microarrays used in these 
experiments contained 4 grid columns and 8 rows, each grid with 12 columns 
and 10 rows. The grid rows begin 1.75 cm from the non-labeled end of the slide.
Reprinted with permission from University Health Network, Microarray Canada.
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should be tightly distributed along a linear regression line. Higher signal correlation 
between the two dyes provides more confidence in detecting smaller changes in 
expression levels and allows for greater resolution of the difference between 
sample and control. The labeling step is critical and can be the primary cause for 
lack of reproducibility of results (Wildsmith etal., 2001).
Cyanine dyes, Cy3™ and Cy5™ dyes (Amersham Biosciences,
Piscataway, NJ) are commonly used in microarray analysis (Schena et al., 1995). 
They are water-soluble and pH insensitive (Wildsmith et al., 2001). These dyes 
are incorporated by labeling a dCTP with the Cy dye, then incorporating the dye 
with a random labeling method. In this method, the Klenow fragment of DNA 
polymerase incorporates the fluorescently labeled nucleotide in a DNA synthesis 
reaction, which is primed with random hexamer primers. This method is 
a practical solution for genomic microarrays although enzymatic reactions do not 
copy all nucleic acid sequences (Microarray Handbook, 2004)
Alexa Fluor dyes (Alexa 555 and Alexa 647) have emerged as an 
alternative to the Cy dyes. Alexa Fluor 555 and Cy3™ are structurally distinct 
dyes that have similar absorption and emission spectra. Their maximum 
absorption peak is at 550nm and their maximum emission peak is at 570nm.
Alexa Fluor 647 and Cy5™ dyes are also structurally distinct dyes that have 
similar absorption and emission data. Both have a maximum absorption peak at 
650nm and maximum emission at 670nm.
The Alexa Fluors are water-soluble dyes as well; this is advantageous 
since nucleic acids that are labeled with Alexa Fluors will not precipitate even in 
high salt concentrations of hybridizations. They are pH sensitive to the range of 
4.0-10.0 (Wildsmith et al., 2001). They are more resistant to quenching (or 
photobleaching) than the Cy dyes (Berlier et al., 2003). (Quenching is defined as 
the diminishing or extinguishing of signal intensity due to intense light exposure). 
The dyes directly label the nucleic acids without using enzymatic incorporation as 
the Cy dyes require. This technique is rapid and efficient and provides a reliable 
method for labeling DNA. The reagents react with the N7 of the guanine residue 
of the DNA, averaging one dye molecule every 20-30 bases (Figure 7). This is
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Figure 7. The Alexa Fluor dyes. The Alexa Fluor label reacts with the N-7 
position of guanine residue to provide a complex between the nucleotide and the 
fluorochrome. Reprinted with permission/copyright owned by Molecular Probes, 
Inc.
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much more efficient labeling and showed higher fluorescent intensity than did the 
Cy dyes. A base:dye ratio can be calculated to determine how well the sample is 
labeled to ensure that there will be adequate signal prior to array hybridization. A 
desired level is a base:dye ratio of less than 25. The absorbance (A) at 260nm is 
measured by UV spectrophotometry and the ratio is calculated (Equation 5).
base:dye = (Abase *  2dye) / (Adye *  EbaSe) (5)
where A base = A26o - (Adye *  CF26o)
A26o is the absorbance of the dye/nucleic acid conjugate 
CF26o is the correction factor listed in the product information sheet 
I dye is the extinction coefficient for the fluorescent dye (found on the 
product information sheet)
ZbaSe is the average extinction coefficient for a base in double 
stranded DNA (dsDNA) or single-stranded DNA (ssDNA) (found in 
the information sheet), (from Molecular Probes product Information 
guide, 2004).
Cox et al., (2004) demonstrated that the brightness of the Alexa Fluor dyes 
showed a linear increase as the amount of dye labeling increased. In contrast, 
the Cy dyes showed a decrease in brightness as the amount of labeling 
increased. They concluded that the Cy dyes could be affected by dye-dye 
interaction that may be responsible for the increased quenching seen with the Cy 
dyes. From this, the researchers determined that an increased sensitivity may be 
obtained when using the Alex Fluor dyes, allowing a 95% predictive value to 
ascertain a difference at 1.3 fold level rather than the standard two-fold level 
difference.
Dye-Swap normalization can be used to avoid artifacts (Rosenzweig et al., 
2004). This involves performing the experiment first with one dye for an aliquot of 
sample and the other dye in the set for a second aliquot of the same sample to
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determine the variability in dye intensity since the ratio in the same sample 
should be 1:1. Alternatively, the sample can be labeled with one dye and the 
control labeled with another, then a second experiment performed with the 
opposite dye for the sample and the opposite for the control. For example, 
initially the control can be labeled with Cy3™ and the sample with Cy5 ™. 
Another experiment 'swaps' the dyes and now the control is labeled with Cy5 ™ 
and the sample with Cy3 ™. These results are then compared to the results when 
the dyes are reversed and the bias is determined.
2.2.3.2 Hybridization time and temperature
The time and temperature of the hybridization are dependent upon the salt 
concentration of the hybridization buffer (Wildsmith and Elcock, 2001). Ideally a 
hybridization buffer contains the following components:
1) A buffering component that acts to stabilize variations in pH
2) A detergent that lowers the surface tension and allow the buffer to flow easily 
under the coverslip
3) Compounds such as formamide that act as rate enhancers, volume excluders, 
or to speed up the hybridization and lower the Tm
Formamide is a denaturing reagent that is often used to lower the Tm of 
the probe and thus the temperature of hybridization. The optimum hybridization 
temperature for microarrays in aqueous buffers can be as high as 65-75 °C. At 
such high temperatures, drying of the slide can become problematic. Likewise, 
the probe is more likely to degrade at higher temperatures. The addition of 
formamide to a buffer decreases the Tm by 0.65 °C for every 1 % concentration 
(Casey and Davidson, 1977). The addition of 50% formamide to the hybridization 
lowers the optimum temperature to a more reasonable 42 °C. However, 
hybridizations carried out in formamide should be left undisturbed for 16 hours 
unless the probe concentration is increased. Hybridization temperatures can be 
calculated as 20-25° C less than the melting temperature using the Tm calculation 
as previously discussed from Sambrook and Russell (1989):
Tm = 81.5 + 16.6 (log10[J+] + 0.41 (%G+C) -  (600/I) -  0.63 (%FA).
Where J+ = concentration of monovalent ions
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
41
L = length of nucleotide 
FA = formamide
Hybridizations generally take place for the allotted time in a hybridization 
chamber submerged in a water bath.
2.2.3.3 Post hybridization washes
After the hybridization time has elapsed, the microarray is exposed to a 
series of post-hybridization washes. The purpose of these washes is to remove 
all unattached and/or loosely bound probe molecules. This prevents false 
positive signals and removes all components of the hybridization buffer, 
preventing background noise that may appear in the form of smearing and/or 
speckles when the image is captured. Likewise, it is important not to remove the 
bound probe. The wash takes place initially under similar salt concentrations and 
temperatures as the hybridization buffer with decreasing concentrations in a 
step-wise manner (Wildsmith and Elcock, 2001). The slides remain light sensitive 
at this stage so the washing steps should be carried out in the dark to minimize 
signal loss due to quenching of the fluorescent dyes. Once the slides have been 
washed, they should immediately be dried by centrifugation to prevent smearing 
that could occur if they were instead air-dried. The slides should then be stored in 
the dark in a desiccator and scanned as soon as possible. After scanning, if it is 
determined that the slides have high background or low stringency, rewashing 
the slide and re-scanning is recommended.
3) A detection system to quantitate the hybridization signal
The detection system used for data analysis involves image acquisition 
and quantification. Image acquisition refers to the scanning of the microarray 
while the quantification pertains to the conversion of the image into numerical 
data stored on a spreadsheet. The array slide is scanned by a laser; the sites 
that are hybridized with the fluorescently labeled DNA will emit light that is 
captured and assessed for intensity (Bednar, 2000). Measuring fluorescent light 
intensity (emitted photons) can be accomplished with any photosensitive device 
such as a photomultiplier tube (PMT) that can be used for low-light intensity.
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This is simply a photoelectric cell with a built-in amplifier. When light of 
sufficient energy hits the photocathode in the PMT, electrons are emitted, and 
the resulting current is amplified. The strength of the current is proportional to the 
intensity of the light detected.
Image acquisition is aided by computer software that can estimate the 
background surrounding a spot and subtract that from the fluorescent signal. 
There are several potential sources of error here: The array spot has a small 
surface area and is therefore representative of a small sample of a background 
that could fluctuate. Also, the signal can 'leak' from the spot, i.e., the signal does 
not remain within the ring of the spot or fills only part of the area. This is a 
frequent cause of expression data seen at low intensity on a scatter plot (Sasik et 
a!., 2004). The image is captured as a TIFF file (tagged image file format) that 
consists of two-dimensional 16 bit images of the array data.
The general requirements for detecting fluorescent signals in microarray 
analysis are:
1) It requires high enough resolution to image a large area (24mm x 
60mm) in a short period of time.
2) At least two fluorescent spectra must be distinguished to 
accommodate differential gene expression experiments using two 
fluorescent dyes.
3) The wide variability of message levels requires an instrument 
with a sensitive fluorescent detection threshold to allow detection of rare 
messages while also allowing wide linear dynamic range to measure the more 
abundant messages.
4) The entire area of the microarray must be scanned uniformly to 
ensure reproducibility (The Microarray Handbook, 2004).
To determine the reliability of data obtained from microarrays, both inter­
assay and intra-assay variation have been calculated. Standard variation on the 
same microarray can exhibit a 5-10% variation in signal intensity (a form of intra­
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assay variation). There can be a 10-30% variation evaluating corresponding 
components on different microarrays ('inter-assay' variation, Stears et a I., 2003).
2.2.3.4 Normalization
Normalization is the process of applying a correction to data that are 
generated from non-biological causes. This typically is used to account for 
inherent differences in the intensities of the two different dyes due to their 
differences in fluorescent properties. The purpose is to ensure uniformity and 
reproducibility of microarray data (Edwards, 2003). Without normalization, 
misleading conclusions could be reached. One method of normalization is 
known as lowess or loess, which is an abbreviation for linear regression 
(Cleveland 1979). Lowess utilizes the best local linear fit of scatter plot data to 
detect non-linear points. The application of these methods to oligonucleotide 
arrays reduces the relative error between replicates by 5-10% compared with a 
standard global normalization method (Workman etal., 2002)
The information workflow
Microarray experiments are divided into several phases. The experimental 
design asks the biological question, provides for adequate controls, and 
determines the goals and pitfalls of the experiment. The experimental process is 
based on the target preparation, printing the arrays, probe preparation and 
labeling, hybridization, processing and detection. In order to accomplish these 
first two steps, the Internet can serve as a valuable resource for sequence 
databases, electronic manuscripts, protocols, etc. Next, the data are extracted, 
normalized, quantitated, transformed, then analyzed by scatter plot, expression 
maps, cluster analysis, etc.
2.3 Preimplantation Genetic Diagnosis (PGP)
PGD offers an opportunity to increase the odds of having a healthy child for 
couples at risk of having offspring with genetic diseases and/or chromosomal 
abnormalities. PGD is a combination of two rapidly advancing fields: molecular 
biology and assisted reproductive technology. The polymerase chain reaction 
made it possible to gather genetic information from small amounts of starting DNA. 
Prior to the discovery of PCR, there were no sophisticated methods to be able to
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determine a genetic diagnosis from a single cell within a short turn-around time. 
Southern Blotting techniques and DNA sequencing methods that determine DNA 
location or sequence were too extensive and not applicable to single cell use due 
to limitations in the sensitivity at the single cell level. The Human Genome Project 
provided the ability to know the specific genetic sequences for many devastating 
heritable conditions. Those scientific advances provided major stepping-stones for 
the foundation of diagnosing genetic predispositions in the developing embryo.
The first successful clinical application of PGD was reported by Handyside 
et a i, in 1989. The technology was used initially to identify at risk male embryos 
from carriers of X-linked diseases; in the reported cases, the women carried either 
X-linked ad renoleukodystrophy or X-linked mental retardation. After embryo biopsy 
at the 6-8 cell stage, PCR was applied to target a specific repeat region on the Y 
chromosome in the removed blastomere; no attempt was made to amplify the X 
chromosome since both males and females have the X chromosome. Although 
this first report resulted in successful pregnancies in two couples, soon after there 
were reports of a pregnancy with a PGD misdiagnosis (Hardy and Handyside,
1992). This was the result of attempting to amplify a segment of the Y 
chromosome only. No amplification of the Y-only segment erroneously meant no Y 
chromosome; in actuality, the situation was that there was no PCR amplification in 
that particular cell that came from an embryo that truly had a Y chromosome as 
evidenced by the implantation and gestation of a male fetus. Even though the 
controls for that test were normal, the misdiagnosis is indicative of the 
experimental nature of the procedure and indicated that further optimization of 
techniques was required to determine the cause.
Subsequent methods were developed using primers designed to 
simultaneously amplify segments of both the X and Y chromosome to minimize the 
possibility of a misdiagnosis (Strom et a i, 1991). The X chromosome serves as an 
amplification control in that it should be present in all cells, both male (XY) and 
female (XX). In previous methods, the researchers found that the Y-specific 
amplification was only 80% reliable; 20% of known male cells did not yield 
amplification of the Y chromosome. This prompted the development of a technique
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that simultaneously amplified both X and Y sequences by multiplex PCR to reduce 
the possibility of a misdiagnosis due to amplification failure. In multiplex PCR, 
more than one set of primers designed to amplify a different gene locus is added to 
the same reaction since there is not enough template to conduct a separate 
reaction. Trials of 141 single lymphoblasts with known gender showed no errors in 
amplification.
Before and after the reported clinical application of PGD, a multitude of 
studies were undertaken to determine the efficacy of the procedure. Many of the 
initial studies came from work performed at the Jones Institute by my 
predecessors. Takeuchi et a i, (1992) demonstrated the efficiency of embryo 
biopsy in the mouse and monitored the subsequent development to the blastocyst 
stage. More than 80% of biopsied embryos continued development to the 
blastocyst stage in culture. At the same time, Morsy et al., (1992) demonstrated 
highly accurate and reproducible amplification when analyzing several replicates of 
a single lymphoblast for specific gene loci by PCR.
Not only is amplification sensitivity an issue, but accuracy is a concern as 
well. Generally, sources of errors can come from two causes, extraneous DNA 
contamination and ADO, the amplification of only one of the two alleles present.
2.3.1 Contamination control
The risk of introducing extraneous DNA is a constant presence even 
though extraneous DNA contamination has never been a problem in our PGD 
laboratory and has only been seen in isolated instances. A PCR technique that is 
sensitive to the level of a single cell would only require the smallest amount of 
measurable DNA for the original sample to be contaminated. Sources of 
extraneous DNA that could affect the PCR reaction include carryover of previous 
PCR products, sample cross-contamination, DNA present in the laboratory, and 
operator contamination (Kwok and Higuchi, 1989). Several contamination control 
measures are undertaken in the laboratory to minimize this risk. These measures 
are listed in Appendix B.
Since DNA particles or amplicons can be aerosolized, it is difficult to keep 
the laboratory totally DNA-free unless one uses a facility similar to high-level
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containment isolation rooms. For most PGD clinics, those facilities are not 
available, may be cost prohibitive, and are somewhat extreme. One of the 
strongest allies in controlling surface contamination in the laboratory is the use of 
UV light. In a little as five minutes, exposed surfaces can be decontaminated (Ou 
et a/., 1991). In our studies, a significant difference was seen in as little as ten 
minutes although it required 20-30 minutes for complete inhibition of PCR 
amplification (Gitlin and Gibbons, 1995).
UV rays have shorter wavelengths (10-400nm) than visible light (400- 
700nm). Exposure to UV irradiation less than 300nm affects the DNA by 
changing the structure of the template; specifically germicidal lamps emit 254 
nm. (Sarkar and Sommer, 1990). The pyrimidine bases (thymine -  T and 
cytosine -  C) are particularly sensitive to UV exposure. UV light causes the 
formation of dimers -stable bonds between identical molecules or units of 
molecules; in this case, T-T or C-C. Polypyrimidine dimers, T-C, can form as 
well. The formation of these dimers interferes with the subsequent DNA 
replication since the pyrimidine dimer cannot fit into the double helix (Stryer, 
1988). The structure of the initial DNA template has now been altered and 
subsequent replication would be blocked as well since the DNA polymerase 
could not bind.
Successful contamination control using UV light is a function of time and 
distance of the UV light source to the exposed surface (Sarkar and Sommer,
1993). In order to determine the risk in our laboratory, a study was designed to 
place DNA-containing PCR reaction tubes in strategic and functional settings in 
the laboratory, then expose the tubes to ultraviolet light at timed intervals. These 
assessments allowed us to determine the limits of potential contamination control 
measures. UV irradiation was shown to be ineffective for products as small as 
380 base pairs (Belak and Ballagi-Pordany, 1993) although there are little 
concurring data available.
UV irradiation is used to minimize the occurrence of contamination. Most 
reagents used in the PGD laboratory are aliquoted for individual use. After 
preparation and dispensing in microcentrifuge tubes, those aliquots are exposed
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to UV light in the event that inadvertent DNA contamination occurred. The 
exception to UV exposure is the Taq polymerase, the oligonucleotide primers, 
and the dNTP's. Frothingham et a i (1992) studied the effect of UV light to 
decontaminate the components of the PCR master mix. Their study 
demonstrated that a longer UV exposure was required when the dNTPs were in 
the mixture versus when the dNTPs were absent (64 minutes versus 4 minutes, 
respectively). The researchers concluded that the dNTPs had a higher 
absorbance of the UV light that effectively decreased the overall efficiency of the 
PCR decontamination. Another arm of the study determined the sensitivity of the 
polymerase and the primers to the UV light exposure. Mixtures containing the 
primers and polymerase ± the dNTPs were exposed to UV light. DNA sample 
was then added to the UV-exposed tubes and the samples were subjected to 
PCR. Those tubes containing the dNTPS amplified while those tubes without the 
irradiated dNTPS did not amplify. This again reflects a protective mechanism of 
the dNTPs that have absorbed the UV radiation and demonstrates the sensitivity 
of the polymerase and primers to UV light exposure (Frothingham et a i, 1992). 
Similar findings were reported that a mixture of dNTPS and primers was not 
decontaminated after UV irradiation even though a stock of the primers in 
solution by themselves was successfully decontaminated (Ou et a i, 1991)
Additionally, the mineral oil used to overlay the PCR reaction was exposed 
to UV light in our laboratory. Caution is exercised when performing the mineral oil 
irradiation based on a study performed by Dohner et a i, (1995). Those 
researchers determined that an inhibitory effect on PCR amplification could be 
achieved in as little time as 30 minutes with a direct exposure of mineral oil in an 
open container. However, that effect was diminished when the oil was exposed 
through the PCR tubes since the plastic will absorb much of the radiation. The 
reason for this was not ascertained; the authors discussed the possibility of either 
inhibition being due to oxidation of some component in the mineral oil or perhaps 
due to ozone formation as a result of the UV irradiation of oxygen in the air.
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2.3.2 Allele dropout
Of great concern is the occurrence of ADO, defined as the amplification of 
only one of the two alleles present in the PCR reaction (Findlay et a i, 1995; Ray 
and Handyside, 1996; Rechitsky et a i, 1998). In the heterozygous condition, both 
the normal and the abnormal allele are present. If only one of those alleles 
amplifies, a misdiagnosis for that cell (and thus subsequent embryo) can occur. 
Since the homozygous normal and homozygous affected conditions have the two 
copies of the same allele, dropping-out of one of the alleles would not be detected 
by conventional PCR.
The allele drop-out rate was determined when analyzing polar bodies in a 
study of over 1000 oocytes by Rechitsky et a i, (2001). The ADO was 7.8%. ADO 
is one of the greatest concerns for a misdiagnosis in PGD, occurring in the 
heterozygous condition when only one of the two alleles present amplifies. One 
disadvantage of PB testing is crossing over or genetic recombination. Analyzing 
both PBI and PBII in a maternal carrier is a means to avoid undetected ADO. 
Rechitsky et a i, (1998, 2001) documented the possible outcomes when 
performing PGD on polar bodies. The researchers ascertained that the most 
accurate information occurred when PBI was determined to be a heterozygote, 
indicating that crossing-over was detected. Results indicating a heterozygous PBI 
and a normal wild-type PBII infer that the oocyte is carrying the mutant allele; the 
heterozygous PBI has both alleles, and thus the remaining strands in the oocyte 
would too. Therefore, upon strand separation, the chromatid in PBII has the 
opposite result of the chromatid remaining in the oocyte. Conversely, a 
heterozygous PBI and a mutant PBII infers that the oocyte is normal.
Further examination of ADO is in the discussion section for Specific Aim # 
2, which studies the effect on amplification specificity when using different DNA 
lysis techniques.
2.3.3 Aneuploidv Screening -  Assessing chromosome number
From 1923 until 1956, the prevailing opinion was that human cells 
contained 48 chromosomes, based on studies by the geneticist Thomas Painter 
(Painter, 1923). The fundamental discovery that normal human somatic cells
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contained 46 chromosomes arranged in pairs was made in 1956 (Tjio and Levan, 
1956; Ford and Hamerton, 1956). However, those researchers also discovered 
that cells and even entire individuals could have a deviation in chromosome 
number from the normal 46. Soon after, the field of cytogenetics began. The 
oldest technique for enumerating chromosomes (ploidy) and analyzing structural 
defects (aberrations) is karyotyping, developed in the late 1950's. As time and 
technology progressed, the resolution and sensitivity of cytogenetic analysis 
have improved more than 10,000-fold with techniques such as chromosome 
banding, fluorescent in situ hybridization (FISH), comparative genomic 
hybridization (CGH), multifluor FISH (mFISH), spectral karyotype analysis (SKY), 
and array CGH as discussed below.
Ten years after the first use of karyotyping, chromosomal banding 
techniques were applied to detect structural abnormalities; metaphase 
chromosomes were stained with quinacrine mustard to produce patterns of light 
and dark bands (Q-bands) along the chromosome (Caspersson etal,, 1968). 
Similarly, the technique of Giemsa staining was used (G-banding); the dark 
regions tend to be heterochromatic, late-replicating and A-T rich while the bright 
regions tend to be euchromatic, early-replicating and G-C rich (Bosman and 
Schaberg, 1973; Comings etal., 1973).
There are two major limitations of karyotyping: the need for cells to be in 
metaphase and the need for higher resolution to detect smaller aberrations in the 
chromosome structure. This prompted the development of cytogenetic 
techniques such as FISH that did not require metaphase chromosomes, (van 
Prooijen-Knegt etal., 1982). In FISH, fluorescent-labeled probes are designed 
complementary to specific regions along the length of the studied chromosome. 
After probe/sample hybridization, the fluorescent signal can easily be detected by 
microscopy. The technique is limited in that it requires prior knowledge of the 
location of the aberration. Also, FISH is used for only a limited number of 
chromosomes due to the ability to detect only a handful of signals. Initially, only 
three fluorochromes were commercially available to label chromosomes 
(fluoroscein isothiocyanate - FITC, tetramethylrhodamine isothiocyanate - TRITC,
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aminomethylcoumarin - AMCA, respectively emitting in green, red, and blue, 
Nederlof et ai, 1990; Dauwerse et at., 1992). To overcome this limitation, 
combinations of these dyes in distinct ratios allowed for their use in labeling more 
than three chromosomes. Currently, there are two additional fluorochromes 
(totaling five) that can be used for labeling. Cells are initially analyzed with one 
set of five fluorochromes, then can be re-analyzed with a different set of labeled 
probes (Benadiva etal., 1996; Martini etal., 1997; Bahge etal., 2000). The utility 
of FISH in PGD has long been debated. Initial reports had determined that there 
was no difference in the pregnancy or implantation rate, but newer data suggest 
that there is an increase in pregnancy (Werlin et a!., 2003) and implantation rates 
(Munne et al., 2002), especially in patients with more than eight pronuclear 
embryos, and in those with less than 2 failed IVF cycles (Munne et al., 2003)
Conventional CGH can detect and map changes in DNA copy number 
(Kallioniemi etal., 1992; Thompson and Gray, 1993). Sample DNA and normal 
reference DNA are labeled with two different fluorochromes. The sample and 
reference DNA are then hybridized simultaneously to a slide containing normal 
metaphase chromosome spreads. Images of both fluorescent signals are 
captured and a ratio of intensities of the two fluorochromes is measured; regions 
of DNA sequence loss or gain (such as deletions, duplications, or amplifications) 
are detected by the ratios. CGH is limited in that it cannot detect mosaicism, 
balanced chromosomal translocations, inversions or whole genome ploidy 
changes (Kallioniemi et al., 1994). Additionally, CGH applications with limited 
template DNA such as single cell analysis would require a WGA technique as 
previously described since most CGH protocols require at least 200ng of DNA 
(Wells, 2004).
Other techniques such as SKY (McNeil and Ried, 2000) and mFISH have 
overcome these limitations by allowing visualization of the entire chromosome 
(as opposed to regions of the chromosome seen in FISH or changes in copy 
number as seen by CGH). SKY involves the simultaneous hybridization of 24 
differently labeled chromosome-painting probes. After a one to three day 
hybridization, images are visualized under fluorescent microscopy and acquired
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via a CCD camera linked to an imaging system. A single image is used to 
analyze fluorescently labeled chromosomes to produce a full karyotype. M-FISH 
is a technique to label every chromosome, generating a 24-color composite 
image (as opposed to the single image in SKY) that can be computer analyzed 
by the appropriate software to produce a karyotype.
Array CGH uses a combination of comparative genomic hybridization and 
microarray technology to determine variation in DNA copy number or to 
determine chromosome aneuploidy (change in chromosome number). The 
method has the sensitivity to detect single copy changes, deletions and 
duplications in the genome with high precision/resolution (Pinkel etal., 1998, 
Pollack et al., 1999; Yu et al., 2003). This technology has been applied to 
successfully detect aneuploidies in tumor cells (Gray and Collins, 2000; Phillips 
et al., 2001; Wilhelm et al., 2002; Linn et al., 2003). Array CGH was compared 
with FISH in 12 patients with known chromosome deletions. One additional 
deletion was detected by array CGH that had not been detected by FISH, 
demonstrating the higher sensitivity of the array CGH (Daigo et al., 2001).
Array CGH can overcome one of the major limitations of CGH; CGH 
requires metaphase chromosomes for hybridization while array CGH utilizes 
cloned DNA fragments that will allow aberrations to be determined in greater 
detail (Oostlander et al., 2004). As in conventional CGH, the sample and the 
normal reference DNA are labeled with two different fluorochromes. The two are 
then simultaneously hybridized to a glass slide array containing genomic or 
cDNA. As in conventional microarray analysis previously explained, the ratio of 
the dye intensities is compared to determine the DNA copy level. One major 
limitation with array CGH, as in conventional CGH, is its inability to detect 
balanced chromosome translocations since the number of chromosomes is the 
same in the balanced state (Daigo et al., 2001)
2.3.3.1 Cytogenetic techniques applied to human oocytes and blastomeres
Advances in cytogenetic techniques have made their use possible in PGD. 
Less than half of naturally conceived pregnancies reach full-term, with the 
majority of pregnancy losses occurring at the early embryo or shortly after
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implantation stages (Shepard and Fantel, 1979; Byrne et al., 1985). Multiple 
factors may be involved in these losses although chromosomal error is 
considered to be one of the most significant factors. These errors could result in 
altering the regulation of gene expression during the complex process of early 
embryo development and implantation. Determining the chromosomal status of 
oocytes and/or embryos during an IVF cycle may be beneficial for several types 
of patients that are at greater risk for chromosomal abnormalities, including those 
over the age of 35 (Hassold et al., 1980; Warburton, 1980; Munne et al., 1995; 
Dailey et a I., 1996), women with a history of recurrent miscarriages (Pellicer et 
al., 1999), women with a history of repeated IVF failure (Gianaroli et al., 1999), 
and/or couples carrying a known chromosomal structural abnormality (Munne et 
al., 1998a). In addition, detecting chromosome errors may provide insight into the 
frequency of abnormalities during gametogenesis, embryonic development, and 
pregnancy (Wells and Levy, 2003).
FISH is the most common technique utilized for detecting an extra or 
missing copy of select chromosomes in oocytes and embryos (aneuploidy). 
Currently, the standard for chromosome analysis in embryos is to analyze a 
single blastomere for nine chromosomes by FISH using two sets of labeled 
probes (Munne et al., 1998b). These researchers tested for chromosomes 13,15, 
16,17,18, 21, 22, X, and Y which encompass the majority of chromosomal 
errors seen in miscarried tissue or in live born. Approximately 85% of the 
chromosomal abnormalities seen in embryos are detected by 9-color FISH 
(Voullaire et al., 2002). Abdelhadi et al. (2003) performed FISH using probes for 
13 chromosomes using three sets of labeled probes with the aforementioned 
chromosomes as well as a third probe set with chromosomes 2,3,4, and 11. In a 
comparison study of 426 embryos, 181 (42%) were aneuploid for one or more 
chromosomes. These researchers detected 97% of the total chromosomal errors 
utilizing the first two probe sets while only an additional 3% of aneuploidy was 
detected with the third set. From these studies, the researchers concluded that it 
may be more efficient to continue with only the first two probe sets and that the
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additional 3% aneuploidy detection may not be time efficient or cost effective for 
the benefit received.
Other cytogenetics techniques have been applied to oocytes/embryos as 
well. Normally, it is difficult to karyotype the oocyte/embryos since the cell 
number is limited and the cell must be in metaphase. In an attempt to karyotype 
the PBII, Vertinsky and Evsikov (1999) removed 38 PBII from normally fertilized 
zygotes and injected them into individual enucleated oocyte cytoplasm. After 
forming a haploid pronucleus, 25 metaphase spreads (66%) could then be 
karyotyped by whole chromosome painting. Although the researchers concluded 
that this method provided a suitable timetable for chromosome analysis and 
utilized extra embryonic material (PBII), the method has not been widely used. 
This is presumed to be due to the labor and time intensity for a method that 
requires further optimization to achieve greater than 66% success.
Clyde et al. (2001) demonstrated the use of mFISH in the oocyte and PBI. 
Marquez et al. (1998) and Sandalinas et al. (2002) applied SKY to analyze the 
chromosomes from polar bodies. That study analyzed 131 fresh oocytes from 
donors. Of those, only 47 could be used for SKY: of the remaining 84, five were 
not metaphase, 11 had incomplete metaphase, and 68 had overlapping 
chromosomes. Twenty-four of the 47 oocytes used were normal or haploid 
(51.1%), broken down into 64% normal for women under 34 and only 25% 
normal in women over 35 years. These studies demonstrated the use of the 
technologies on human oocytes (polar bodies), however further optimization 
appears to be needed before their practical clinical use.
CGH has been applied to clinical PGD cycles (Voullaire et al., 2002;
Wilton et al., 2003). In the former study, 141 embryos were biopsied and 
analyzed by CGH; 126 (89.3%) had analyzable signals. Seventy-six of 126 
(60%) of the single biopsied blastomeres from 20 women with repeated IVF 
failure were diagnosed as abnormal by CGH. Had those cells been analyzed by 
standard 9-chromosome FISH instead, at least 18 of those 76 abnormal embryos 
(23.7%) would have been diagnosed as normal since the aneuploidy detected by 
CGH was found in a chromosome outside of the standard nine. The researchers
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concluded that by using CGH, additional chromosomal abnormalities were 
diagnosed in this patient population that would not have previously been 
detected by FISH and may thus help explain their repeated IVF failure.
The use of CGH to analyze a single cell is limited since the technique 
generally takes over 72 hours to perform; embryos biopsied on day 3 would need 
to be cryopreserved for transfer in a later cycle since results would not be 
available during the normal implantation window of 5-6 days after egg retrieval.
In a promising study, Wells et al. (2002) demonstrated that full chromosome 
complement information from the PBI could be obtained by CGH. Using an 
accelerated CGH protocol, the time was reduced in half from 60 hours to 30 
hours, enabling embryo transfer on day 4. In that study, 12 oocytes were 
subjected to PBI biopsy. Of the 11 available for analysis, 10 demonstrated CGH 
results, yielding only one normal embryo available for transfer. Where possible, 
results were confirmed by FISH after subsequent single cell embryo biopsy. 
Interestingly, four of the 9 abnormal embryos demonstrated aneuploidy for 
chromosomes 2, 5,14, and 20; these chromosomes are not routinely used in 
FISH analysis. Had only FISH been used for the aneuploidy screen, those 
embryos would have been eligible for transfer. This demonstrated the utility of 
the CGH technique in being able to screen for all chromosomes and detect errors 
that would have otherwise been undiagnosable with the standard technique.
Array CGH to enumerate chromosomes in human single cells has had 
limited use thus far. The first published study obtained single lymphoblast cells 
from normal and trisomic cell lines, then subjected individuals cells to array CGH 
using DOP as the WGA technique (Hu et al., 2004). Fourteen normal male or 
female cells were analyzed with the correct ratio 97% (300/308) of the time for the 
22 autosomes. While 93% (13/14) of the X chromosomes were detected, only 
29% (4/14) of the Y chromosomes were detected. The trisomic cell lines were all 
diagnosed correctly as falling in the correct ratio range of 0.75-1.25 (as previously 
discussed, the ratio of dyes should be 1:1. Here the limits of the ratio were 1.0 
±0.25). The overall time for the entire procedure was 30 hours. In a separate 
study, MDA was used as the WGA prior to array CGH of trisomy 21 single
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lymphocytes (n = 3, Hellani et al., 2004). All three samples demonstrated the 
ability to detect trisomy 21. From these studies, the researchers concluded that 
array CGH could become a feasible option for aneuploidy studies in human 
oocytes/embryos although further optimization is required, especially in the ability 
to detect the Y chromosome.
The studies of this dissertation
The largest collection of PGD data to date is from the ESHRE (European 
Society for Human Reproduction and Embryology) PGD consortium, collating data 
from 25 PGD centers worldwide including our institution (ESHRE PGD consortium 
steering committee, 2002). Even though those data support the usefulness of the 
technology, a few key points need to be discussed. The overall amplification 
efficiency in that report was only 83% for all embryos biopsied (n=14,040). This 
suggests there is much room for improvement of amplification efficiencies. Even 
more compelling is the misdiagnosis rate for PGD cases utilizing the polymerase 
chain reaction as the diagnostic tool. Overall, the misdiagnosis rate was 3.4% for 
the 145 cases reported.
Lewis etal., (2001) reported on a mathematical model designed to aid in 
determining the accuracy of PGD using single cells. It determines that in any 
biological system, variability can occur that can affect clinical decisions. The model 
examines values for the probabilities of amplification occurring, the cell's 
chromosome content, and the probability for contamination occurring. The authors 
state that the major sources of error leading to a misdiagnosis are identifiable.
This dissertation addresses the three main sources of error that Lewis et al. (2001) 
and Navidi and Arnheim (1991) list:
1) analyzing the anucleate cell
2) contamination
3) non-amplification of alleles
Further, the authors suggest that acceptable levels of accuracy and 
contamination be established. They established a decision-making model as part 
of the process to determine which embryos can be transferred and which can be 
discarded, knowing that the assessed genotype has a high probability of stemming
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from an affected embryo. The importance of being able to optimize the conditions 
for genetic analysis while avoiding the sources of error may translate into the 
ability to have more embryos available for transfer. The number of embryos is 
positively correlated with the chance of establishing a successful pregnancy 
(Vandervost et a/.,1998).
This dissertation presents studies that were conducted to optimize the 
conditions involved in the current diagnostic procedure of PGD in addition to 
developing new technologies. These efforts to maximize the amplification 
efficiency while minimizing the events that could lead to a misdiagnosis are part 
of the critical basic science background that lead to the clinical fruition of this 
technology. This continues as part of an ongoing effort to offer other single cell 
diagnostic procedures for clinical application. To that effect, the specific aims of 
these studies are as follows:




Specific Aim # 1
Inadequate sensitivity of the PCR reaction may result in amplification failure 
when starting from a one or two copy DNA template. If DNA is truly present 
in the initial PCR reaction tube yet does not amplify, modification of reaction 
conditions or techniques might subsequently produce sufficient quantities 
of DNA to demonstrate PCR amplification after gel electrophoresis.
Aim: To increase amplification efficiency to ‘rescue’ those cells fail initial PCR 
amplification.
Hypothesis: Whole genome amplification methods (WGA) can be used to 
increase the number of target sites of the initial starting template in attempts to 
increase amplification results.
Experiments: Experiment # 1 will to use a WGA technique consisting of a mixture 
of random primers sequences (in this case, random 15-mers) in PCR cycling 
conditions with dNTPS and Taq polymerase, producing multiple copies of DNA 
sequences in the genome. It is estimated that 78% of the genome is copied at 
least 30 times with the WGA technique, even from a single cell (Zhang et al., 
1992). Having multiple copies of initial starting template can aid in the elimination 
of the variable amplification efficiencies seen when starting with a template from 
one cell.
Experiment #2 will attempt to provide additional genetic information from 
previously PCR-processed DNA by amplification of a different gene in that 
reaction. For example, PGD samples that were previously diagnosed for gender 
determination will be tested for the specific X-linked mutation that is now known. 
The initial starting template is still present in the reaction tube although the 
reaction also contains amplified product, dNTPs, primers, etc. Rather than 
subjecting embryos to another biopsy procedure, this experiment proposes to 
recover the previously PCR'ed reaction tubes, add additional specific primers and 
PCR master mix in an attempt to obtain further genetic information from the 
initially biopsied cell. Outcomes will be measured by successful PCR
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amplification while negative controls will also be tested to ensure that 
contamination has not occurred.
Specific Aim # 2
Allele drop-out (ADO) has been identified as a cause for misdiagnoses in 
PGD cycles (Grifo etal., 1998; ESHRE PGD consortium steering committee, 
2002). ADO is defined as the amplification of only one of the two alleles 
present in a cell.
Aim: To increase the amplification efficiency through optimization of DNA lysis 
conditions and to decrease the incidence of ADO .
Hypothesis: DNA contained in the cell may not be fully accessible by the presently 
used DNA lysis conditions; alternatively, the template may not be fully denatured. 
Consequently, the PCR primers and subsequent polymerase cannot attach to 
amplify that segment of the DNA.
Experiments: In these experiments, individual lymphoblast cells known to be 
heterozygous at specific DNA loci will be used to compare different methods of 
DNA lysis with amplification results, analyzing not only the efficiency of 
amplification (as a percentage), but also the accuracy as determined by the 
presence of both alleles in these known heterozygous cells. Both heterozygote and 
compound heterozygote cells will be used to compare the rates of amplification 
efficiency and ADO. The lysis techniques selected were the most commonly used 
techniques for DNA lysis in single cell analysis (Handyside etal., 1990; Zhang et 
al., 1992; Verlinsky and Kuliev, 1992; Gibbons et al., 1995a; Grifo et al., 1998). 
Specific Aim # 3
After the above Specific Aims are addressed, there remain instances when 
PCR amplification may be limited when using a single blastomere from the 
embryo.
Aim: To identify characteristics of the blastomeres from an embryo before and 
after embryo biopsy that can aid in determining the success of obtaining PCR 
amplification.
Hypothesis: Defining optimal characteristics of the blastomere in an embryo 
before and after biopsy would allow better predictions and determinations of
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obtaining successful amplification results. It is important to be able to choose a 
blastomere to biopsy that has a greater chance of providing a genetic result. 
Experiments: These experiments will identify conditions relating to morphology of 
the removed blastomere and correlate those with amplification efficiencies. The 
following morphological criteria will be assessed by microscopy: the presence or 
absence of the blastomere nucleus (which may relate to the state of the DNA), 
the presence of the cell membrane, the encroachment of the cytoplasm (intact or 
not). These assessments will be compared with PCR amplification results. 
Specific aim # 4
The diagnosis of having missing or extra chromosomes is known as 
aneuploidy. Aneuploidy is common in human embryos studied after in vitro 
fertilization (Munne et al., 1998b). Currently, the state of the art to identify 
chromosomal information in a single cell is limited to primarily using nine- 
color fluorescent in situ hybridization (FISH) for the most common 
chromosome abnormalities in either liveborn or miscarried tissues 
(chromosomes X,Y, 13,15,16,17 18,21, and 22.)
Aim: To identify the chromosomal complement in a single cell.
Hypothesis: Array CGH can be used to study aneuploidy in single cells including 
blastomeres biopsied from human embryos.
Rationale: Array CGH combines the principles of CGH (comparing a normal 
control with the unknown sample labeled in a different color fluorochrome), then 
hybridizing those samples to a microarray. Array CGH has been proposed in the 
field of tumor biology as a reliable method for assessing chromosome number 
(Pollack et at., 2002).
Experiment #1: Initial experiments will address the issue of the limited amount of 
template DNA in a single cell. Generally 5-1 Opg of DNA is needed for adequate 
hybridization of a microarray. To increase the amount of DNA available in a single 
cell, WGA technique known as Multiple Displacement Amplification (MDA) will be 
used (Lage et at., 2003). In an overnight MDA reaction, over 35pg of DNA can be 
produced from the initial starting quantity of 10pg in a single cell to achieve 
quantities adequate for microarray analysis.
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Experiment #2: Once the MDA technique is specific and sensitive for use in a 
single cell, the DNA will be fluorescently labeled and prepared for microarray 
analysis. The experiments proposed here will determine a labeling technique that 
is optimal for microarray analysis.
Experiment #3: Third, the labeled DNA will be hybridized to a cDNA microarray 
and analyzed to determine the chromosome complement. Initially, normal euploid 
cells will be used a controls until proof of concept is established. Once answered, 
the feasibility of the use of array CGH for study of aneuploidy in humans will be 
addressed, an IRB proposal submitted, and the final aspects of the study with 
regards to sensitivity and specificity of the technique will be determined. This will 
be accomplished initially by using single cells with known chromosomal 
abnormalities (e.g. amniocytes, and/or cancer cell lines obtained from the 
cytogenetics laboratory) prior to assessing aneuploidy rates in human 
supernumerary embryos donated for research.
3.1 Study models
Three types of cells were used in these experiments as described in the 
Material and Methods sections of each Specific Aim. Human cells were used 
exclusively since the ultimate object of these studies was to diagnose human 
disease. The limited availability of human embryos/blastomeres with the studied 
disease necessitated another cell type for study. Human lymphoblast cells 
served as an excellent source for optimization studies in Specific Aims # 1 ,2 ,  
and 4 since cell lines with and without specific disease mutations were easily 
obtained. However, different cell types such as lymphoblasts may behave 
differently due to the chromatin arrangement for the particular cell, therefore 
supernumerary human embryos that were donated for research were used for 
final optimization of studies to control for those differences. Finally, blastomeres 
from actual IVF/PGD patients were obtained and studied for Specific Aims # 1 
and 3. All procedures were performed under protocols approved by the 
Institutional Review Board of Eastern Virginia Medical School as deemed 
necessary.
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SECTION 4 
STUDIES FOR SPECIFIC AIM # 1
Specific Aim # 1: To increase amplification efficiency by attempting to 
‘rescue’ those ceils that show no initial PCR amplification.
4.1 Material and Methods for Specific Aim # 1 
Sources of DNA
DNA was obtained from three sources:
1) Single cells were collected using lymphoblast cultures of known DNA 
mutations (Coriell Institute, Camden, NJ). Cells were cultured in RPMI-1640 
media supplemented with 15% Fetal Bovine Serum (Invitrogen, Carlsbad, CA) in 
a 37°C incubator with 5% CO2 and air. Single cells were isolated under a 
dissecting microscope and serially rinsed through three microdrops of PCR buffer 
to remove any extraneous cells. The individual cell was then visualized under the 
dissecting microscope as it was placed in a PCR reaction tube (Gene-Amp, 
Perkin-Elmer, Norwalk, CT) containing 60 pi sterile DNAse-free water overlaid 
with sterile mineral oil. Similarly, cells from these cultures were pooled to obtain 
genomic DNA controls.
2) Individual blastomeres were obtained from growth-arrested abnormally 
fertilized human embryos. Embryos were placed in an acidified Tyrode’s medium 
to remove the zona pellucida, and then rinsed in culture media. The zona-free 
embryo was subsequently placed in a calcium-free/magnesium free phosphate 
buffered saline supplemented with 1% Bovine Serum albumin (Sigma, St. Louis, 
MO) to dissociate the cells. Individual cells were then collected as described 
above for the lymphoblasts.
3) Individual blastomeres were obtained from couples undergoing a PGD 
procedure. Individual cells were removed from the embryo by micromanipulation 
(embryo biopsy) as described below.
Embryo Biopsy
Embryo biopsy was performed using a Nikon Diaphot Microscope (Nikon, 
Melville, NY) with Hoffman optics (Modulation Optics, Greenvale, NY). Three sets
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of Narishige micromanipulators MN-2 (Narishige USA, Greenvale, NY) were 
used for the holding pipette, acidified media, and the biopsy pipette.
Micropipettes were prepared with a Sutter P-87 pipette puller that initially pulled 
borosilicate capillary tubes. A Nikon MF-9 microforge was then used to fire-polish 
the pipettes to their respective diameters listed below.
The embryo was held in place with a 35 micron holding pipette connected 
to a Narishige IM-6 microinjector. Acidified Tyrode’s medium was delivered 
through a 10 micron I.D. micropipette attached to a similar microinjector. Biopsy 
was accomplished through a 35-50 micron micropipette attached to a 
picoinjector.
A dish containing acidified Tyrode’s was placed on the microscope stage. 
The respective pipette was lowered into the acidified media and filled. That dish 
was then replaced on the stage by a square culture dish containing a droplet of 
Hepes-buffered Earle’s media supplemented with 7.5 % synthetic serum 
substitute (Irvine Scientific, Santa Ana, CA) layered with washed and equilibrated 
mineral oil.
Embryos for biopsy were individually removed from their culture dish and 
placed into the droplet. The embryo was immobilized by suction applied to the 
aforementioned holding pipette. Care was taken to situate the embryo so that a 
blastomere would easily be accessible. The acid pipette was then placed next to 
the zona pellicuda, and acidified Tyrode’s was slowly released while the pipette 
was moved against the zona in an up and down motion. After several seconds, 
an opening broke through the zona and the acid flow was stopped. The acid 
pipette was moved away from the embryo, and the biopsy pipette was placed 
into the field. Embryo biopsy was performed by inserting the biopsy pipette in 
through the newly-created opening in the zona and placing the mouth of the 
pipette next to the arc of the desired blastomere. Suction was slowly applied so 
that the cell could be drawn into the pipette. The pipette was then removed from 
the embryo, and the aspirated cell was released into the media. The cell was 
then aspirated into a drawn-out Pasteur pipette and rinsed through a series of 
three droplets of PCR buffer to remove any potential contaminating extraneous
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cells (from sperm or corona cells). The aspirated blastomere was then placed 
into a 0.5|il GeneAmp PCR reaction tube (Perkin Elmer, Norwalk, CT) containing 
60pl sterile DNAse free water and layered with sterile mineral oil. A stereo 
microscope was used to visualize that the cell was successfully transferred to the 
PCR tube. The tube was then frozen/thawed twice in liquid nitrogen and heated 
to 100°C for 10 minutes to lyse the cell. All samples that were not analyzed 
immediately were stored at -20°C until use.
Initial Polymerase Chain Reaction
For these experiments, the PCR region to be amplified encompassed the 
4 base pair (bp) insertion (1278+TATC) of the p-hexosaminidase A gene, the 
most common mutation causing Tay-Sachs disease. Outer and nested primer 
sequences are listed in Table II.
Reagents
A standard PCR master mix consisted of a 10X reaction buffer (1.5 mM 
MgCb, 10 mM Tris-hydrochloric acid, pH 8.3, 50 mM potassium chloride, and 
0.01% [wt/vol] gelatin), 200 pM dNTPs (USB, Cleveland, OH), 0.2 pM primers 
(Genosys, The Woodlands, Tex.), and 0.5 unit of Tag polymerase (Perkin- 
Elmer). The remainder of the 100pl volume consisted of 2pl sample and 60pl of 
sterile water overlaid with 60pl oil.
Nested reaction:
A 2 pi aliquot of the initially amplified product was removed and added to a 
new PCR reaction tube containing 60pl of sterile water overlaid with 60pl oil, 
along with fresh master mix containing the new primer set in addition to the other 
master mix components (buffer, dNTPs, Tag polymerase).
Thermocycling conditions continued as described in Table III.
Heteroduplex Formation
A four base pair difference in the PCR product is difficult to distinguish 
between the normal and abnormal condition when applied to a fast-running 
polyacrylamide gel. Therefore, an artifact known as heteroduplex formation is 
used to distinguish between small base pair insertions and deletions (Nagamine 
et al., 1989; Triggs-Raine and Gravel, 1990). The rationale for this comes from











Table II. Oligonucleotide primer sequences
Gene Loci Outer primers 5’ to 3’ Nested primers 5’ to 3’
exon 11, 4 bp insertion 
p-Hexosaminidase A. 
(Tay-Sachs disease)
F -  CAACAACAGT CT GGT GAT GG 
R - GCCAGACACAATCATACAGG
F- AAGGAGCT GGAACT GGT CAC 
R - CTCTCAACCACCTTCCCAAT




F - GACTTCACTTCTAATGATGAT 
R- CT CTT CT AGTT GGCATGC
F- TGGGAGAACTGGAGCCTT 
R -GCTTT GAT GACGCTT CT GT AT
F= forward primer, R = reverse primer.
Outer primers used for first 20 cycles of PCR at specified annealing temperatures, Nested primers used for remaining 30 
cycles of nested PCR. PCR conditions described in Table III.
2
Table III. Thermocycling conditions
Initial reaction Nested
For the 4bp insertion of the (3-hexosaminidase A gene:
94°C Initial denaturation 3 minutes 
20 cycles of:
Denatu ration at 94°C for 1 minute 
Annealing at 61 °C for 1 minute 
Extension at 72°C for 1 minute 
+2 second increase after each cycle
For the AF508 mutation of cystic fibrosis: 
Initial reaction I
94°C Initial denaturation 3 minutes 
20 cycles of:
Denaturation at 94°C for 1 minute 
Annealing at 40°C for 1 minute 
Extension at 72°C for 1 minute 
+2 second increase after each cycle
94°C Initial denaturation 3 minutes 
30 cycles of:
Denaturation at 94°C for 1 minute 
Annealing at 54°C for 1 minute 
Extension at 72°C for 1 minute 
+2 second increase after each cycle
Nested
94°C Initial denaturation 3 minutes 
30 cycles of:
Denaturation at 94°C for 1 minute 
Annealing at 50°C for 1 minute 
Extension at 72°C for 1 minute 
+2 second increase after each cycle
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Figure 8. Gel migration for small insertion or deletion. Polyacrylamide gel (7%) 
photo representing the gel migration pattern for the 4 bp insertion in exon 11 of 
the p-hexosaminidase A gene (Tay-Sachs, TSD-11).
Lane 1 -  negative (no DNA control)
Lane 2 -normal, wild-type
Lane 3 -  heterozygous carrier for TSD-11
Lane 4 -  affected TSD-11 with the 4 base pair insertion
Lane 5 -  negative
Lane 6 -  pGEM DNA marker
This gel illustrates the need for further information when attempting to discern the 
difference in the four base pair insertion. Although the normal (and thus smaller) 
DNA fragment ran slightly faster on the gel, the information is insufficient to make 
the critical diagnosis between normal and affected.
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the heterozygous condition that has one normal allele and one abnormal allele 
with the extra four base pairs in this particular case. Those alleles do not exactly 
match up at the insertion, therefore, an unmatched loop of 4 base pairs is 
created. That loop causes a resistance in the migration pattern of the DNA when 
applied to a polyacrylamide gel, resulting in the characteristic heteroduplex or 
double band formation seen on the gel (Figure 8).
The above example is for the known heterozygous condition. To 
distinguish the 4-base pair difference between the normal and abnormal alleles in 
an unknown sample, a mixing experiment is performed. Previously amplified 
known normal and known abnormal DNA samples is added or mixed with the 
unknown sample into separate PCR reaction tubes. This is accomplished by 
adding an equal volume of the known amplified product to the unknown PCR 
sample in separate aliquots. The mixture is heated to 95°C for 5 minutes to 
denature the strands, cooled to 65°C for 5 minutes to allow the new mixed 
strands to anneal, and then cooled to 4°C to stop the reaction. Thus each 
unknown has 3 lanes on the polyacrylamide gel: the unknown by itself, the 
unknown plus known amplified normal PCR product, the unknown plus known 
amplified abnormal PCR product. The pattern of the gel migration and 
heteroduplex formation will determine the diagnosis (Figure 9).
Post PCR Gel Electrophoresis
Five microliters of a bromophenol blue loading buffer was added to 20pl of 
PCR amplified or mixed product and applied to a 7% polyacrylamide gel (29:1 
acrylamide:bis), run at 175 V using a Fisher Biotech power supply for 90 minutes. 
The gel was dismantled and stained for 15 minutes in 0.5mg/ml ethidium bromide 
(Sigma, St. Louis, MO), de-stained with ultrapure water, and photographed under 
ultraviolet light trans-illumination.
Reamplification Experiments
PEP was used as the WGA method to ascertain if the amplification failure 
was due to lack of sensitivity. Samples that had previously been subjected to 
PCR were stored frozen at -20°C  in the original PCR tubes containing the cell
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11
Figure 9. Heteroduplex formation. Polyacrylamide gel (7%) photo representing 
heteroduplex formation used for diagnosis of TSD-11 (and other 
deletions/insertions). The artifact known as the heteroduplex is present only 
when the normal allele and the affected (4bp inserted) allele are in the sample 
together and do not match up, causing a slower migration pattern on the gel. The 
diagnosis is made by evaluating the migration pattern of three lanes, knowing 
that only the normal and affected together will produce the heteroduplex.
Lane 1 - Normal (wild-type) sample
Lane 2 - Normal sample mixed with known normal DNA (+N)
Lane 3 - Normal sample mixed with known affected DNA (+U)
Lane 4 -  Negative control 
Lane 5 -  Heterozygous sample
Lane 6 - Heterozygous sample mixed with known normal DNA (+N)
Lane 7 - Heterozygous sample mixed with known affected DNA (+U)
Lane 8 - Negative control 
Lane 9 - Affected sample
Lane 10 - Affected sample mixed with known normal DNA (+N)
Lane 11 - Affected sample mixed with known affected DNA (+U)
Lane 12 -  Negative control 
Lane 13 -  pGEM DNA marker
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until further use. The initial PCR reaction volume was 100 pi and the PEP 
reagents were added directly to the initially tested reaction tube. A published 
PEP protocol (Zhang et al., 1992) used a smaller reaction volume of 60pl; 
reagent volumes in the reamplification process were adjusted accordingly to 
maintain the same concentrations. The PEP reaction consisted of 13.5jjJ 10x 
Potassium-free buffer (100mM Tris-HCI, pH 8.3, 25mM MgCh, 1 mg/ml gelatin), 
12[il PEP primers (random 15-mers, Operon Technology, Alameda, CA), 12pl 
mixture of the 4 dNTPs at 2mM each (USB, Cleveland, OH), and 2.5pl Taq 
polymerase (15 units, Perkin-Elmer). Fifty cycles were carried out using a Perkin 
Elmer Thermocycler (Perkin Elmer Cetus, Norwalk, CT) as follows: 1 minute 
denaturation at 92°C, 2 minute annealing at 37°C, followed by a timed ramping 
segment of 10seconds/degree to 55°C, followed by an extension incubation step 
at 55°C for 4 minutes. A 5pl aliquot of the post PEP product was then removed 
and subjected to PCR as described above.
Reamplification without PEP using standard PCR
Reamplification was also attempted by simply re-analyzing the sample by 
PCR with additional master mix components without the PEP procedure. Since 
the volume of the initial failed reaction was 100pl, the volumes of the master mix 
components were adjusted accordingly to reflect the same final concentration of 
reagents in the increased volume. Reamplification was attempted with either 
primers for the 4 base pair insertion of the p-hexosaminidase A gene or for the 3 
base pair deletion of the AF508 mutation of the cystic fibrosis transmembrane 
conductor regulator gene (CFTR). Primer pairs are listed in Table II; thermal 
cycling conditions are listed in Table III.
Contamination Controls
Negative PCR reaction controls that were previously subjected PCR were 
simultaneously analyzed in each reamplification reaction to serve as 
contamination controls for the reamplification process. Negative controls do not 
contain starting DNA template and showed no initial amplification due to lack of 
starting template.
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Statistical analysis
Fisher's exact statistical testing was used to compare results of 
amplification for the different genes used (Appendix C). The computer program 
GRAPHPAD INSTAT (Graphpad Software, San Diego, CA) was used to assist in 
analysis.
4.2 Results for Specific Aim # 1
Of the 187 single cell lymphoblasts initially evaluated for Tay-Sachs, 
97/187 amplified (51.9%). Of the 107 single cell lymphoblasts initially evaluated 
for cystic fibrosis (OF), 87/107 amplified (81.3%). The amplification efficiency for 
TSD was significantly lower than for OF (P<0.0095). Since the amplification 
efficiency was so low for TSD as compared with the other loci studied, a 
sensitivity study was performed. One cell, two cells combined, three, four, five 
cells were evaluated. Amplification efficiencies were significantly greater when 
analyzing two cells combined as compared to a single cell (97/187 vs. 16/17, 
51.9% vs. 94.1% respectively, P=0.0006. Table IV).
Reamplification Studies without Primer Extension Preamplification (PEP)
After the DNA failed to amplify the first time with TSD primers, another 
attempt with additional TSD primers and fresh master mix did not improve the 
amplification rate as only three in 19 cells attempted demonstrated PCR 
amplification. This was in stark contrast to reamplification experiments with CF 
primers in cells that initially did not amplify for TSD. Of those, 18/25 (72%) 
amplified for the CF locus after failed TSD amplification. These data 
demonstrated that DNA was present in at least some of the PCR reaction tubes 
that initially failed to amplify and that it is technically possible to reamplify DNA in 
the stored PCR reaction tubes from previous amplification failures (Table V). This 
could circumvent the need to rebiopsy the embryo to obtain a genetic diagnosis. 
Reamplification with PEP
Fifty-nine single lymphoblasts that did not initially amplify using the Tay- 
Sachs primers were subjected to PEP. An aliquot of the sample after the PEP 
reaction was then PCR analyzed using TSD primers. Amplification occurred 
52.5% of the time (31/59) cells. This was statistically greater than when
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Table IV. PCR amplification efficiencies
Number of Cells Amplification efficiency
One cell 97/187 (51%)a
Two cells 16/17 (89%)a
Three cells 17/17(100%)
Four cells 8/9 (89%)
Five cells 7/8 (87.5%)
With 2 cells or greater 32/34 (94%)
aP=0.0006.
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Table V. Results of reamplification experiments
Experiment Amplification result
Lymphoblast Reamplification by standard 
PCR Targeting same gene locus (TSD)
3/19 (16%)a,b,c
Lymphoblast Reamplification by standard 
PCR Targeting a different locus (CF)
18/25 (72%)a
Lymphoblast Reamplification by PEP 
Targeting the same locus (TSD)
31/59 (53%)b
Blastomere reamplification by PEP 
Targeting the same locus
13/24 (54%)°
Blastomere reamplification for PGD 
(initially 4/6 amplified, therefore 6 failed)
4/6 (67%)
a P=0.0003. 
b P = 0.007. 
c P = 0.0127.
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compared with the reamplification attempt not using the PEP procedure at the 
TSD gene locus (16% versus 53%, P=0.007).
Reamplification using PEP for failed blastomere diagnosis
Initially, blastomeres (n=54) from supernumerary human embryos that 
failed to amplify were reanalyzed by PEP and subsequent PCR testing for TSD. 
Blastomeres were re-analyzed to ascertain if the procedure could be done for a 
clinical PGD. Thirteen of 24 amplified (54%) which was not statistically different 
from the 53% seen in PEP reamplification of the lymphoblasts. With this 
knowledge, we proceeded to reanalyze the contents of six PCR tubes from failed 
amplification in a PGD cycle. After the PEP protocol and subsequent PCR for the 
same TSD mutation, four of the six blastomeres amplified, and a diagnosis was 
made. Included in this experiment were three negative (no initial DNA) controls 
that were subjected to the same protocols. All three failed to amplify as expected, 
thus minimizing the possibility that inadvertent contamination of the PCR tubes 
with extraneous DNA was the source of the new amplification seen (Table VI).
4.3 Discussion for Specific Aim # 1
For couples where both partners carry a mutation for a recessive disease, 
the risk of having an affected child is 25% based on Mendelian genetics. When 
one partner carries the gene for a dominant disease, that risk increases to 50%. 
For many couples, especially those who have had a pregnancy and perhaps a 
live birth of an affected child, a 25% risk may be too great. The success with the 
technology used in PGD must far exceed the anticipated risk in nature, i.e., the 
PGD success has to exceed the 75% rate that nature statistically would provide. 
The question then becomes, what risks are acceptable? Since there is never a 
100% guarantee of success with a scientific technology, how close to 100% must 
the test be and still allow a couple to accept that risk? Some of those risk 
evaluation issues were addressed by the studies presented here.
The initial pre-clinical studies performed in our laboratory demonstrated 
amplification rates over 90% when using individual lymphoblasts and 
blastomeres as the source of DNA. However, upon performing a PGD cycle for 
our first patient, the diagnosis rate was only 4/7 embryos, a disappointing 57%.
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Table VI. Reamplification of blastomeres from PGD embryos
Embryo number Blastomere reamplification result
for PGD using PEP
RA Embryo 2 Reamplification failed
RA Embryo 4 blastomere 1 Amplified/normal diagnosis
RA Embryo 4 blastomere 2 Amplified/normal diagnosis
RA Embryo 5 blastomere 2 Amplified/normal diagnosis
RA Embryo 7 blastomere 1 Reamplification failed
RA Embryo 7 blastomere 2 Amplified/normal diagnosis
************************************************* **************************************** 
Blastomere amplification for a
different loci from previously sexed
embryos
JB Embryo 1 Male -  affected muscular
dystrophy
JB Embryo 1A Male - affected muscular
dystrophy
JB Embryo 2 Male - affected muscular
dystrophy
JB Embryo 5A Male -  Normal
JB Embryo 5B Male -  Normal
JB Embryo 7 Male -  reamplification failed
JB Embryo 8 Male -  reamplification failed
The reamplification result of Tay-Sachs disease is given on the right. JB embryos 
were previously diagnosed for gender only. The amplification result for the 
muscular dystrophy deletion is given on the right.
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This led us to address the issues of amplification failure -  what 
circumstances might cause it to occur and how to alleviate those possibilities. 
Once the test had been performed and initial amplification failed, was there 
anything that could be done to try to salvage the genetic diagnosis and provide 
that couple with the best information and possible opportunity at achieving 
pregnancy? That question led us to the experiments that were conducted in 
Specific Aim # 1.
One concern in the pre-clinical studies was the limited quantity of DNA in 
the starting template from a single cell. Amplification then becomes a sensitivity 
issue. Nested PCR was implemented to increase the sensitivity to the level of 
DNA in a single cell. Studies performed in our laboratory supported the 
hypothesis that 20 cycles of PCR followed by another 30 cycles of nested PCR 
was much more sensitive at DNA amplification than 50 cycles together (Figure
3). This supports the concept that PCR is a finite reaction; there is a limit to the 
exponential amplification process. The concentration of the dNTP's and Taq 
polymerase will begin to decline with subsequent cycles of PCR. Removal of an 
aliquot after several PCR cycles and refreshing the reaction with new primers, 
buffers, Taq polymerase rather than to just continue with additional cycles of 
PCR yielded a greater sensitivity in the detection of target DNA sequences.
After the results of poor amplification were revealed in the first clinical test, 
one corrective measure was to determine if having more initial template could 
resolve that issue. The original DNA remains in the PCR reaction tube, along 
with the PCR reagents and presumably amplified product. In the first phase of 
these studies, we used a WGA technique that had been shown to produce a 
minimum of 30 copies of at least 78% of the genome (Zhang et al., 1992). The 
WGA technique used in the initial experiments is known as PEP. Primers are 
designed that randomly contain 15 base sequences of the nucleotides in every 
possible combination. When added to an initial DNA template, PCR is carried 
out over 50 cycles of denaturation, annealing of these random sequences, then 
new strand extension. This technique did not appear to have a practical clinical 
application in the initial amplification process since it takes approximately 10
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hours to perform prior to the standard PCR testing for a PGD cycle. However, 
after these initial studies were performed, other researchers investigated 
methods to decrease the time involved in the procedure (Xu et a i, 1993; Sermon 
etal., 1996). Less time could allow for the technique to become more practical 
for de novo PGD applications.
In the studies by Xu et a i (1993), the annealing time was decreased from 
the initial 150 seconds to 90 seconds and the initial four-minute extension time 
was decreased by either 10 seconds or 20 seconds. Those two changes resulted 
in a decrease of their overall reaction time from 8 hours to either 5 hours, 45 
minutes or 4 hours, 4 minutes. The shortest time period showed no significant 
decrease in amplification efficiencies when compared to the longest time period 
(26/36 versus 48/60, respectively, P  = 0.4543)
Initially, our study was deemed as proof of concept that the initial template 
be rescued after having been subjected to PCR amplification. The studies 
described here in the first experiments demonstrate that indeed the initial 
template can successfully be accessed and that subsequent PCR amplification 
can occur.
One of the issues of concern with a small amount of starting template is 
that reamplification could introduce contamination, especially in an assay 
designed to be sensitive to the level of a single cell. In these studies, negative 
controls (no initial starting template) were also subjected to the reamplification 
procedure. As expected, there was no amplification in those reactions; those 
results helped to rule out contamination or extraneous DNA as a cause for the 
amplification seen during the second attempt.
The reason for the inability to achieve successful amplification in the initial 
PCR attempt is not known. Clearly, there was DNA present in those tubes that 
subsequently amplified on the second attempt. The DNA may be in an 
unfavorable conformation and have a certain degree of secondary structure that 
may have prevented adequate strand denaturation or primer annealing in the first 
reaction. It is interesting to note that the reamplification attempts with a second 
set of PCR primers were more successful, even without using the whole genome
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amplification step. This may suggest that the gene structure itself for the p- 
hexosaminidase A gene may then abrogate primer annealing or polymerase 
extension since amplification was successful 72% of the time when a different 
gene was studied in the same tubes.
Another reason for the initial amplification failure could be due to 
sensitivity of the PCR. The rationale for using a WGA technique is to increase the 
number of copies of the starting template for the PCR reaction. This attempt to 
reamplify for the same mutation after using PEP resulted in successful 
amplification in 53% of the cells when analyzing the lymphoblasts. Clinically, the 
method resulted in obtaining a diagnosis on two of the three embryos that did not 
previously have a genetic answer for the gene studied. However, the increase in 
time that the procedure requires has limited its clinical use for our laboratory. 
Instead, our laboratory chose to focus on other methods that may improve both 
the sensitivity and specificity while maintaining the ability to provide a genetic 
diagnosis within a day. That led us to perform the experiments listed in Specific 
Aim # 2 that follows this discussion.
As stated above, we demonstrated efficient amplification targeting 
different loci, even without performing the whole genome amplification. Those 
studies served as a model for a clinical application of diagnosing frozen embryos 
that had previously been tested for gender determination in the X-linked 
diseases. For example, a carrier of X-linked Duchenne Muscular Dystrophy 
(DMD) completed a PGD cycle where only the sex was determined for the 
embryos. After diagnosis and embryo transfer, the supernumerary embryos were 
cryopreserved. The amplified PCR tubes were stored at -20°C. Upon developing 
the technique for diagnosing the specific DMD deletion, the PCR tubes 
containing the blastomeres from previously-determined male embryos were 
thawed and subjected to amplification with the primers for that specific deletion. 
Successful amplification occurred in five of seven embryos, with three embryos 
being diagnosed as affected with the DMD deletion. This allowed for a 
subsequent transfer of the two normal male embryos without the need to re­
biopsy the cell (Table VI).
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4.4 Conclusions for Specific Aim # 1
From these studies we conclude that the process of whole genome 
amplification and subsequent PCR testing can be performed as a means of 
rescuing samples that previously failed to amplify in initial tests of PCR. The time 
involved to perform these tests limits the use of the PEP protocol initially, but the 
method still can serve as an alternative if amplification fails and the genetic 
status of the embryo is not known. This could abrogate the need to re-biopsy the 
embryo since an additional non-invasive technique is used to obtain the genetic 
answer. In addition, these studies laid the foundation for the clinical application of 
a reamplification procedure assessing a different genetic locus that resulted in 
the embryo transfer of male embryos whose previous genetic status was 
unknown in an at-risk X-linked carrier.
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SECTION 5 
Studies for Specific Aim # 2
Specific Aim # 2: To increase the amplification efficiency through 
optimization of DNA lysis conditions and to decrease the incidence of allele 
drop-out.
5.1 Materials and Methods for Specific Aim # 2 
Cell collection
Single and double cells were collected using lymphoblast cultures 
(#GM03770 Coriell Institute, Camden NJ) known to be heterozygous for the 4 
base pair (bp) insertion on exon 11 of the p-hexosaminidase A gene (TSD-11). 
Heterozygous cells were chosen because a single cell contains copies of both 
the normal and affected allele. Cells were isolated under a dissecting microscope 
either singularly or in groups of two, then serially rinsed through three microdrops 
of PCR buffer to remove any extraneous cells. The cells were then placed in a 
PCR reaction tube (Gene-Amp, Perkin-Elmer, Norwalk, CT) and 100 samples 
were evaluated in each of the following methods of DNA preparation:
1). Liquid Nitrogen (LN2) - cells were placed in 60ja.L of sterile ultrapure water with 
a mineral oil layer, frozen-thawed twice in LN2 then boiled at 100°C for 10 
minutes (standard procedure).
2). Potassium Hydroxide (KOH) - cells were placed in 5pL of KOH solution, 
(200mM potassium hydroxide/50mM dithiothreitol), centrifuged, heated at 65°C 
for 10 minutes, then 5jj,L neutralizing solution (900mM Tris-HCI pH 8.3, 300mM 
potassium chloride, 200mM hydrogen chloride ) was added. Fifty microliters of 
sterile ultrapure water was added along with a mineral oil layer.
3). Boiling (Bl) - cells were placed in 60 sterile ultrapure water, layered with 
mineral oil, then boiled at 100°C for 10 minutes.
4). Water (H20) - cells were placed in 60pL sterile ultrapure water and layered 
with mineral oil without further preparation prior to PCR and genetic analysis
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Cells were analyzed by PCR using nested primers as noted above in the 
Materials and Methods section for Specific Aim # 1, with the following exception 
in the PCR buffer for the first round of amplification: For the KOH group, the 
buffer was 10mM Tris-HCI (pH 8.3), 2.5 mM MgCI2 chloride, 0.1% (w/v) gelatin. 
(Due to the potassium ions in the KOH, potassium chloride was not used on the 
initial buffer). The LN2, Bl, and H20 groups first round PCR, plus all groups 
nested round PCR, used the regular PCR buffer (10mM Tris-HCI pH 8.3, 50mM 
potassium chloride, 1.5mM MgCI2, 0.1% w/v gelatin). Additional PCR 
experiments were performed using the alternate concentrations to control for the 
differences in buffers.
PCR products were loaded onto a 7% polyacrylamide gel as described 
above in Specific Aim # 1. The appearance of a single band rather than the 
characteristic heteroduplex formation indicated the amplification of only one 
allele.
Statistical analysis
Amplification rates and accuracy of diagnoses between the different 
methods of DNA preparation were compared by Chi-Square, using Yates' 
correction for continuity (Appendix C). The computer program GRAPHPAD 
INSTAT (Graphpad Software, San Diego, CA) was used to assist in analysis.
5.2 Results for Specific Aim #  2
A representative gel is shown in Figure 10. Results are shown in Table VII 
for the single cells. Ninety-seven percent of the KOH group samples 
demonstrated amplification of at least one allele. This was significantly greater 
than for LN2, Bl, and H20 group where amplification was detected in 38, 41 (both 
P<0.00001) and 85% (P <0.006) of samples, respectively. The sensitivity of the 
KOH method is even greater when comparing amplification of both alleles in the 
heterozygous cell, a requirement for a correct diagnosis. Ninety-one of the 97 
single cells that amplified using the KOH method showed the presence of both 
alleles. In the LN2 group, not only was the amplification rate low (38%), of those 
cells that did amplify only 11 showed amplification of both alleles. Although the
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Figure 10. Two of the DNA preparation techniques. Both 15-lane 
polyacrylamide gels (7%) were set up the same with a negative control in the 1st 
and 14th lanes and a normal and heterozygous control in the 2nd and 13th lanes, 
respectively. Lanes 3-12 display the amplification results from the PCR of known 
heterozygous single cells. This upper gel demonstrates the results of the 
KOH/DTT lysis method in which all 10 single cells (lanes 3-13) exhibit the 
characteristic heteroduplex formation and correctly amplified both the normal and 
affected alleles. The lower gel represents the use of the Liquid Nitrogen method. 
In this instance only 4 of 10 heterozygous single cells amplified. Of those 4, only 
2 (lanes 4,6) correctly displayed the heteroduplex formation, indicating a correct 
diagnosis.
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Table VII. Comparison of different iysis methods used in 400 single cells
Amplification Rate/ 
Lysis Method LN2 KOH BL H2O
Normal allele only 16/100 5/100 13/100 16/100
(16%) (5%) (13%) (16%)
Affected allele only 11/100 1/100 11/100 28/100
(11%) (1%) (11%) (28%)
Both Alleles (expected result) 11/100 91/100 17/100 41/100
(11%) (91%) (17%) (41%)
Total Amplification 38/100a 97/100a-b 41/100a 85/100b
(38%) (97%) (41%) (85%)
aP<0.00001.
bP<0.006.
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Table VIII. Comparison of different lysis methods used in 200 two cells
Amplification Rate/ LN2 KOH
Lysis Method
Normal allele only 14/100 1/100
(14%) (1%)
Affected allele only 18/100 0/100
(18%) (0%)
Both Alleles (expected result) 53/100 96/100
(53%) (96%)
Total Amplification 85/100a 97/100a
(85%) (97%)
a P = 0.006.
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H20 method had a high amplification rate (85%) for single cells, less than half 
(n=41) of the cells amplified both alleles.
When amplification of a single band was seen, heteroduplex formation 
determined if the normal or the affected allele was amplified. There was no 
significant difference seen in which of the alleles amplified. This also suggests 
that the single bands are probably not due to contamination since the laboratory 
workers are homozygous normal for TSD-11 DNA. No evidence of 
contamination was observed in any of the negatives or media controls for the 
experiments used in this study.
Using two cells per reaction did not increase the amplification rate for the 
KOH method (97% vs. 97%), but dramatically increased the rate for the LN2 
method (85 vs. 38%; P  <0.00001). However, only 53 of those cells correctly 
amplified both alleles (Table VIII).
5.3 Discussion for Specific Aim # 2
Maximizing the benefits of a PGD cycle relies upon the success rate of its 
implementation. Specific Aim # 1 focused on the sensitivity of obtaining a genetic 
answer; this study tested both sensitivity and specificity - not only obtaining 
amplification, but also ensuring that the information obtained is correct. One of the 
greatest concerns is that a misdiagnosis after genetic testing would actually 
supersede the PGD in the first place. Most of the couples pursuing PGD cycles are 
fertile and are opting for PGD not only to have a child, but to have an unaffected 
child.
When studying a heterozygote in the autosomal recessive condition with a 
single mutation, amplification of only the normal allele and not the affected allele 
would result in making eligible for embryo transfer a true phenotypically normal 
embryo (genotypically heterozygous), an event that would not be detrimental for 
the resulting offspring. However, amplification of only the abnormal allele would 
then remove a true phenotypically normal embryo from the pool of embryos eligible 
for transfer, thus decreasing the chances for pregnancy. (Table IX -  Condition A). 
One cause of misdiagnoses reported in the literature (Grifo et a I., 1998; ESHRE
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Table IX. The effect of Allele Drop-out (ADO)
Condition A -  autosomal recessive disease such as Tay-Sachs (T and t alleles)
True Observed Eligible for Impact of
Genotype________ Genotype_________ Transfer?________ Error______________
Tt (normal T (normal) Yes Tolerable
phenotype) t (affected) No Healthy embryo not
transferred
Condition B -  ADO in an autosomal dominant disease such as Garner Syndrome 
(G and g alleles)
True Observed Eligible for Impact of
Genotype________ Genotype_________ T ransfer?_________ Error_____________
Gg (affected) G (affected) No Acceptable
g (normal) Yes Transfer of affected
embryo
Condition C -  ADO in an autosomal recessive disease such as Cystic Fibrosis 
with two different mutations (C, c, F, f alleles)
True Observed Eligible for Impact of
Genotype_________ Genotype T ransfer?______________ Error
CcFf CFf (normal) Yes Transfer of affected embryo
(affected) cFf (affected) No Acceptable
CcF (normal) Yes Transfer of affected embryo
CF (normal) Yes Transfer of affected embryo
cF (normal) Yes Transfer of affected embryo
Cf (normal) Yes Transfer of affected embryo
cf (affected) No Acceptable
Table modified from Navidi and Amheim, 1991. Capital letters (T,G,C,F) 
represent the dominant allele while lower case letters (t,g,c,f) represent the 
recessive allele.
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2002) has been attributed to ADO or the random amplification of only one of the 
two alleles present in a single cell. The two main considerations regarding ADO 
are with either: 1) An autosomal dominant condition where the heterozygous 
condition is phenotypically affected. Amplification of only the normal allele in a 
heterozygous cell with a dominant condition could result in the transfer of an 
affected embryo (Table IX -  Condition B), or 2) An autosomal recessive condition 
involving two different mutations in the same gene (one from each parent) where 
the affected condition actually carries both mutations. This is known as a 
compound heterozygote since it is heterozygous for two different mutations in the 
same gene. In the case of a compound heterozygote, there are actually four 
alleles to amplify -  the normal and abnormal at each of the two mutation sites. 
Amplification of only a normal allele at either of those sites could also result in a 
misdiagnosis and subsequent transfer of a truly affected embryo. (Table IX -  
Condition C)
The first trials of PGD reported in the literature used a lysis method where 
the biopsied cell was placed into a tube of sterile water to break the cell 
membrane (Strom et a i, 1991; Morsy et a i, 1992; Liu et al., 1993). The 
difference in the osmotic pressure was thought to be enough to break the cell 
wall and make the DNA more accessible. Trials of amplification efficiencies 
produced results with amplification rates over 90% so the method was accepted 
as quick and easy.
At the onset of the initial clinical studies performed in our laboratories, the 
state of the art for PGD was to lyse the cell by the freeze thaw method (Verlinsky 
and Kuliev, 1992) or liquid nitrogen (Handyside et al., 1992), similar to the 
protocols outlined in the Materials and Methods section. This method also 
appeared to be quick and easy to break open the cell membrane by changes in 
temperatures and to allow access to the DNA. However, after several other PGD 
clinics reported poor amplification results and misdiagnoses, other methods for 
DNA lysis were explored.
Earlier reports of the PEP technique also used the KOH method for lysing 
the cells. Zhang et al. (1992) demonstrated the method for individual sperm cells,
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which are known to have highly condensed DNA. The KOH/DTT method was 
similar to a sperm lysis technique reported by Cui et al. (1989). It was thought 
that that method could be used for the lysis of the blastomere as well. This 
concept led to the second phase of our optimization studies and the evaluation of 
different lysis methods.
As our results demonstrated, the KOH lysis method proved superior to the 
other methods that at the time of the studies were considered the status quo. The 
exact mechanism for the superiority of the KOH lysis technique is not known. 
Alkaline buffers are known to hydrolyze the cell membrane, thus making the DNA 
more accessible. Other DNA protocols use an alkaline lysis buffer to increase 
DNA isolation (Sambrook and Russell, 1989). DTT is added to the lysis buffer as 
well. DTT reduces disulfide bonds (Cleland, 1964). Reduced sulfide bonds 
minimizes the formation of protein aggregates. As stated above, the KOH/DTT 
protocol was first used to access the DNA in tightly condensed sperm cells. It 
stands to reason then that the use of DTT may aid in the decondensation of the 
blastomere DNA as well, thus providing more accessible DNA that can be used 
for amplification.
The initial step in PCR is elevating the temperature to just below the 
boiling point of water so that the hydrogen bonds of the double stranded DNA will 
dissociate and become single stranded DNA. The process is reversible; upon 
lowering the temperature, the hydrogen bonds will re-form. In the case of PCR, 
before the bonds re-form, oligonucleotide primers will quickly bind to their 
complementary sites and extend a newly formed strand in the presence of Taq 
polymerase and dNTPs. One explanation for the occurrence of ADO is that there 
is insufficient strand separation during the denaturation step. By increasing the 
temperature during the initial denaturation steps, it is thought to aid in more 
efficient strand separation (Ray and Handyside, 1996).
ADO could be due to DNA degradation (Piyamongkol et al., 2003). 
Random breaks in the DNA strands are expected to occur. This may jeopardize 
the amplification of larger segments of DNA since there is a greater risk of strand 
breakage between the primers. In a study of seven different loci, Piyamongkol et
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al. (2003) compared ADO rates with the size of the PCR product and noted that 
ADO rates increased with the size of the amplicon. These researchers found a 
linear correlation between the product size and ADO; the greater the size of the 
final PCR product, the greater the ADO rate, even in differences of 100 base 
pairs. Sermon et al. (1996) and Vrettou et al. (1999) have anecdotally reported 
increased rates of ADO and amplification failure with longer amplified products 
as well. Vrettou et al., (1999) also concluded from their studies that the DNA 
sequence, denaturation temperature (contrary to the findings of Ray and 
Handyside, 1996), and cell type had little affect on the ADO rates.
In the study presented here, testing one cell versus two cells had an 
inverse effect on the ADO rate. With the superior KOH lysis method, testing two 
cells showed a decrease in the ADO rate from 6% to 1 %, but that difference was 
not statistically different (P = 0.1182) since the ADO rates were low to begin with. 
However, when testing two cells rather than one cell using the LN2 method, there 
was a significant improvement in amplification rates (85% versus 38%, 
respectively, P = 0.008) and decreased ADO rates (71% versus 38%, 
respectively, P < 0.0001). Although the ADO rate was still unacceptably high for 
this method, these results demonstrated that the ADO rate changes with the 
amount of starting DNA. Piyamongkol et al. (2003) corroborated the effect of the 
amount of DNA on ADO rates by testing one, two, three cells, and determining 
the ADO rate decreased significantly between one and two cells (from 24% for a 
single cell to 4% for two cells, 3% for three cells, P < 0.0001 using a proteinase K 
lysis technique).
Ray and Handyside (1996) demonstrated that, once the ratio of one allele 
versus the other is over 1:4, the reaction would likely not recover from the altered 
ratio due to the exponential amplification of both products. These researchers 
mixed known quantities of starting template of normal versus affected allele for 
the AF508 mutation of CFTR at 1:1, 1:2, 1:4, 1:16, and 1:256 ratios. The 1:1, 1:2, 
and 1:4 all showed adequate heteroduplex formation, demonstrating the 
amplification of both alleles. However, the samples containing 1:16 ratio or 
greater displayed only weak formation of the characteristic heteroduplex bands,
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indicating the amplification of only one allele even though the starting template 
contained both alleles. This suggests that once the amplification of one allele 
over the other has occurred after as early as three cycles of PCR (4 copies), the 
eventual outcome of ADO cannot be altered.
More sensitive techniques such as Fluorescent PCR (F-PCR) may aid in 
detecting the occurrence of ADO (Findlay et al., 1995; Piyamongkol et al., 2001). 
Fluorescently-labeled primers are added to the PCR master mix. Rather than 
using standard gel electrophoresis, the resulting PCR product is quantitated with 
the aid of computer-assisted software to determine the presence or absence of 
the studied locus. In the instance of ADO, a lower value may be assigned at that 
particular locus, but the allele is still present nonetheless.
As demonstrated by Table IX, the impact of ADO can result in a 
misdiagnosis and transfer of an affected embryo, the very outcome that couples 
who undergo PGD are trying to avoid. ADO and other issues of amplification 
efficiency, diagnosis, and outcome were studied by varying for this dissertation by 
varying DNA lysis methods in hopes of optimizing the sensitivity and accuracy of 
the PGD procedure while minimizing the risk to the patient. Achieving a greater 
diagnostic sensitivity and specificity could result in having more embryos available 
for transfer which in turn could increase the overall pregnancy rate and giving more 
couples the opportunity of having a healthy child.
5.4 Conclusions for Specific Aim # 2
In Specific Aim #2, we concluded that different lysis techniques can affect 
both the sensitivity and specificity of single cell diagnosis. The KOH lysis method 
produced a significantly higher rate of amplification and higher accuracy when 
compared with the other methods tested. Using this method, there was no 
statistical difference in amplification rate and diagnostic accuracy when testing 
one versus two cells. These studies also demonstrated the importance of 
optimizing the PCR conditions by evaluating heterozygous cells that contain both 
alleles so that the incidence of ADO can be assessed.
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SECTION 6 
STUDIES FOR SPECIFIC AIM # 3
Specific Aim # 3: To identify characteristics of the blastomeres from an 
embryo before and after embryo biopsy that can aid in determining the 
success of obtaining PCR amplification.
6.1 Materials and Methods for Specific Aim # 3
Individual blastomeres were evaluated from embryos from couples 
undergoing a PGD procedure. Individual cells were removed from the embryo by 
micromanipulation (embryo biopsy) as described above in the Materials and 
Methods section of Specific Aim # 1.
Evaluation of the nuclear and cytoplasm status
The characteristics of the cytoplasm and the nucleus were evaluated 
using both a SMZ-10 Nikon stereo microscope and a Nikon diaphot inverted 
microscope with Hoffman optics. Nuclei from blastomeres were classified as 
present or absent, intact or ruptured. The cytoplasm was classified as either 
intact, or ruptured/degenerating (Figure 11).
Polymerase Chain Reaction analysis
The individual blastomeres were analyzed by nested PCR for the patient 
specific disease. An example of the protocol for that is listed above in the 
Materials and Methods section of Specific Aim # 1.
Statistical analysis
Fisher's exact statistical testing was used to compare results of 
amplification for the different nuclear/cytoplasmic characteristics (Appendix C). 
The computer program GRAPHPAD INSTAT (Graphpad Software, San Diego, 
CA) was used to assist in analysis.
6.2 Results for Specific Aim # 3
Table X illustrates the amplification results when a nucleus is present 
compared with when no nucleus is visible. Of the 89 total blastomeres, 59 
(66.3%) had a visible nucleus while 30 (33.7%) did not have a visible nucleus. All 
59 of those blastomeres with a visible nucleus amplified in the subsequent PCR













Figure 11. Representation of nuclear and cytoplasmic integrity in human blastomeres. Panel A illustrates a biopsied 
balstomere with no visible nucleus. The overall amplification rate of cells in this category was 11/30 (36.7%) Panel B 
illustrates a biopsied blastomere with a visible nucleus. Note the defined nuclear membrane. Nucleoli can be seen in the 
nucleus as well. Cells in this category demonstrated 100% amplification rates (59/59). Panel C shows the cell membrane 
of a biopsied blastomere that has ruptured and the cytoplasm is degenerating. Of the 14 cells that lost cytoplasmic 
integrity, the amplification rate followed the pattern of their nuclear status -  if the nucleus was intact, the cell amplified 
(11/11 = 100%); if the nucleus was not intact, then the amplification rate was poor (0/3 = 0%).
9 2
Table X. Evaluation of blastomere morphology and amplification rate
Nuclear status Amplification rate (%)
Visible Nucleus present 59/59 (100%)a
No nucleus seen 11/30 (36.7%)a
Cytoplasm/membrane intact 59/75 (78.7%)
With visible nucleus 48/48 (100%)b
No nucleus seen 11/27 (40.7%)b
Cytoplasm /membrane disrupted 11/14(78.6%)
With visible nucleus 11/11 (100%)
No nucleus seen 0/3(0%)
a'b P <  0.0001.
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reaction while only 11/30 (36.7%) without a visible nucleus subsequently 
amplified in the PCR. This difference was statistically significant (P<0.0001). Of 
the 30 blastomeres without a visible nucleus, one blastomere initially had a 
nucleus seen, but upon biopsy, the cell lost the nuclear integrity and did not 
subsequently amplify.
The cytoplasm of nine blastomeres degenerated during or after the biopsy 
process and the blastomere membrane ruptured in an additional five cells. These 
breaches did not have an effect on the amplification rate; the amplification rates 
in the intact versus disrupted cytoplasm groups were equal at almost 79%. Those 
categories were further split into the cells that had a visible nucleus versus those 
that did not. Of those 14 blastomeres that showed loss of cytoplasmic/membrane 
integrity, 11 had a visible nucleus (i.e. nuclear membrane remained intact in spite 
of the cytoplasmic integrity). All 11 with a visible nucleus subsequently amplified 
while the three with no visible nucleus did not amplify. Again, the amplification 
rates followed the pattern of nuclear morphology; regardless of the cytoplasmic 
integrity, cells with a visible nucleus amplified 100% of the time.
A total of 89 blastomeres were biopsied from 51 embryos obtained from 
couples seeking PGD. Overall, the amplification rate per embryos analyzed was 
47/51 (92.2%). The four embryos that showed no PCR amplification had no 
visible nucleated cells at the time of the biopsy (One, one, two, and three 
blastomeres removed from those four embryos). No other form of nuclear 
assessment such as the use of Hoechst dye was performed since these cells 
were evaluated immediately after biopsy for clinical PGD.
6.3 Discussion for Specific Aim # 3
Theoretically, it should come as no surprise that blastomeres with visible 
nuclei should have greater amplification efficiency than those that do not. In 
simplistic terms, the DNA in interphase nuclei (when the nucleus is visible) is 
more accessible than the tightly condensed DNA in cells where the nuclear 
envelope has broken down as the cell prepares for cytokinesis. Interphase 
chromosomes are thin and extended; the chromosomes themselves are not 
readily visible under the microscope, but rather the chromatin appears as well
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dispersed fibers and filaments throughout the nucleus. (Comings, 1980) This 
dispersion allows the DNA to be more accessible for the regions of the chromatin 
in the nucleus that are transcriptionally active. Dispersed DNA strands provide an 
accessible template for PCR amplification.
In contrast, metaphase chromosomes are tightly coiled, reducing a 5cm 
length of DNA to approximately 5pm. This coiling, mediated by H1 histone 
phosphorylation, protects the chromosomes from breakage during segregation. 
Mitotic chromosomes are transcriptionally inactive and RNA synthesis is 
temporarily halted while the chromosomes are condensed. (Alberts et al., 1994). 
The tightly-bound DNA template may consequentially be difficult to access during 
the PCR process. Under normal PCR conditions using large quantities of DNA, 
this does not appear to be an issue of concern since there will be asynchronous 
cell cycles and interphase cells should be present at any given time. However, in 
PGD when only one cell is involved, the ability to amplify that single cell is 
crucial.
The visible nuclear envelope is composed of two membranes. The inner 
surface is associated with the nuclear chromatin. It was first described by 
Fleming in 1882 as " the existence of a special achromatinous lamella, that is 
real - though in most types of nuclei very thin -  layer of substance which is not 
merely the expression of the region of contact between nuclear substance and 
cytoplasmic structure" (republished as historical work years later, Fleming, 1965). 
Thus, the envelope serves as a 'barrier' between the nucleus and the organelle- 
containing cytoplasm.
Nuclear envelope breakdown is part of the normal cell cycle to allow the 
chromosome pairs to migrate to the cell periphery in anticipation of cytokinesis. 
Even though it is driven by the mitotic spindle, chromosome segregation is 
mediated by nuclear envelope components. The kinetochore is functional once 
the envelope has broken down; the pores have disassembled and nuclear pore 
components have been transferred to the kinetechore. This may be a fail-safe 
mechanism that determines the mitotic status of the cell (Salina et al., 2003)
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When the nuclear envelope is exposed to mechanical stress, the membrane 
proper may no longer be visible. (Franke et al., 1981). The basic structural 
elements of the pore complex can remain intact under stress conditions. Lack of 
a visible nucleus may then reflect some degree of DNA degradation. DNA 
degradation can also occur due to changes in temperature, pH, and DNA 
secondary structure (Lindahl, 1993). In normal metabolically active cells, there is 
some ensuing degree of DNA repair. Although there is evidence for DNA repair 
in embryos, those mechanisms are poorly understood (Harrouk et al., 2000; 
Menisser-de Murcia et al., 2001; Makarevich and Markkula, 2002; Zeng et al., 
2004). This DNA degradation could lead to a reduced or no PCR amplification.
How does partial DNA degradation affect the PCR signal? If small parts of 
the nitrogenous bases are involved in the degradation, the Taq polymerase can 
still incorporate the DNA, but the signal will be reduced. This would 
consequentially result in a weak signal (Cui and Matthews, 1996). However, if 
there is more serious damage to the bases or the base-sugar bonds, 
phosphodiester bonds are broken; subsequently the Taq will not incorporate the 
bases and extension will stop. This was well illustrated by Cui and Matthews 
(1996) who demonstrated that in normal DNA, the Taq polymerase works 
efficiently as it incorporates the bases and extends new DNA strands. However, 
if there are bases that are degraded (due to hydrolysis, oxidation and/or 
methylation, Lindahl, 1993), the incorporation rate is very slow. If the degradation 
is severe and the phosphodiester bonds are broken, the Taq will not recognize 
the DNA strand to attach to, and extension will cease. These observations were 
made in blastomeres with nuclei that were severely abnormal or absent (Cui and 
Matthews, 1996).
The ability to perform this study was made possible by first optimizing the 
amplification efficiency. Knowing what conditions work well in single cell 
amplification provides a strong foundation to try to assess the differences when 
optimal conditions are altered. Examples are instances when new reagents or 
reaction temperatures are altered to determine the effect of that particular change. 
Initial studies in our laboratory to optimize single cell diagnosis set the baseline for
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the ability to discern these differences as clinical studies came to fruition (Morsey 
et al., 1992). As in the previous study for Specific Aim # 2 demonstrating lysis 
conditions that improved amplification efficiencies, this study provides objective 
criteria to select optimal cells for PGD.
6.4 Conclusions for Specific Aim # 3
This set of studies demonstrated the importance of biopsying a 
blastomere with a visible nucleus. The integrity of the blastomere membrane or 
the integrity of the cytoplasm itself does not affect the amplification results if the 
nucleus and nuclear membrane remains intact.
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SECTION 7 
Studies for Specific Aim # 4
Specific Aim #4: To identify the chromosomal complement in a single cell.
7.1 Materials and Methods for Specific Aim # 4 
Cell collection
A male lymphoblast cell line normal for the studied genes and a male cell 
line heterozygous for the AF508 mutation of CFTR were obtained from Coriell 
Institute for Medical Research, Camden NJ (lines GM 03070 and GM07828, 
respectively). Cells were cultured as described in Specific Aim # 1. Lymphoblast 
cells were isolated, counted, and collected under a dissecting microscope using 
a drawn out sterile Pasteur pipette. Replicates of 1,2,3,4,5,6,8,10, and 20 cells 
were placed in individual PCR reaction tubes (USA Scientific, Ocala FL) 
containing 0.5pl of the lysis buffer (400mM KOH, 100mM DTT, 10mM EDTA).
The tubes containing the cells were incubated on ice for 10 minutes. 
Subsequently 0.5pl of a neutralizing buffer consisting of 400mM HCI, 600mM 
Tris-HCI (pH 0.6) was added. The samples were stored on ice if being prepared 
for immediate assay or stored long-term at -20°C.
Whole Genome Amplification -  Multiple Displacement Amplification (MPA)
The WGA technique of MDA was used to generate sufficient quantities of 
DNA for microarray analysis. MDA was accomplished through the use of a 
GenomiPhi™ DNA amplification kit (Amersham Biosciences, Piscataway, NJ). 
The kit supplied sample buffer, reaction buffer containing the random hexamers 
and dNTPs, along with the enzyme mix containing 029 polymerase. Other 
components and concentrations are unknown due to the proprietary nature of the 
kit. The kit supplied a 10ng/pl control (lambda DNA) to use as a positive MDA 
control. Negative controls were used as well that contained the kit components 
and were exposed to the same conditions as the samples, but did not contain 
template DNA.
Nine microliters of sample buffer were added to the template. The sample 
was denatured at 95°C for 3 minutes, then cooled on ice. Nine microliters of
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reaction buffer and 1pl of enzyme mix were added to each cooled sample. The 
sample was then incubated at 30°C for 16-18 hours. After that time, the sample 
was heated to 65°C for 10 minutes to inactivate the enzyme, then cooled to 4°C 
until subsequent use.
Agarose gel verification
To confirm that amplified product had been generated, a representative 
1pl sample was run on a 1% agarose gel and the gel stained with ethidium 
bromide. The gel was analyzed and photographed under UV light for evidence of 
a streak of DNA to confirm the presence of amplified DNA (see Figure 12). The 
streak is represented of the multiple copies of varying sizes of DNA products 
generated from the MDA.
Purification of amplified sample
Post-amplification purification or clean-up is recommended to remove any 
remaining reagents, enzymes, and oligonucleotides from the MDA process. This 
was accomplished by the use of a QiaQuick PCR purification kit (Qiagen, 
Valencia, CA) that is 90-95% successful at recovering 100bp-10 kb products 
while removing oligonucleotides. The sample was diluted with five times the 
volume of supplied buffer, the diluted sample was applied to the silica membrane 
of the QiaQuick spin column, and centrifuged to bind the DNA. The column was 
then washed with ethanol. Lastly, the DNA was eluted from the column with 
sterile water and was ready for subsequent use.
Quantification
Representative samples were quantitated by fluorometry and PicoGreen® 
dsDNA reagent kit (Molecular Probes, Eugene, OR) after purification. This 
method is preferred over standard UV spectrophotometry (absorbance at 260 
nm) that may provide inaccurate readings due to contaminants commonly found 
in preparation methods. The PicoGreen is sensitive to the level of 25 pg/ml. A 
working stock of control DNA was used to generate a standard curve to 
extrapolate the quantitative value of the sample DNA. PicoGreen reagent was 
added to all samples and the standard curve stock samples. All were read using














Figure 12. DNA products after multiple displacement amplification (MDA). 
Agarose gel (1%) image demonstrating the ’smear1 of DNA in lane 1 in the 
product after successful MDA. Lane 2 is a Lambda DNA/Hind III size ladder 
(indicating the base pair sizes). The presence of a smear illustrates that large 
quantities of DNA in various sizes were produced after the amplification 
technique.
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a Versa Fluor fluorometer (Biorad, Hercules, CA) with a 480/20(nm) excitation 
filter and a 520/10 (nm) emission filter.
PCR
A V  aliquot from each sample was subsequently analyzed by PCR for 
one to seven different loci:
1) APC = Adenomatous polyposis coli gene on chromosome 5 (5q21-q22)
2) CF = Cystic fibrosis transmembrane conductance regulator gene on 
chromosome 7 (7q 31.2)
3) DYT = Dystonia gene on chromosome 9 (9q34)
4) SC = Sickle cell, IJ-globin gene on chromosome 11 (11 p15.5)
5) TSD = Tay-Sachs disease, ft-hexosaminidase A gene on chromosome 15 
(15q23-24)
6) ZFX = Zinc finger region of the X chromosome (Xp22.2-p21.3)
7) ZFY = Zinc finger region of the Y chromosome (Yp11.3)
These loci were chosen since they involve seven different chromosomes 
that had primers readily available in our laboratory and were known to efficiently 
amplify: this served as a means to determine that separate regions of the 
genome were amplified. PCR using nested primers was performed as previously 
described in the Material and Methods section of Specific Aim # 1 with the 
exception of the different primers and annealing temperatures as listed in Table 
XI. The PCR experiments confirmed the presence of DNA on several different 
chromosomes and illustrated that multiple loci were amplified by the MDA.
An additional buffer was added during the initial PCR process for single 
cells only. This buffer contained 10mM Tris (pH 8.0), 0.1% Tween 20 and 
37.5pg/ml BSA.
Restriction Enzyme Digestion
MDA generates DNA fragments ranging from 100bp-10kb in length. In 
order to optimize the hybridization of the DNA to the microarray, the fragments











Table XI. Geni Loci and Primers. Below lists the gene loci and the primers used for the PCR experiments performed after 
whole genome amplification by multiple displacement amplification.
Gene Loci Outer primers 5’ to 3’ Nested primers 5’ to 3’
(annealing temperature) (annealing temperature)
Adenomatous polyposis F-ACAG AAAGAT GT GG AATT AA F-ACAGAAAGAT GT GG AATT AA
coli chromosome 5q21-q22 R-TTCTCCAGCAGCTAACTCAT R-AT GGCAGAAAT AAT ACATT C
(55°C) (54°C)
A F508 mutation of cystic F - GACTTCACTTCTAATGATGAT F- T GGGAGAACT GGAGCCTT
fibrosis transmembrane R- CTCTTCTAGTTGGCATGC R -GCTTTGATGACGCTTCTGTAT
regulator gene. (40°) (50°)
Chromosome 7q31.2
Dystonia F-CCT GGAAT ACAAACACCT A F-GGCTGCCAAT CAT GACT GT C
Chromosome 9q34 R-GT GGAAGGACT GAGT GTT G R-GT GGAAGGACT GAGT GTT G
(61 °C) (58°C)
Sickle cell F- GGCTGAGGGTTTGAAGTCCA F- ACT CCTAAG CCAGT GCCAGA
Beta globin gene R -  CCATAGAAAAGAAGGGGAAA R- AT CAAGGGT CCCATAGACT C
Chromosome 11 p15.5 (49°C) (58°C)
Tay-Sachs F -  CAACAACAGT CT GGT GAT GG F- AAGGAGCT GGAACTGGT CAC
p-hexosaminidase A R -  GCCAGACACAAT CAT ACAGG R -  CT CT CAACCACCTT CCCAAT
chromosome 15q23-24 (61 °C) (54°C)
Zinc Finger region F-ACCRCT GT ACT GACT GT GATT ACAC F-AYAACCACCTGGAGAGCCACAAGCT




should be reduced in size to bind to the less than 1kb size of the microarray 
spotted DNA. In initial experiments, the post-MDA products were incubated at 
37°C for 90 minutes with 20 units of the restriction enzyme Dpnl (New England 
Biolabs, Beverly, MA) that recognized and cleaved (cut) the sequence GATC. In 
later experiments, 20 units of Dpnl and 20 units of EcoRI (New England Biolabs) 
that recognized and cut the sequence G'AATTC were used.
Fluorescent labeling of DNA for microarrav analysis
The protocol was followed in low-light or in darkness where applicable to 
minimize the photobleaching of the dyes. In the initial phase of microarray 
analysis, samples were labeled either using Cy 3 and Cy 5 dyes. For the proof of 
concept phase of the experiments, the samples were equally divided, and half 
was separately labeled with each dye. (Theoretically, the sample of interest 
would be labeled with one dye and the normal control labeled with the other dye). 
The Cy dyes were incorporated by random-priming using the BioPrime® DNA 
labeling system. The kit supplied several of the reagents needed, including the 
random primer solution, the Klenow fragment of DNA polymerase and the stop 
buffer. The kit dNTP mixture was not used, but rather Cy3 CTP and Cy5 CTP 
(Amersham, Piscataway, NJ) were used along with standard dNTPs (USB, 
Cleveland OH). The sample volume was brought up to 20pl after purification and 
the sample was placed on ice. Twenty microliters of the supplied 2.5X random 
primers solution was added, the sample mixture was denatured for 5 minutes at 
100°C, then the mixture was cooled on ice. Two and a half microliters each of 
dATP, dGTP, and dTTP(1.2 mM) was added along with 1.25pJ (0.6 mM) dCTP. 
Three microliters of Cy5-dCTP or Cy3-dCTP (1 mM stocks) was added, along 
with 1pl of the supplied Klenow polymerase. The sample was mixed gently and 
briefly centrifuged. The reaction was incubated in the dark at 37°C for 1 to 2 
hours. At the end of that time, 5ftl of the supplied stop buffer was added to each 
sample. The labeled probe was individually purified using the QiaQuick DNA 
purification kit as described above. The final volume for each sample was 
adjusted to 30jal with sterile water. The two samples were then combined in a 
new microcentrifuge tube.
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Alexa Fluor Dyes
After the initial microarray experiments, Alexa Fluor dyes 546 and 647 
were substituted for the Cy dyes and used to directly label the DNA with the 
Ulysis® nucleic acid labeling kit (Molecular Probes, Eugene, OR). Rather than 
using the random primers for labeling, the following protocol was used. After 
Qiaquick clean-up, the sample volume was adjusted to 21 pi and was denatured 
at 95°C for 5 minutes, briefly centrifuged and then placed on ice. Four microliters 
of the respective Alexa Fluor dye was added for a final volume of 25pl. The 
mixture was heated in the dark at 80°C for 15 minutes, briefly centrifuged, then 
placed on ice. QiaQuick purification was used individually on each sample as 
described above. The final volume for each sample was adjusted to 30pl. The 
two samples were then combined in a new microcentrifuge tube.
After the respective labeling method and the combination of the samples, 
30-50pg of human Cot-1 DNA (Invitrogen, Carlsbad, CA) was added (to block 
hybridization to repetitive DNAs if present on array). One hundred micrograms 
yeast tRNA (Invitrogen) was added (to block non-specific DNA hybridization). 
Twenty micrograms of poly(dA)-poly(dT) (Sigma, St. Louis, MO) was added (to 
block hybridization to polyA tails of cDNA array elements).
The mixture was dried in a Savant Speed Vac Concentrator (Thermo 
Electron, Woburn, MA) to a volume of 24pl or less. If less, the volume was 
brought up to 24pl total with sterile water. A mixture of 5.1 pi 20X SSC (Fisher 
Chemical, Fairlawn NJ) and 0.9pl 10% SDS (Fisher chemical) was added (for a 
final conc. of 3.4%SSC and a final conc. of 0.3% SDS).
The hybridization mixture was denatured at 100° C for 1.5 minutes, then 
incubated for 30 minutes at 37°C (as a Cot-1 preannealing step). During the 30 
minutes, the microarray slide (University Health Network, Toronto, Canada) and 
the hybridization chamber were prewarmed to 65°C or 37°C, corresponding to 
the eventual hybridization temperature. The microarray slide (GAPII, Coming,
NY) was shipped ready for use, spotted with double stranded DNA as 1718 
different ESTs (Expressed Sequence Tags) derived from PCR amplification of 
the EST clones which are potential mRNAs. The slide appears as 8 grid rows
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and 4 columns similar to the diagram (Figure 6). Each grid has 10 rows and 12 
columns of spots.
The hybridization chamber has a small well in the edge of the lower slide 
holder. At the end of the 30 minutes, a 10 pi drop of sterile water was added to 
the well to maintain humidity in the chamber. The microarray slide was placed on 
the bottom half of the chamber. The probe solution was then added to the center 
of the array where the slide is spotted. The final volume of hybridization was 
30ul. This volume was appropriate for hybridization under a 30x50 mm2 
coverslip. The coverslip was polished with ethanol and dried. The edge of the 
coverslip was held at the edge of the drop of the probe mixture and gently 
dragged back and laid in place over the microarray with minimal air bubbles. The 
top portion of the hybridization chamber was assembled over the slide. The 
entire chamber was submerged into a water bath and hybridized overnight (16- 
20 hrs) at either 65°C (following the protocol of Brown, 
http://cmgm.stanford.edu/pbrown/protocols/4_genomic.html) or 37°C at the 
manufacturer's recommendation. At the end of the hybridization time, the 
chamber was removed from the water bath, the chamber's edges were dried, and 
the chamber was carefully disassembled so water did not enter the chamber.
The slide was removed and passed through a series of washes in Coplin jars as 
outlined in Table XII below. In the first wash (1A) the slide was placed in the 
Coplin jar and left undisturbed until the coverslip fell. After the coverslip was 
safely removed, a gentle agitation was performed for the allotted time.
It is important that the slides are rinsed well; detergents can form aggregates that 
can trap unbound dye. These aggregates can dry on the side and interfere with 
interpretation of results. After the series of washes, the slide was spun dry for 
one minute in a microcentrifuge equipped with a slide holder. The slide was 
either scanned immediately or held in a dark slide box in a desiccator for up to 
three days.
Scanning
The microarray slides were scanned using ScanArray® Express microarray 
scanner (Perkin Elmer Life Sciences, Boston, MA). Slides were scanned at a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
105









2x SSC, 0.03% 
SDS
200 200 ml 2x 0.6 ml
2 min 37° 
or65°C
1B 2x SSC 200 200 ml 2x — rinse
2 1x SSC 200 200 ml 1x - - 2 min 37°





Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
106
10pm resolution at the appropriate wavelength for the dyes used: Cy3 or Alexa 
Fluor 546 versus Cy5 or Alexa Fluor 647. The software package has preset 
wavelengths for various fluorophores that are highlighted appropriately. PMT Gain 
settings were used that will measure the signal to noise ratio. A good general 
starting value is PMT gain of 70-80%. Several settings
were measured and saved so the intensities were available during the 
analysis. The spotted portion of the array was defined by moving the mouse to 
the edges of the dimensions of the array area.
Quantitation
The software package with Scanarray express assisted with quantitation.
A GAL file (Gene Array List) was supplied with the microarray slide detailing the 
contents at each spot, the gene, the corresponding loci, and the accession 
number for identification in Genbank (collection of sequences from NCBI -  the 
National Center for Biotechnology Information). The software package allows for 
imaging of each individual spot that can be highlighted in a subarray grid. An 
adaptive circle method was used for the software to measure the intensity of 
each pixel within a defined spot that is manually circled. In the adaptive method, 
the initial spot mask and background mask are constructed as with the fixed 
circle method. This method was refined using a modified statistical testing 
process (Mann Whitney test) on a pixel by pixel basis. This method compensated 
for changes in the spot morphology since not every spot will hybridize as a 
perfect circle. Once all spots are highlighted, the software package found the 
spots and diagramed each spot on a scatter plot. Normal samples or samples of 
equal value should have a 1:1 ratio of each dye. A different PMT gain setting 
may be chosen to adjust that ratio as close to 1:1 as possible.
Degenerate Oligonucleotide Primer (POP )
Replicates of 1,5, and 10 lymphoblast cells were collected as decribed 
above. The cells were placed into a 0.5ml PCR tube containing the lysis buffer 
and neutralized as described above. The reaction contained 2pM DOP primer (5'
-  CCGACTCGAGNNNNNNATGTGG- 3', Sigma Genosys, The Woodlands, TX), 
200jiM dNTP mixture, PCR buffer (10mM Tris -HCI pH 9.0, 50mM KCI, 1.5mM
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Table XIII. PCR amplification after 20 cells were subjected to MDA
MDA APC(5) CF(7 o CD SC(11) TSD(15) ZFX ZFY
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + + + +
2 0  cells + + + + — + +
Control faint + + + + + +
Control faint + + + — + +
Blank — — — — -- —
APC = Adenomatous polyposis coli gene on chromosome 5 (5q21-q22). 
CF = Cystic fibrosis transmembrane conductance regulator gene on 
chromosome 7 (7q 31.2).
DYT = Dystonia gene on chromosome 9 (9q34).
SC = Sickle cell, Rglobin gene on chromosome 11 (11 p15.5).
TSD = Tay-Sachs disease, fc-hexosaminidase A gene on chromosome 15 
(15q23-24).
ZFX = Zinc finger region of the X chromosome (Xp22.2-p21.3).
ZFY = Zinc finger region of the Y chromosome (Y11.3).
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Table XIV. Results of PCR amplification after MDA
MDA
# of cells APC(5) CF(7) DYT(9) SC(11) TSD(15) ZFX ZFY
10 cells + + + + + + +
10 cells + + +
10 cells + + +
8 cells ADO + +
6 cells + + +
4 cells ADO + +
1 cells* - - -
1 cells* - - -
2 cells ADO - -
2 cells + + +
3 cells - - -
4 cells +
3 cells +
1 cell + ADO + + + + +
1 cell ADO + +
1 cell + + -
1 cell - + -
1 cell + + +
1 cell + + +
2 cell ADO + +
2 cell ADO + +
3 cells + + +
1 cell + + +
1 cell - - -
1 cell ADO + +
1 cell ADO + +
2 cell - - -
2 cell - - -
3 cell ADO + +
1 cell ADO + +
1 cell - + +
1 cell - + +
1 cell + + +
1 cell - - -
1 cell ADO + +
ADO = allele dropout, only one of the two alleles amplified. * - did not use 
additive buffer. (+) represents PCR positive amplification, (-) indicates no PCR 
amplification. Blank spaces indicate that those loci were not tested on that cell.
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Mg2+, 0.1% (v/v) Triton X-100 and 0.01% (w/v) gelatin, 2.5 units Amplitaq 
polymerase. After an initial denaturation of 5 minutes at 96°C, cycling ensued at 
94°C for 1 minute, 30°C for 1.5 minute, then 72°C for three minutes for 8 cycles. 
This was followed by 50 cycles of 94°C for 1 minute, 62°C for 1 minute, then 
72°C for three minutes. Samples were then cooled to 4°C and held at that 
temperature if assayed immediately or stored long-term at 20°C.
7.2 Results for Specific Aim # 4
Initially, 20 cells per reaction tube (n=10 replicates) were subjected to 
MDA to determine the reproducibility and reliability of the technique. The samples 
were subsequently analyzed by PCR for the seven different loci. Those results 
are listed in Table XIII. All 10/10 (100%) showed PCR amplification after MDA, 
demonstrating that the MDA reaction was successful at the 20-cell level of 
sensitivity. Additionally, seven loci amplified for each of the 10 replicates (100%), 
demonstrating that multiple areas of the genome were successfully amplified 
(Figure 13).
Three replicates of 10 cells per reaction tube were subjected to MDA and 
analyzed by PCR. All samples successfully amplified at all loci tested as 
indicated in Table XIV. Subsequently 8,6, or 4 cells respectively were subjected 
to MDA, and those demonstrated PCR amplification as well. Results of single cell 
amplification were sporadic and only occurred in 11/16 cells (69%). Allele drop­
out was seen in 6/11 of the amplified single cells.
DNA Quantitation
Representative samples post amplification were quantified using the Pico 
Green Kit. Values for single cells ranged from 2-3.4pg.
Microarravs
Microarray experiments are listed in Table XV with comments on the 
hybridization results (Figure 14). After poor hybridization results following the 
initial hybridization temperature of 65°C (Microarrays 1 and 2), DNA from an 
outside source (MCF7 breast cancer cell line from Dr. Tim Bos of Eastern 
Virginia Medical School) was used to confirm the labeling and hybridization 
technique. After successful amplification at 37°C, a comparison study was
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Figure 13. Representative gel of PCR amplification after multiple displacement 
amplification (MDA). Six single cell replicates for four different loci from each cell 
are represented (cystic fibrosis, chromosome 7, zinc finger region of X/Y 
chromosome, sickle cell, (i-globin of chromosome 11). An additional restriction 
enzyme digest of the ZFX/Y product (not shown here) will determine the 
presence of the Y chromosome.
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Figure 14. Microarray resuits. Portions of microarray images illustrating poor 
quality (A) versus good quality (B) hybridization. Both image A and B are 
composite images of both dyes. Both images illustrate three grids -  10 rows and 
12 columns. In poor quality hybridizations, few spots are recognizable and there 
is higher background outside the spots. In good quality hybridizations, the 
majority of spots are recognized. Some spots are intentionally blank.



















Enzyme Purpose of Expts and comments Hybridization01
1 65° Cy3/5 5 cells s/p MDA Dpnl 20units Proof of concept
Increase enzyme for smaller DNA
Poor
Poor
2 65° Cy3/5 5 cells s/p MDA Dpnl 40units fragments
3 37° Cy3/5 genomic s/p MDA Dpnl/EcoR1 20units Increase enzyme;change hyb temp, 
use of 'proven' DNA, no WGA,
Some
Poor
4 65° Cy 5 MCF7 DNA 5 ug Dpnl/EcoR1 20units compare hyb temp
use of 'proven' DNA, no WGA, Good
5 37° Cy 5 MCF7 DNA 5 ug Dpnl/EcoR1 20units compare hyb temp
optimized conditions, 2 dyes, proven Good
6 37° Cy 3/5 Bos DNA 5 ug Dpnl/EcoR1 20units DNA
optimized conditions with 10 cells, Weak
7 37° Cy 3 10 cells s/p MDA Dpnl/EcoR1 20units MDA, 1 dye
optimized conditions, 1 cell, MDA, 1 Weak
8 37° Cy 3 1 cell MDA 2ug Dpnl/EcoR1 20units dye
optimized conditions, 1 cell, MDA ,2 Some
9 37° Cy3/5 1 cell each 3ug Dpnl/EcoR1 20units dyes, cells combined/split 
optimized conditions, 1 cell, MDA ,2 Poor
10 37° Cy 3/5 1 cell each 2.4ug Dpnl/EcoR1 20units dyes, cells combined/split


















Enzyme Purpose of Expts and comments Hybridization21
12 37° 546/647 1 cell each 3.4pg Dpnl/EcoR1 20units Repeat above -  strong Strong
hybridization
13 37° 546/647 1 ceil 3.4 ug/ Dpnl/EcoR1 20units Test 'neg' MDA Sample- strong
MDA neg Negative -  strong
14 37° 546/647 DOP 10 cell/ Dpnl/EcoR1 20units Compare DOP with MDA DOP-strong
DOP neg Negative -none
15 37° 546/647 PEP 5 cell Dpnl/EcoR1 20units Test PEP cells None
each - 1ug no hybridization
aHyb temp = Hybridization temperature, bDyes = dyes in labeling Cy 3/Cy5 or Alexa Fluor 546/Alexa Fluor647, CDNA 
type/quant -  cells were lymphocytes at the quantity indicated except for the MCF7 DNA, which was proven hybridizable 
DNA from a cancer line, dExamples of'poor' and 'good' quality hybridizations are shown in Figure 17.
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performed at 37°C and 65°C. The 65°C array was initially chosen based on 
other Array-CGH protocols. However, no hybridization occurred at 65°C in our 
studies so the lower stringency of the 37°C was used, resulting in successful 
hybridization. Subsequent experiments were performed at 37°C.
Concurrently, the amount of restriction enzyme used to cut the post-WGA 
fragments was increased. Poor hybridization was seen after the initial use of 20 
units of Dpnl; that amount was doubled with no improvement of results. 
Subsequently, an additional restriction enzyme, 20 units of EcoRI was added at 
the time when other variables were changed as well. With successful 
hybridization results, both enzymes were used for the remaining experiments.
After these initial changes in experimental conditions, the use of MDA 
cells continued as in Microarray 7. Two samples were combined and equally split 
so that there would not be variation from sample to sample. For example, a 
single cell sample and a single cell sample were combined, the DNA measured, 
then the sample was equally split and labeled separately. Those arrays still 
exhibited weak or minimal hybridization.
Next, the Alexa Fluor dyes were used for the labeling process instead of 
the Cy dyes. Microarrays 11 and 12 exhibited strong hybridization signals.
Non-specific DNA is generated after MDA that had minimal amounts of 
starting template due to the random primers that are available in the reaction to 
amplify fragments of DNA. To test the impact of the non-specific amplification, a 
reaction tube that contained only reagents and no template DNA was subjected 
to MDA. This 'negative' sample was subsequently assayed by PCR and yielded 
no PCR amplification in the seven loci tested. However, due to the nature of DNA 
fragments on the microarray, a test was designed to determine if the non-specific 
DNA interfered with hybridization. Microarray 13 (Figure 15) shows the results 
when a single cell post-MDA was labeled with Alexa 546 and the MDA negative 
control were labeled with Alexa 647. Both the sample and the negative control 
showed hybridization, indicating that the negative DNA samples did indeed 
hybridize to the microarray slide.
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Figure 15. Microarray experiment with Alexa Fluor Dyes. Composite photo of 
the microarray results in experiment 13 after multiple displacement amplification 
(MDA). The single cell sample post- MDA is labeled with Alexa Fluor 546 while 
the sample subjected MDA without added DNA (MDA negative) is labeled with 
Alexa Fluor 647. There is a composite from both dyes even though the MDA 
negative contained no template DNA. This demonstrates the hybridization of 
non-specific DNA generated from the MDA process.
Figure 16. Composite of Microarray 14 with samples from Degenerate 
Oligonucleotide Primers (DOP). A ten-cell sample was labeled with Alexa Fluor 
546 while a DOP negative containing no template DNA was labeled with Alexa 
Fluor 647. In contrast to the sample without starting template (negative) after 
MDA in Figure 15, no hybridization was seen with the DOP negative and the 
composite to be of uniform color. These results suggest that DOP-generated 
products may have a use for future microarray experiments.
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Figure 17. A composite of microarray 15 after single cells were exposed to 
primer extension preamplification (PEP). It is difficult to determine where the 
spots of the array begin due to the increased background intensity. These results 
suggest that PEP by itself is insufficient to generate enough DNA for 
hybridization.
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N/A N/A 60pl 5/10 = 50% N/A
4 cycles 10 hours 5pl 60jnl N/A 0/5 = 0%
4 cycles 10 hours 5pl 30pl N/A 0/5 = 0%
4 cycles 12 hours 5pl 60pl 1/3 = 33% 0/3 = 0%
4 cycles 12 hours 5jxl 30pl 0/3=0% 0/3=0%
10 cycles 10 hours 1pl 60pl 3/5 = 60% 0/5 = 0%
50 cycles 10 hours 5pl 60pl 3/3 = 100% 0/3=0%
N/A = not applicable.
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To determine if the negative sample hybridization was an artifact of the 
actual MDA process, a similar experiment was conducted with a sample using 
DOP-generated DNA and a DOP negative. Microarray 14 (Figure 16) 
demonstrates that the DOP sample hybridized with strong signals while the DOP 
negative did not, indicating that the artifact was probably generated from the 
MDA process.
Non-specific DNA presumably does not interfere with larger quantities of 
starting template in the MDA process since the majority of the reagents will have 
template to react with. To compensate for the effect of the non-specific DNA, 
experiments were designed that involved the use of PEP to initially produce 
several starting copies of the single cell template prior to the initiation of MDA.
Previous experiments demonstrated the effective use of PEP. Microarray 
15 (Figure 17) shows the results of using cells after PEP for the microarray 
hybridization. No hybridization was seen. The results of those experiments are in 
Table XVI. No subsequent PCR amplification was seen in these combination 
experiments.
7.3 Discussion for Specific Aim # 4
Cytogenetic techniques allow for the assessment of chromosome 
numbers. Classical techniques of karyotyping have given way to newer 
techniques such as FISH and CGH. These techniques have been used 
successfully to diagnose certain chromosomal aneuploidies in oocytes and 
embryos (Delhanty et al., 1993; Munne et a!., 1998b; Verlinsky et a l, 1998;
Wilton et al., 2001, Wells and Delhanty, 2000). FISH is limited to analysis of a 
small number of chromosomes (Delhanty et al., 1993; Munne et al., 1998b; 
Verlinsky et al., 1998). Interpretation of results can be difficult due to signal 
overlap or loss of hybridization signals (Wells and Delhanty, 2000). A major 
limitation of CGH is that the technique takes almost 72 hours to complete and 
requires the use of metaphase chromosomes. (Wilton et a/.,2001; Wells and 
Delhanty, 2000). Microarray technology (array CGH) is emerging as another 
molecular technique that can be used to assess chromosome number. Array 
CGH can detect all chromosomes, is easier to perform than conventional CGH,
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and does not require metaphase cells (Oostlander et al., 2004). The purpose of 
this study was to determine if array CGH can be used to assess chromosome 
number in single cells. The work is ongoing as techniques are continually 
evaluated.
Initially, the focus of these experiments was to identify a WGA strategy 
that would provide an adequate amount of DNA for hybridization in array CGH. 
MDA appeared to be an attractive WGA technique because it is a simple 
isothermal reaction and reported to amplify up to 35pg quantities of the genome 
from a single cell (Handyside et al., 2004; Hellani et al., 2004). Our quantitation 
results from a single cell were approximately ten times less than those reports 
although still ample amounts to be used in array CGH. Additionally, our results in 
single cells were inconsistent, and amplification was seen less than 70% of the 
time with half of the cells showing absence of one allele. The reasons that these 
results differ from those of other investigators are unclear. One possible 
explanation is that there could be DNA degradation in the lymphoblast samples 
that were used in these experiments. Another possible explanation is that, 
although our protocols and those of Handyside et a/.(2004) and Hellani et al. 
(2004) all use the MDA technique with 029 polymerase, our laboratory used a 
different commercially available kit (GenomiPhi™, Amersham Biosciences) than 
did other researchers (Repli-G™, Molecular Staging). The differences between 
these kits are not known since information regarding reagent concentrations and 
quantities is proprietary. The GenomiPhi™ kit was the only kit available when 
these studies were initiated, and Repli-G™ was primarily available overseas 
where the other studies were conducted. Repli-G™ is now widely available in the 
United States, and trials in our laboratory using that kit for MDA are in progress. 
Additionally, 029  polymerase is now commercially available without purchasing 
the corresponding reagents. This would allow for more flexibility in optimization 
trials. However, the essential components of the reaction will need to be 
determined by trial and error; there is little information in the literature to 
determine the foundation for MDA protocols outside the use of supplied kit 
reagents.
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Nonetheless, even with our WGA results, many of the initial experiments 
were deemed proof-of-concept that there were adequate quantities of DNA in 
samples that did amplify post-MDA to continue to the array CGH phase. There 
were no published protocols for the use of array CGH in single cells at the time 
these experiments were initiated so the knowledge of optimal conditions was 
limited. Microarrays can cost hundreds of dollars and contain hundreds to 
thousands of gene sequences. In addition to cost, the choice of arrays to use in 
initial experiments was made based on the reputation and results of the providing 
institution. Literature searches provide array CGH protocols with 65°C 
hybridization temperatures. That appeared to be a foundation for the protocol 
here since higher temperatures translated into higher stringencies; single cell 
analysis most certainly requires higher stringencies. However, after two 
experiments with poor hybridization results, the hybridization temperature was 
changed to 37°C, in accordance with the manufacturer's protocols that were for 
standard microarray and not array CGH. Some hybridization signals were seen 
at the lower temperature; this prompted a side-by-side temperature comparison 
at 37°C and 65°C of two arrays that contained aliquots of the same labeled 
sample. In those results, the 37°C exhibited stronger hybridization signals and 
was used from that point forward. The 37°C temperature theoretically decreases 
the stringency of the reaction; further optimization experiments will determine if 
this change has compromised the results and could be the cause of non-specific 
binding.
Concurrent with the hybridization temperature change was the addition of 
another restriction enzyme to cut the post-MDA product. MDA products can be 
as large as 10 kb while the microarray slides are spotted with cDNA fragments 
that are generally less than 1 kb. A restriction enzyme is used after MDA to 
randomly reduce the size of the fragments so that the MDA products are 
theoretically not larger than the target DNA on the slide. Initially, Dpnl was 
chosen as the restriction enzyme for these experiments. Dpnl recognizes the 
sequence GATC and is thus called a '4-cutter', that is, there is a one in 4 chance 
that a particular nucleotide will be in a specific position in a DNA sequence and
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this enzyme recognized 4 nucleotides. Theoretically, this sequence should 
appear once every 44 or every 256 bases. Four-cutters are used to produce 
many small fragments of DNA (Lucito et al., 1998). The first microarray in our 
experiments did not hybridize. It was not certain if enough restriction enzyme was 
used and the DNA fragments were still too large. Therefore, the amount was 
doubled for the next experiment. After another poor hybridization, the 
hybridization temperature was changed; concurrently another restriction enzyme, 
EcoRI, was added. EcoRI recognizes the sequence GAATTC and is therefore a 
6-cutter. Theoretically, the recognized sequence should be present every 46 
times or every 4096 bases and would produce larger fragments than the Dpnl. 
However, it is possible the Dpnl may actually 'over' cut the sample and cut 
essential sequences that recognize the target DNA on the array. Since the 
addition of the EcoRI enzyme occurred in the same successful hybridization 
experiment as the temperature change, it is not known if the effect was a result of 
the temperature change or the new enzyme. This could easily be ascertained by 
reverting to one and then subsequently the other previously used method of 
enzyme and temperature; these experiments should be performed in the future.
There are many variables in experimental conditions that could also affect 
the results including the labeling procedure. The next set of experiments used 
DNA from a MCF7 cancer cell that has been successfully hybridized to other 
microarrays containing suspected cancer genes. This experiment was conducted 
to ascertain if the labeling and hybridization conditions were sufficient to produce 
strong hybridization signals and demonstrated that the techniques were 
successful for at least 5pg DNA. However, less than 5pg DNA was obtained from 
our single cells. The next several attempts at array analysis with similar 
conditions using the known cell line did not have consistent results and 
hybridizations were weak for the most part. This prompted the switch from the Cy 
dyes to the Alexa Fluor dyes since the Alexa Fluor dyes are much more efficient 
at labeling and showed higher fluorescent intensity than the Cy dyes (Berlier et 
al., 2003). From that point on, strong hybridization signals were seen. This may 
be due to the lower resistance to photobleaching seen in the Alexa Fluors. This is
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the first report of the use of Alexa Fluors in single cell analysis. Further 
optimization could determine if stronger hybridizations will contribute to their 
future use as a preferred dye for labeling.
Phi-29 polymerase is a robust enzyme that can yield higher quantities of 
DNA than the standard WGA techniques of PEP or DOP and can provide reliable 
representation of the genome (Hosono et al., 2003). Our results support those 
findings as demonstrated by the microgram quantities recovered and by the 
ability to amplify at least seven loci from a single sample. However, one limitation 
of the robust <1>29 is that the enzymatic reaction can create non-specific DNA 
products. These are products that randomly amplify segments of bases, even if 
no starting template is added to the reaction, due to excess polymerase and 
dNTPs in the reaction. Short sequences of DNA can be created that are not 
complementary to any specific gene sequence. Low quantities of starting 
template could theoretically promote the generation of the non-specific 
sequences since there is little template for the reagents to bind to in the initial 
phase of the amplification. This does not interfere with subsequent PCR 
reactions as evidenced by the lack of PCR amplification. However, there was a 
possibility that these sequences would hybridize to the microarray, especially 
after restriction enzyme digest into smaller fragments that could anneal to the 
DNA targets on the array. An experiment was conducted that demonstrated 
these samples could in fact hybridize to the arrays and thus could invalidate the 
microarray results by not being able to differentiate between hybridization of true 
DNA versus non-specific DNA.
To answer the question if the non-specific hybridization was an artifact of 
the MDA technique versus other WGA techniques, samples that were amplified 
with either PEP or DOP (as the sole WGA) were labeled and hybridized to the 
array along with a negative control exposed to the respective WGA procedure 
that showed no PCR amplification (Figure 16). The PEP samples showed poor 
hybridization results; this was thought to be due to the low overall quantity of 
DNA that was less than 1fig. The DOP-amplified sample did show strong 
hybridization signals while the DOP-negative (no template DNA) did not. These
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results suggest that the hybridization of non-specific DNA seen after MDA may 
indeed be an artifact of the MDA technique and not of other WGA methods. With 
a larger template, MDA generally provides a higher representation of the 
genome, but due to the non-specific nature of the low-copy template 
amplifications, further research into the use of DOP as an alternative WGA 
technique may be warranted.
The possibility that the excess hybridization was an artifact of the stronger 
Alexa Fluor dyes was successfully minimized since the negative DOP samples 
did not hybrid even when labeled with one Alexa Fluor while the DNA-containing 
sample demonstrated strong hybridization signals. There is little scientific basis 
to suggest that the dyes could be a cause of non-specific hybridization, but the 
possibility of that occurring could concomitantly be ruled out nonetheless.
In attempts to overcome the creation of non-specific DNA, several cycles 
of PEP were attempted and an aliquot was removed, then subjected to MDA.
This was performed to enable the MDA reaction to begin with higher quantities of 
template DNA than what would be otherwise initially limited from a single cell. 
With the higher quantity of DNA in the starting MDA reaction, it was surmised 
that less non-specific DNA would be amplified since there is more target 
available for the 029 polymerase to anneal to. Unfortunately, the initial attempts 
at amplifying DNA with PEP then MDA failed to demonstrate subsequent PCR 
amplification at the attempted volumes and concentrations. The reason for failure 
could be as simple as sub-optimal reaction conditions since there are many 
variables in both reactions that must be compensated for including differences in 
reaction volumes, concentration of reagents, and cycling conditions. Both PEP 
and MDA use an alkaline lysis method for template preparation. The PEP 
product was not subjected to further lysis since those components will remain in 
the aliquot used for MDA. Excess reagent conditions such as potassium and 
magnesium can lower amplification efficiencies (Rolfs et al., 1992). It is difficult to 
ascertain reagent concentrations due to the proprietary nature of the MDA kit; 
reagent concentrations cannot be adjusted accordingly to identify optimal 
conditions. PCR clean-up kits such as the QiaQuick kits that are used after a
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complete MDA might have a role in optimization. PCR purification kits remove 
components less than 100 bp while recovering 90-95% of the DNA. This could 
remove any remaining random hexamers from the PEP reaction, but would not 
be effective for removing other reagents in the reaction. Further investigations 
into optimization of these variables are warranted as well.
Microarray containing spotted oligonucleotides or bacterial artificial 
chromosomes (BAC) are also available. Although oligo arrays have the 
advantage of also providing genotyping data as well as DNA copy number (which 
could be advantageous in PGD cycles), they appear to have a higher degree of 
variability than do the BAC arrays; accurate genotyping has been reported while 
changes in chromosome number were not reliably detected which may rule out 
their use in our aneuploidy research (Bignell et al., 2004). BAC array CGH is an 
alternative to the cDNA arrays as BAC clones are becoming more widely 
available (Cheung et al., 2001). Genomic DNA can be cloned in BAC vectors 
and spotted onto arrays; the BAC clones serve as a more stable environment for 
large fragments of DNA (Shizuya et al., 1992). The preparation of the BACs can 
be problematic since BAC cultures yield very low quantities of DNA. Additionally, 
it is difficult to maintain ample concentration of DNA to spot the array (Snidjers et 
al., 2001). Once these obstacles are overcome, the BAC arrays yield more 
intense signals and are superior over the cDNAs at detecting single chromosome 
gains and losses (Segraves et al., 2003; Guillaud-Bataille et al., 2004). As a 
supplement to the experiments here, two attempts were made at BAC array 
hybridization; no signal was detected (data not shown). Although the 
manufacturer recommends sophisticated hybridization stations that are not 
currently available at our facility, further study is warranted to optimize the 
conditions for the use of BAC arrays.
7.4 Conclusions for Specific Aim # 4
These experiments in Specific Aim # 4 lay the foundation for future 
experiments as suggested above to continue optimization of the use of 
microarrays for single cell analysis. From the results obtained, several 
conclusions can be drawn:
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1) MDA can generate microgram quantities of DNA from a single cell
2) Alexa Fluor dyes can be used to produce strong microarray 
hybridizations
3) DOP may be a substitute for MDA as the WGA prior to microarray 
analysis
It appears that post-MDA samples are not optimized at this time for microarray 
analysis due to the generation of non-specific products. However, the larger 
quantities of DNA may have other applications that would allow for multiple loci to 
be analyzed from a single sample. This could include experiments for DNA 
fingerprinting or sequence analysis, which require large amounts of starting DNA 
(Fiorentino et al., 2004).




PGD is an option that allows at-risk couples to have their embryos 
evaluated for genetic diseases prior to the establishment of pregnancy. The 
adaptation of PCR methodologies to amplify DNA from a single-cell has resulted 
in limitations of sensitivity and specificity for a technique that was designed for 
larger amounts of starting template. The studies presented in this dissertation are 
part of an ongoing process to evaluate the sensitivity and specificity, and 
optimize single cell diagnosis. Reproducible and reliable single cell diagnoses 
can be achieved, and the limitations can be overcome. The development of these 
methodologies can be costly and time-consuming, but are of the utmost 
importance for a clinic offering the technology of PGD. The knowledge gained 
from these studies has contributed both to the direction of research and clinical 
applications in the field.
From these experiments, the following conclusions were made:
Specific Aim #1: The process of whole genome amplification and subsequent 
PCR testing can be performed as a means of rescuing samples that previously 
failed to amplify in initial tests of PCR. The time involved to perform these tests 
limits the use of the PEP protocol initially, but the method still can serve as an 
alternative if amplification fails and the genetic status of the embryo is not known. 
This could abrogate the need to re-biopsy the embryo since an additional non- 
invasive technique is used to obtain the genetic answer. In addition, these 
studies laid the foundation for the clinical application of a reamplification 
procedure assessing a different genetic locus that resulted in the embryo transfer 
of male embryos whose previous genetic status was unknown in an at-risk X- 
linked carrier. The studies of Specific Aim #1 introduced a novel method to 
achieve a genetic diagnosis from previous amplification failure in a single cell 
(Gibbons et al., 1995b). The techniques have been applied to embryos about 
which little was previously known in order to provide further genetic information.
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Specific Aim #2: Different lysis techniques can affect both the sensitivity and 
specificity of single cell diagnosis. The KOH lysis method produced a 
significantly higher rate of amplification and higher accuracy when compared with 
the other methods tested. Using this method, there was no statistical difference 
in amplification rate and diagnostic accuracy when testing one versus two cells. 
These studies also demonstrated the importance of optimizing the PCR 
conditions by evaluating heterozygous cells that contain both alleles so that the 
incidence of ADO can be assessed. The study for Specific Aim # 2 was one of 
the first and certainly the most comprehensive study investigating different lysis 
buffers and their effect on sensitivity and specificity of single cell analysis. Most 
PGD clinics today use the alkaline lysis buffer protocol and have referenced 
these studies (Gitlin etal., 1996).
Specific Aim #3: This set of studies demonstrated the importance of biopsying a 
blastomere with a visible nucleus. The integrity of the blastomere membrane or 
the integrity of the cytoplasm itself does not affect the amplification results if the 
nucleus and nuclear membrane remains intact. The studies for Specific Aim # 3 
have provided insight to the optimal blastomere morphology for the improved 
chances of successful amplification (Gitlin et al., 1997). Blastomere morphology 
continues to be the preferred method for blastomere selection prior to biopsy. 
Specific Aim # 4 : From the results obtained, several conclusions can be drawn:
1) MDA can generate microgram quantities of DNA from a single cell
2) Alexa Fluor dyes can be used to produce strong microarray hybridizations
3) DOP may be a substitute for MDA as the WGA prior to microarray analysis
The experiments for Specific Aim # 4, though preliminary, lay the 
foundation for future experiments as the field of detecting chromosome number 
expands to include the use of array CGH.
The technology used in PGD is rapidly evolving. New gene sequences 
and mutation analyses will increase the repertoire of conditions that can be 
diagnosed. With continuing studies to optimize sensitivity and specificity, one 
could imagine the future ability to obtain a complete chromosome or genetic 
profile from a single cell using microarray technology. Other advances could be
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in the direction of stem cell research and/ or gene therapy. Currently embryos 
that are diagnosed as affected are not transferred to the uterus. Most couples 
discard those embryos although some elect to have them cryopreserved in the 
event that future technology may enable their transfer to initiate a pregnancy. 
Technologies for gene therapy and/or embryonic stem cells may provide a 
promising role in the study of human diseases and the possibility to actual correct 
the cause of these devastating medical conditions.
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Molecule Name: TAY SACKS 11 494 BPS Report Date: 0 2 /0 5 /0 5
PCR Primer Design Report
---- L E F T  P R I M E R  - — --    -■---------------
S p e n c e  : 5 ’ -GCCAGACACAATCATACAGG - 3 *
Length: 20 Bp-pOS: 21K3C: SO; Tm C: 66; Cofflposition: A:8 C:6 <3:4 T:2
Criteria: I GC: Min 45, Max 55; Tm C: Min 55, Max 80
Energy cutoff: 0 ,0  keal; Reject runs »« 3 basesMeets criteria selected; YES
      - — — .                R I G H T  P R I M E R  - —
Sequence: S’- CAACmCAGTCTGGTGATGG- 3 '
Length: 20 Bp-pos: 388%GC: 50; Tm C: 67; Composition: A:6 C:4 G:6 tT:4
Criteria: % GC: Min 45, Max 55; Tm C: Min 55, Max 80
Energy cutoff: 0-0 keal; Reject runs >= 3 bases
Meets criteria selected: YES
Primer Balance: Left Right Comment
Length 2:0 20% SC 50 50
Tm C m 67 1C difference
Primer Cautions: Left Right
3 or more S or C at 3* end SO NORuns of bases wo NO {see criteria forSecondary structure wo NO (primers, above
Primer interactions:






Figure 18. Primer design report. Primer design reports are software generated 
after sequence and preference input, in this case for Tay-Sachs disease.
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APPENDIX A (continued)
Largest Duplexes reported in Primer Interactions
Priffier-Mmers with 3* end involvement:
Left:Left:l s • -G e c m & c h c m 'm & 'r& c m G -i ’
L 3 ’ - SGAC&mCTAACACAGACCG - 3'
Right:Right:
R 51 -CMCAaCAGTClSeTCATOG- 3 '
R 3 ' -G@mGTGGT^3WmcmC-S *
Left:Right:L 5'-GCCAGACACAATCATACAGG-31
R 3 ' -GGTAGlGGTCTOftCMCAAC-- 5 ■
Other Primer-Mmera:
Left:Left:
L 51 -GCCAGAChCAATCATACAGG-3’ 
L 3’-GGACATACTAACACAGACCG-S’
Right:Right:R 5 * -CAACAACAGTCTCGTGATGG-31
R 3 * - GGTAGTCG'TCreACMCAAC- 5 *
Left slight:
L 5' -GCCaGACACM.TCI.TACftSG-3'
R 3 > -S®raflTCGTcisft.CA&CAAC- 5 ’




As a complement to the experiments reported here in this dissertation, 
extraneous DNA contamination was simulated by adding genomic DNA into PCR 
reaction tubes containing 60pL sterile water overlaid with oil (Gitlin and Gibbons, 
1995). Tubes were placed in 4 typical PCR lab settings under conditions of timed 
exposure to UV germicidal lighting at 254nm: 1) bench top
2) microcentrifuge tube rack (tubes were placed in rack as normal)
3) inside a glass beaker, closed with aluminum foil (used for sterilization)
4) inside a plastic beaker (used for storage). Tubes were removed from UV 
exposure after 10, 20, 30, 60, 90, 210 minutes and 14,18 hours (simulating 
overnight irradiation). Ten or twenty tubes were assigned to each datum point 
although some data points were not collected if the results were anticipated to be 
repetitive. After exposure, all samples along with non-exposed control tubes 
were analyzed for a known DNA sequence by nested PCR for greater sensitivity. 
PCR was carried out as previously described in the Materials and Methods 
section. Fisher's exact statistical test was used to compare results of 
amplification for the different genes used. The computer program GRAPHPAD 
INSTAT (Graphpad Software, San Diego, CA) was used to assist in analysis.
Results for the UV light exposure studies are shown in Table XVII and 
Figure 19. All non-exposed control samples (n=20) demonstrated amplification 
at all time durations as expected. A decrease in amplification rates was seen in 
the bench top specimens in as little as 10 minutes after UV exposure. Even 
though 75% of the samples amplified, the decrease over the 100% amplification 
rate of the controls was still significant (P = 0.0471). A 30-minute exposure 
completely eliminated PCR amplification in the bench top samples.
Thirty-minute exposure was not sufficient to irradiate the DNA from PCR 
tubes that were in a housed in a PCR rack or glass beaker. However, PCR tubes 
that were in a plastic beaker for 30 minutes began to display the significant
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APPENDIX B (continued)
effects of UV irradiation and only 40% of those displayed PCR amplification (P = 
0.004). It required more than one hour for samples held in the PCR rack to 
exhibit the effects of the UV exposure. At one hour, there was 100% 
amplification while after a three hour, thirty minute exposure, there was a slight, 
but not significant decrease in amplification rates to 85%. Significance was 
achieved after a longer exposure that ranged between 3.5 hours to 14 hours. At 
14 hours (simulating overnight exposure), the samples in the PCR rack amplified 
at a significantly lower rate than the non-exposed controls (20% versus 100% 
respectively, P<0.001).
The DNA samples in PCR tubes housed in a glass beaker did not show a 
decrease in amplification rates, even after an 18-hour exposure.
These studies were undertaken to minimize the risk of contaminating 
DNA. From this set of studies, we conclude that a 30-minute exposure to 
ultraviolet irradiation is sufficient to decontaminate most bench top and other 
surfaces in the PCR lab. However, caution must be exercised when relying on 
UV irradiation, as some laboratory settings will not be affected. The inability of 
the UV radiation to penetrate glass should be considered when storing sterile 
tubes and reagents in these types of containers.
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of Sample on 
Benchtop
Amplification 
of Sample in 
Plastic Beaker
Amplification 
of Sample in 
PCR rack
Amplification 




10 minutes 15/20a (75%) N/A N/A N/A
20 minutes 9/20 (45%) N/A N/A N/A
30 minutes 0/ 1 0 (0%) 4/10b (40%) N/A N/A
1 hour N/A 4/20 (20%) 10/ 10° (100%) 10/ 108 (100%)
1.5 hours N/A 7/20 (35%) 10/ 1 0 (100%) 10/1 0 (100%)
3.5 hours N/A 3/20 (15%) 17/20 (85%) 10/10 (100%)
14.5 hours N/A 0/ 1 0 (0%) 2/ 10d (20%) 10/1 0 (100%)
18 hours N/A 0/ 1 0 (0%) 3/10(30% ) 10/ 10e (100%)
a P = 0.0471. 
bP =  0.004.
c,eno significant difference. 
d P <0.001.
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Table XVIII. Basic guidelines for quality control
• Perform Pre- and post- PCR in separate rooms.
• Maintain sterile/DNA-free techniques.
• All reagents should be aliquoted for single-use where possible.
• Centrifuge aliquots prior to use and use microcentrifuge tube opener.
• Wear caps, masks, gloves. Change Often
• Restrict PCR laboratory access to minimize traffic.
• Autoclave and filter water, buffer, oil, etc.
• Designate aliquoted reagents for clinical use.
• Randomly test in PCR.
• Use forceps to handle tubes, use lid openers, etc.
• Use positive displacement pipettes or use aerosol resistant tips with 
standard pipettors
• Clean and decontaminate lab surfaces, instruments, racks, etc. with 10% 
bleach or UV lights.
• Use underpads or liners on benchtop surfaces for easier containment and 
clean-up.
• Save remaining aliquots of all materials for reference.













Hours of UV Exposure
benchtop - A -  plastic —i— rack - s — glass
Figure 19. The effect of Ultraviolet irradiation. Reaction tubes containing DNA 
were placed in four common PCR lab settings and time-exposed to UV lights 
mounted 18 inches above.




The materials and methods section for each set of experiments lists the 
statistical method that was applied for data analysis. The P  value is the 
probability that a study will show a statistical significance when no real difference 
exists (Dawson and Trapp 2004). This is known as a type I error -  that a true 
null hypothesis (the hypothesis being tested) is rejected or that a difference is 
detected when a difference does not truly exist. A P value less than 0.05 means 
that there is less than a 5% chance of a type I error -  that the results show a 
false statistical difference. Thus, the lower the P value, the greater the statistical 
significance.
Another aspect of experimental design is power analysis, or the 
determination of the ability of the statistical test to an actual difference of effect 
(Dawson and Trapp 2004). This is in relation to a Type II error -  a false null 
hypothesis is not rejected or a difference is concluded when a difference does 
not exist. The power is calculated as (1 minus a type II error, or 1-p). This 
relates to the number of samples needed to detect a statistical significance when 
one truly does exist.
The main statistical test used in this dissertation is Fisher's exact test. This 
is used when the sample size is too small for the Chi-Square analysis. An 
explanation of both follows. It was Ronald Aylmer Fisher in 1922 that defined 
three fundamental issues of statistics:
1) specification of the kind of population that the data came from
2) estimation (choice of the method to calculate)
3) distribution (Fisher 1925).
Fisher arranged experiments into sub-experiments that differ from each other by 
several factors, treatments, or other variables. The differences could then be 
detected by statistical outcomes; this advance allowed for greater flexibility in 
experimental design and allowed for more than one experimental variation rather
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than the inefficient existing approach at the time of only varying one technique at 
a time.
Chi-Square is used to test the hypothesis that all classifications or factors 
have the same level of frequency or distribution (Armitage 1994). Chi-Square 
tests are appropriate for actual numbers of occurrences, not on percentages, 
proportions, means of observations, or other derived statistics (Swinscow 1997). 
This is one reason why Chi-Square (and Fisher's exact test) are the most 
suitable for statistical computation here. Chi Square is an approximate and 
versatile test in that it does not matter how a question is stated -  it measures the 
observed versus the expected frequency. Although most statistical computations 
are now calculated by computer software packages, the calculation for Chi- 
square (x2) is listed in Equation 6.
X2(df) = S (Observed frequencv-Expected frequency)2 (6)
Expected frequency
df=  degrees of freedom, calculated as df=  (r-1 )(c-1), the number of rows minus 
one times the number of columns minus one (Dawson and Trapp 2004).
Yates correction may be applied to a 2x2 contingency table (Dawson and 
Trapp 2004). This correction involves subtracting half the difference between the 
observed and expected frequencies before squaring. This makes the x2 value 
smaller. Smaller %2 are attractive because it means that the null hypothesis is 
rejected less often; thus, it is a more conservative test. Going back to the 
definitions, this reduces the chance of a Type I error, although it does increase 
the chance of a type II error.
The following demonstrates a 2x2 contingency table used to calculate if 
there is a difference in a treatment group, as in the dissertation when a different 
lysis method is used. The difference between Chi-Square and Fisher's is 
calculated in Table XIX.
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Table XIX. Example of contingency table for statistical calculation
Amplification No Amplification Total
Control a b 











And Fisher's exact test is:
P = (a+b)!(c+d)!(a+c)!(b+d)l 
alblcldln!
where ! is the symbol for factorial (n-1 )(n-2), etc., (Dawson and Trapp 2004).
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As previously stated, a 2x2 frequency table with small numbers of expected 
frequencies (in case the total number of observations is less than 20) should 
have the statistics calculated differently. Fisher’s exact test should be used rather 
than the Chi-Square. Many times, the computer software will apply the most 
appropriate test when the sample size is in question.
There are other statistical tests that compare two data sets as does the 
Chi-Square and Fisher's exact (Dawson and Trapp 2004). One is the 
Kolmogorov-Smirnov test (KS-test); however, it is not as sensitive. Fisher's exact 
test is more appropriate since it retains more power with small sample sizes.
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LIST OF COMMON ABBREVIATIONS USED
A Adenine
ADO Allele drop-out
BAG Bacteria artificial chromosomes
Bl Boiling
bp Base pair(s)
BSA Bovine serum albumin
C Cytosine
CF Cystic fibrosis
CFTR Cystic fibrosis transmembrane conductor regulator gene
CGH Comparative Genomic Hybridization
DNTP Deoxynucleotide triphosphate
DOP Degenerate oligonucleotide primers
DTT Dithiothreitol
FISH Fluorescent in situ hybridization
G Guanine
H20 Water
ICM Inner cell mass
IVF In vitro fertilization
kb Kilobases
KCI Potassium Chloride
l n 2 Liquid Nitrogen
MDA Multiple displacement amplification




PBI First polar body
PBII Second polar body
PCR Polymerase chain reaction
PEP Primer extension preamplification
PGD Preimplantation genetic diagnosis
SDS Sodium dodecyl sulfate








WGA Whole genome amplification
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